{"81c77f6ea4ad20908978c014fea0abb7d5c557aa": [["Background and epidemiologyCOVID-19 (Coronavirus Disease-2019), a disease caused by the coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading communicable disease affecting more than 100 countries across the globe at present.", [["Coronavirus Disease", "DISEASE", 37, 56], ["Acute Respiratory Syndrome", "DISEASE", 119, 145], ["epidemiologyCOVID-19", "ORGANISM", 15, 35], ["Coronavirus Disease-2019", "ORGANISM", 37, 61], ["coronavirus SARS-CoV-2", "ORGANISM", 88, 110], ["Severe Acute Respiratory", "ORGANISM", 112, 136], ["coronavirus SARS-CoV", "SPECIES", 88, 108], ["SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2", "SPECIES", 100, 159], ["epidemiologyCOVID", "TEST", 15, 32], ["Coronavirus Disease", "PROBLEM", 37, 56], ["a disease", "PROBLEM", 64, 73], ["the coronavirus SARS", "PROBLEM", 84, 104], ["CoV", "TEST", 105, 108], ["Severe Acute Respiratory Syndrome", "PROBLEM", 112, 145], ["Coronavirus", "PROBLEM", 146, 157], ["a rapidly spreading communicable disease", "PROBLEM", 177, 217], ["coronavirus", "OBSERVATION", 88, 99], ["Severe", "OBSERVATION_MODIFIER", 112, 118], ["Acute", "OBSERVATION_MODIFIER", 119, 124], ["Respiratory Syndrome", "OBSERVATION", 125, 145], ["rapidly", "OBSERVATION_MODIFIER", 179, 186], ["spreading", "OBSERVATION_MODIFIER", 187, 196], ["globe", "ANATOMY", 263, 268]]], ["The disease is primarily spread through large respiratory droplets, though the possibility of other routes of transmission cannot be ruled out, as the virus has been found in stool and urine of affected individuals [1] .", [["respiratory droplets", "ANATOMY", 46, 66], ["stool", "ANATOMY", 175, 180], ["urine", "ANATOMY", 185, 190], ["stool", "ORGANISM_SUBSTANCE", 175, 180], ["urine", "ORGANISM_SUBSTANCE", 185, 190], ["The disease", "PROBLEM", 0, 11], ["large respiratory droplets", "PROBLEM", 40, 66], ["the virus", "PROBLEM", 147, 156], ["affected individuals", "PROBLEM", 194, 214], ["disease", "OBSERVATION", 4, 11], ["large", "OBSERVATION_MODIFIER", 40, 45], ["respiratory droplets", "OBSERVATION", 46, 66]]], ["The disease severity has varied from mild self-limiting flu-like illness to fulminant pneumonia, respiratory failure and death.", [["respiratory", "ANATOMY", 97, 108], ["flu-like illness", "DISEASE", 56, 72], ["pneumonia", "DISEASE", 86, 95], ["respiratory failure", "DISEASE", 97, 116], ["death", "DISEASE", 121, 126], ["The disease severity", "PROBLEM", 0, 20], ["mild self-limiting flu-like illness", "PROBLEM", 37, 72], ["fulminant pneumonia", "PROBLEM", 76, 95], ["respiratory failure", "PROBLEM", 97, 116], ["death", "PROBLEM", 121, 126], ["disease", "OBSERVATION", 4, 11], ["mild", "OBSERVATION_MODIFIER", 37, 41], ["self-limiting", "OBSERVATION_MODIFIER", 42, 55], ["flu", "OBSERVATION", 56, 59], ["fulminant", "OBSERVATION_MODIFIER", 76, 85], ["pneumonia", "OBSERVATION", 86, 95], ["respiratory failure", "OBSERVATION", 97, 116]]], ["There are regional variations in the mortality rates and these estimates are rapidly changing as more data are becoming available.", [["regional variations in the mortality rates", "PROBLEM", 10, 52], ["regional", "OBSERVATION_MODIFIER", 10, 18], ["variations", "OBSERVATION_MODIFIER", 19, 29]]], ["There were 95,333 confirmed cases of COVID-19 worldwide with a mortality rate of 3.4% according to the situation report of World Health Organisation on March 5, 2020 [2] .", [["COVID", "DISEASE", 37, 42], ["COVID", "TEST", 37, 42], ["a mortality rate", "TEST", 61, 77]]], ["However, a much lower mortality of 1.4% has been reported in analysis of data of 1099 patients with laboratory-confirmed COVID-19 from 552 hospitals in mainland China [3] .", [["patients", "ORGANISM", 86, 94], ["patients", "SPECIES", 86, 94], ["a much lower mortality", "PROBLEM", 9, 31], ["COVID", "TEST", 121, 126]]], ["Considering that the number of unreported and unconfirmed cases is likely to be much higher than the reported cases, the actual mortality may be less than 1%, which is similar to that of severe seasonal influenza [4] .", [["influenza", "DISEASE", 203, 212], ["severe seasonal influenza", "PROBLEM", 187, 212], ["likely to be", "UNCERTAINTY", 67, 79], ["severe", "OBSERVATION_MODIFIER", 187, 193], ["seasonal", "OBSERVATION_MODIFIER", 194, 202], ["influenza", "OBSERVATION", 203, 212]]], ["The understanding of epidemiological characteristics of this infection is evolving on a daily basis as the disease is spreading to different parts of the globe.Diabetes, respiratory infections and COVID19Individuals with diabetes are at risk of infections, especially influenza and pneumonia.", [["respiratory", "ANATOMY", 170, 181], ["infection", "DISEASE", 61, 70], ["Diabetes", "DISEASE", 160, 168], ["respiratory infections", "DISEASE", 170, 192], ["diabetes", "DISEASE", 221, 229], ["infections", "DISEASE", 245, 255], ["influenza", "DISEASE", 268, 277], ["pneumonia", "DISEASE", 282, 291], ["globe", "ORGAN", 154, 159], ["this infection", "PROBLEM", 56, 70], ["the disease", "PROBLEM", 103, 114], ["Diabetes", "PROBLEM", 160, 168], ["respiratory infections", "PROBLEM", 170, 192], ["COVID19Individuals", "PROBLEM", 197, 215], ["diabetes", "PROBLEM", 221, 229], ["infections", "PROBLEM", 245, 255], ["influenza", "PROBLEM", 268, 277], ["pneumonia", "PROBLEM", 282, 291], ["infection", "OBSERVATION", 61, 70], ["disease", "OBSERVATION", 107, 114], ["globe", "ANATOMY", 154, 159], ["respiratory", "ANATOMY", 170, 181], ["infections", "OBSERVATION", 182, 192], ["diabetes", "OBSERVATION", 221, 229], ["infections", "OBSERVATION", 245, 255], ["influenza", "OBSERVATION", 268, 277], ["pneumonia", "OBSERVATION", 282, 291]]], ["All people with diabetes (above 2 years of age) are recommended pneumococcal and annual influenza vaccinations.", [["diabetes", "DISEASE", 16, 24], ["people", "ORGANISM", 4, 10], ["people", "SPECIES", 4, 10], ["pneumococcal", "SPECIES", 64, 76], ["diabetes", "PROBLEM", 16, 24], ["pneumococcal", "TREATMENT", 64, 76], ["annual influenza vaccinations", "TREATMENT", 81, 110], ["diabetes", "OBSERVATION", 16, 24]]], ["Not only this, patients with diabetes have a severe disease when infected with respiratory viruses.", [["diabetes", "DISEASE", 29, 37], ["respiratory viruses", "DISEASE", 79, 98], ["patients", "ORGANISM", 15, 23], ["patients", "SPECIES", 15, 23], ["diabetes", "PROBLEM", 29, 37], ["a severe disease", "PROBLEM", 43, 59], ["respiratory viruses", "PROBLEM", 79, 98], ["severe", "OBSERVATION_MODIFIER", 45, 51], ["disease", "OBSERVATION", 52, 59], ["respiratory viruses", "OBSERVATION", 79, 98]]], ["Indeed, diabetes was seen as an important risk factor for Data about COVID-19 in patients with diabetes is limited at present.", [["diabetes", "DISEASE", 8, 16], ["diabetes", "DISEASE", 95, 103], ["COVID-19", "GENE_OR_GENE_PRODUCT", 69, 77], ["patients", "ORGANISM", 81, 89], ["patients", "SPECIES", 81, 89], ["diabetes", "PROBLEM", 8, 16], ["COVID", "TEST", 69, 74], ["diabetes", "PROBLEM", 95, 103], ["diabetes", "OBSERVATION", 8, 16]]], ["Diabetes was present in 42.3% of 26 fatalities due to COVID-19 in Wuhan, China [8] .", [["Diabetes", "DISEASE", 0, 8], ["fatalities", "DISEASE", 36, 46], ["COVID-19", "CHEMICAL", 54, 62], ["Diabetes", "PROBLEM", 0, 8], ["COVID", "TEST", 54, 59]]], ["In a study in 140 patients with COVID-19 in Wuhan, China, diabetes was not a risk factor for severe disease course [9] .", [["diabetes", "DISEASE", 58, 66], ["patients", "ORGANISM", 18, 26], ["patients", "SPECIES", 18, 26], ["a study", "TEST", 3, 10], ["COVID", "TEST", 32, 37], ["diabetes", "PROBLEM", 58, 66], ["severe disease course", "PROBLEM", 93, 114]]], ["However, another study in 150 patients (68 deaths and 82 recovered patients) in Wuhan showed that the number of co-morbidities to be a significant predictor of mortality [10] .", [["deaths", "DISEASE", 43, 49], ["patients", "ORGANISM", 30, 38], ["patients", "ORGANISM", 67, 75], ["patients", "SPECIES", 30, 38], ["patients", "SPECIES", 67, 75], ["another study", "TEST", 9, 22]]], ["Analysis of 11 studies regarding laboratory abnormalities in patients with COVID-19 did not mention raised blood glucose or diabetes as predictor of severe disease [11] .", [["blood", "ANATOMY", 107, 112], ["glucose", "CHEMICAL", 113, 120], ["diabetes", "DISEASE", 124, 132], ["COVID-19", "CHEMICAL", 75, 83], ["glucose", "CHEMICAL", 113, 120], ["patients", "ORGANISM", 61, 69], ["blood", "ORGANISM_SUBSTANCE", 107, 112], ["glucose", "SIMPLE_CHEMICAL", 113, 120], ["patients", "SPECIES", 61, 69], ["Analysis of 11 studies", "TEST", 0, 22], ["laboratory abnormalities", "PROBLEM", 33, 57], ["COVID", "TEST", 75, 80], ["raised blood glucose", "PROBLEM", 100, 120], ["diabetes", "PROBLEM", 124, 132], ["severe disease", "PROBLEM", 149, 163], ["severe", "OBSERVATION_MODIFIER", 149, 155]]], ["Notwithstanding these small series, a report of 72,314 cases of COVID-19 published by Chinese Centre for Disease Control and Prevention showed increased mortality in people with diabetes (2.3%, overall and 7.3%, patients with diabetes) [12] .Measures to prevent COVID-19Our knowledge about the prevalence of COVID-19 and disease course in people with diabetes will evolve as more detailed analyses are carried out.", [["diabetes", "DISEASE", 178, 186], ["diabetes", "DISEASE", 226, 234], ["diabetes", "DISEASE", 351, 359], ["people", "ORGANISM", 166, 172], ["patients", "ORGANISM", 212, 220], ["people", "ORGANISM", 339, 345], ["people", "SPECIES", 166, 172], ["patients", "SPECIES", 212, 220], ["people", "SPECIES", 339, 345], ["COVID", "TEST", 64, 69], ["Disease Control", "TREATMENT", 105, 120], ["increased mortality", "PROBLEM", 143, 162], ["diabetes", "PROBLEM", 178, 186], ["diabetes)", "PROBLEM", 226, 235], ["COVID", "TEST", 308, 313], ["diabetes", "PROBLEM", 351, 359], ["small", "OBSERVATION_MODIFIER", 22, 27], ["increased", "OBSERVATION_MODIFIER", 143, 152], ["mortality", "OBSERVATION", 153, 162]]], ["For now, it is reasonable to assume that people with diabetes are at increased risk of developing infection with SARS-CoV-2.", [["diabetes", "DISEASE", 53, 61], ["infection", "DISEASE", 98, 107], ["SARS", "DISEASE", 113, 117], ["people", "ORGANISM", 41, 47], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 113, 123], ["people", "SPECIES", 41, 47], ["SARS-CoV", "SPECIES", 113, 121], ["diabetes", "PROBLEM", 53, 61], ["developing infection", "PROBLEM", 87, 107], ["infection", "OBSERVATION", 98, 107]]], ["Coexisting heart disease, kidney disease, advanced age and frailty are likely to have further increase in the severity of disease.Measures to prevent COVID-19Following measures are suggested for prevention of this disease in patients with diabetes:Measures to prevent COVID-19A.", [["heart", "ANATOMY", 11, 16], ["kidney", "ANATOMY", 26, 32], ["heart disease", "DISEASE", 11, 24], ["kidney disease", "DISEASE", 26, 40], ["diabetes", "DISEASE", 239, 247], ["COVID-19A", "CHEMICAL", 268, 277], ["COVID-19A", "CHEMICAL", 268, 277], ["heart", "ORGAN", 11, 16], ["kidney", "ORGAN", 26, 32], ["patients", "ORGANISM", 225, 233], ["COVID-19A", "GENE_OR_GENE_PRODUCT", 268, 277], ["patients", "SPECIES", 225, 233], ["Coexisting heart disease", "PROBLEM", 0, 24], ["kidney disease", "PROBLEM", 26, 40], ["the severity of disease", "PROBLEM", 106, 129], ["COVID-19Following measures", "TREATMENT", 150, 176], ["this disease", "PROBLEM", 209, 221], ["diabetes", "PROBLEM", 239, 247], ["COVID", "TEST", 268, 273], ["heart", "ANATOMY", 11, 16], ["disease", "OBSERVATION", 17, 24], ["kidney", "ANATOMY", 26, 32], ["disease", "OBSERVATION", 33, 40], ["increase", "OBSERVATION_MODIFIER", 94, 102], ["severity", "OBSERVATION_MODIFIER", 110, 118], ["disease", "OBSERVATION", 122, 129]]], ["Specific Measures in Patients with Diabetes:Measures to prevent COVID-19a.", [["Diabetes", "DISEASE", 35, 43], ["Patients", "ORGANISM", 21, 29], ["Patients", "SPECIES", 21, 29], ["Diabetes", "PROBLEM", 35, 43], ["COVID", "TEST", 64, 69]]], ["It is important that people with diabetes maintain a good glycaemic control, as it might help in reducing the risk of infection and also the severity.", [["diabetes", "DISEASE", 33, 41], ["infection", "DISEASE", 118, 127], ["people", "ORGANISM", 21, 27], ["people", "SPECIES", 21, 27], ["diabetes", "PROBLEM", 33, 41], ["a good glycaemic control", "TREATMENT", 51, 75], ["infection", "PROBLEM", 118, 127], ["infection", "OBSERVATION", 118, 127]]], ["More frequent monitoring of blood glucose levels (with use of self-monitoring blood glucose) is required.", [["blood", "ANATOMY", 28, 33], ["blood", "ANATOMY", 78, 83], ["glucose", "CHEMICAL", 34, 41], ["glucose", "CHEMICAL", 84, 91], ["glucose", "CHEMICAL", 34, 41], ["glucose", "CHEMICAL", 84, 91], ["blood", "ORGANISM_SUBSTANCE", 28, 33], ["glucose", "SIMPLE_CHEMICAL", 34, 41], ["blood", "ORGANISM_SUBSTANCE", 78, 83], ["glucose", "SIMPLE_CHEMICAL", 84, 91], ["blood glucose levels", "TEST", 28, 48], ["blood glucose", "TEST", 78, 91]]], ["Good glycemic control may lessen chances of superadded bacterial pneumonia as well.Measures to prevent COVID-19b.", [["pneumonia", "DISEASE", 65, 74], ["COVID-19b", "CHEMICAL", 103, 112], ["COVID-19b", "CHEMICAL", 103, 112], ["COVID-19b", "GENE_OR_GENE_PRODUCT", 103, 112], ["COVID-19b", "DNA", 103, 112], ["superadded bacterial pneumonia", "PROBLEM", 44, 74], ["COVID", "TEST", 103, 108], ["glycemic control", "OBSERVATION", 5, 21], ["bacterial", "OBSERVATION_MODIFIER", 55, 64], ["pneumonia", "OBSERVATION", 65, 74]]], ["Patients with diabetes and co-existing heart disease or kidney disease need special care and attempts should be made to stabilise their cardiac/renal status. c.", [["heart", "ANATOMY", 39, 44], ["kidney", "ANATOMY", 56, 62], ["cardiac", "ANATOMY", 136, 143], ["renal", "ANATOMY", 144, 149], ["diabetes", "DISEASE", 14, 22], ["heart disease", "DISEASE", 39, 52], ["kidney disease", "DISEASE", 56, 70], ["Patients", "ORGANISM", 0, 8], ["heart", "ORGAN", 39, 44], ["kidney", "ORGAN", 56, 62], ["cardiac", "ORGAN", 136, 143], ["renal", "ORGAN", 144, 149], ["Patients", "SPECIES", 0, 8], ["diabetes", "PROBLEM", 14, 22], ["co-existing heart disease", "PROBLEM", 27, 52], ["kidney disease", "PROBLEM", 56, 70], ["special care", "TREATMENT", 76, 88], ["diabetes", "OBSERVATION", 14, 22], ["heart", "ANATOMY", 39, 44], ["disease", "OBSERVATION", 45, 52], ["kidney", "ANATOMY", 56, 62], ["disease", "OBSERVATION", 63, 70], ["renal", "ANATOMY", 144, 149]]], ["Any deficiencies of minerals and vitamins need to be taken care of. d.", [["minerals", "SIMPLE_CHEMICAL", 20, 28], ["vitamins", "SIMPLE_CHEMICAL", 33, 41], ["Any deficiencies of minerals", "PROBLEM", 0, 28], ["vitamins", "TREATMENT", 33, 41]]], ["Exercise has been shown to improve immunity, though it might be prudent to be careful and avoid crowded places like gymnasia or swimming pools. e.", [["gymnasia", "DISEASE", 116, 124]]], ["It is important to take influenza and pneumonia vaccinations.Measures to prevent COVID-19The latter may decrease chances of secondary bacterial pneumonia after respiratory viral infection, however, data in present viral epidemic is not available.", [["influenza", "DISEASE", 24, 33], ["pneumonia", "DISEASE", 38, 47], ["pneumonia", "DISEASE", 144, 153], ["respiratory viral infection", "DISEASE", 160, 187], ["COVID-19", "CHEMICAL", 81, 89], ["influenza", "PROBLEM", 24, 33], ["pneumonia vaccinations", "TREATMENT", 38, 60], ["COVID", "TEST", 81, 86], ["secondary bacterial pneumonia", "PROBLEM", 124, 153], ["respiratory viral infection", "PROBLEM", 160, 187], ["pneumonia", "OBSERVATION", 38, 47], ["secondary", "OBSERVATION_MODIFIER", 124, 133], ["bacterial", "OBSERVATION_MODIFIER", 134, 143], ["pneumonia", "OBSERVATION", 144, 153], ["respiratory", "OBSERVATION_MODIFIER", 160, 171], ["viral infection", "OBSERVATION", 172, 187]]], ["Thorough handwashing with soap and water should be encouraged since it kills the virus.", [["soap and water", "TREATMENT", 26, 40], ["the virus", "PROBLEM", 77, 86]]], ["Use of alcohol-based hand rubs is also useful. b.", [["hand", "ANATOMY", 21, 25], ["alcohol", "CHEMICAL", 7, 14], ["alcohol", "CHEMICAL", 7, 14], ["alcohol", "SIMPLE_CHEMICAL", 7, 14]]], ["There is a need to practise proper respiratory hygiene with covering of mouth and nose with bent elbow or tissue when coughing or sneezing.", [["respiratory", "ANATOMY", 35, 46], ["mouth", "ANATOMY", 72, 77], ["nose", "ANATOMY", 82, 86], ["elbow", "ANATOMY", 97, 102], ["tissue", "ANATOMY", 106, 112], ["sneezing", "DISEASE", 130, 138], ["mouth", "ORGANISM_SUBDIVISION", 72, 77], ["nose", "ORGANISM_SUBDIVISION", 82, 86], ["elbow", "ORGANISM_SUBDIVISION", 97, 102], ["tissue", "TISSUE", 106, 112], ["mouth and nose with bent elbow or tissue", "PROBLEM", 72, 112], ["coughing", "PROBLEM", 118, 126], ["sneezing", "PROBLEM", 130, 138], ["respiratory hygiene", "OBSERVATION", 35, 54], ["mouth", "ANATOMY", 72, 77], ["nose", "ANATOMY", 82, 86], ["elbow", "ANATOMY", 97, 102], ["tissue", "ANATOMY", 106, 112]]], ["Touching of mouth, nose and eyes should be avoided. c.", [["mouth", "ANATOMY", 12, 17], ["nose", "ANATOMY", 19, 23], ["eyes", "ANATOMY", 28, 32], ["mouth", "ORGANISM_SUBDIVISION", 12, 17], ["nose", "ORGAN", 19, 23], ["eyes", "ORGAN", 28, 32], ["mouth", "ANATOMY", 12, 17], ["nose", "ANATOMY", 19, 23], ["eyes", "ANATOMY", 28, 32]]], ["Contact with an affected person needs to be minimised.", [["person", "SPECIES", 25, 31]]], ["Use of recommended face masks is advised if there is a contact with someone with respiratory symptoms. d.", [["respiratory", "ANATOMY", 81, 92], ["respiratory symptoms", "DISEASE", 81, 101], ["face masks", "TREATMENT", 19, 29], ["respiratory symptoms", "PROBLEM", 81, 101]]], ["Non-essential travel to major affected areas should be avoided in order to restrict the spread of infection.Measures in Patients of diabetes with COVID 19 infectiona.", [["infection", "DISEASE", 98, 107], ["diabetes", "DISEASE", 132, 140], ["Patients", "ORGANISM", 120, 128], ["Patients", "SPECIES", 120, 128], ["major affected areas", "PROBLEM", 24, 44], ["infection", "PROBLEM", 98, 107], ["diabetes", "PROBLEM", 132, 140], ["COVID 19 infectiona", "PROBLEM", 146, 165], ["major", "OBSERVATION_MODIFIER", 24, 29], ["affected", "OBSERVATION", 30, 38], ["infection", "OBSERVATION", 98, 107], ["diabetes", "OBSERVATION", 132, 140]]], ["In case a person with diabetes develops fever, cough, running nose or dyspnoea, the appropriate health authority needs to be notified as testing for this disease is available at selected places only. b.", [["diabetes", "DISEASE", 22, 30], ["fever", "DISEASE", 40, 45], ["cough", "DISEASE", 47, 52], ["dyspnoea", "DISEASE", 70, 78], ["person", "SPECIES", 10, 16], ["diabetes", "PROBLEM", 22, 30], ["fever", "PROBLEM", 40, 45], ["cough", "PROBLEM", 47, 52], ["running nose", "PROBLEM", 54, 66], ["dyspnoea", "PROBLEM", 70, 78], ["this disease", "PROBLEM", 149, 161]]], ["The affected person needs to be isolated for 14 days or till the symptoms resolve (whichever is longer).Country-specific guidelines need to be followed. c.", [["person", "ORGANISM", 13, 19], ["person", "SPECIES", 13, 19], ["the symptoms", "PROBLEM", 61, 73]]], ["Majority of patients have a mild disease and can be managed at home.", [["patients", "ORGANISM", 12, 20], ["patients", "SPECIES", 12, 20], ["a mild disease", "PROBLEM", 26, 40], ["mild", "OBSERVATION_MODIFIER", 28, 32], ["disease", "OBSERVATION", 33, 40]]], ["Hydration should be maintained and symptomatic treatment with acetaminophen, steam inhalation etc. can be given. d.", [["acetaminophen", "CHEMICAL", 62, 75], ["acetaminophen", "CHEMICAL", 62, 75], ["acetaminophen", "SIMPLE_CHEMICAL", 62, 75], ["Hydration", "TREATMENT", 0, 9], ["symptomatic treatment", "TREATMENT", 35, 56], ["acetaminophen", "TREATMENT", 62, 75], ["steam inhalation", "TREATMENT", 77, 93]]], ["Patients with type 1 diabetes should measure blood glucose and urinary ketones frequently if fever with hyperglycemia occurs.", [["blood", "ANATOMY", 45, 50], ["urinary", "ANATOMY", 63, 70], ["type 1 diabetes", "DISEASE", 14, 29], ["glucose", "CHEMICAL", 51, 58], ["fever", "DISEASE", 93, 98], ["hyperglycemia", "DISEASE", 104, 117], ["glucose", "CHEMICAL", 51, 58], ["ketones", "CHEMICAL", 71, 78], ["Patients", "ORGANISM", 0, 8], ["blood", "ORGANISM_SUBSTANCE", 45, 50], ["glucose", "SIMPLE_CHEMICAL", 51, 58], ["urinary", "ORGANISM_SUBSTANCE", 63, 70], ["ketones", "SIMPLE_CHEMICAL", 71, 78], ["Patients", "SPECIES", 0, 8], ["type 1 diabetes", "PROBLEM", 14, 29], ["blood glucose", "TEST", 45, 58], ["urinary ketones", "TEST", 63, 78], ["fever", "PROBLEM", 93, 98], ["hyperglycemia", "PROBLEM", 104, 117], ["diabetes", "OBSERVATION", 21, 29], ["urinary", "ANATOMY", 63, 70]]], ["Frequent changes in dosage and correctional bolus may be required to maintain normoglycemia. e.", [["normoglycemia", "DISEASE", 78, 91], ["Frequent changes in dosage", "TREATMENT", 0, 26], ["correctional bolus", "TREATMENT", 31, 49]]], ["Anti-hyperglycemic agents that can cause volume depletion or hypoglycemia should be avoided.", [["hypoglycemia", "DISEASE", 61, 73], ["Anti-hyperglycemic agents", "TREATMENT", 0, 25], ["volume depletion", "PROBLEM", 41, 57], ["hypoglycemia", "PROBLEM", 61, 73], ["volume depletion", "OBSERVATION", 41, 57]]], ["Dosage of oral anti-diabetic drugs may need to be reduced.", [["oral", "ANATOMY", 10, 14], ["oral", "ORGANISM_SUBDIVISION", 10, 14], ["oral anti-diabetic drugs", "TREATMENT", 10, 34]]], ["Patients should follow sick day guidelines and may need more frequent monitoring of blood glucose and drug adjustment. f.", [["blood", "ANATOMY", 84, 89], ["glucose", "CHEMICAL", 90, 97], ["glucose", "CHEMICAL", 90, 97], ["Patients", "ORGANISM", 0, 8], ["blood", "ORGANISM_SUBSTANCE", 84, 89], ["glucose", "SIMPLE_CHEMICAL", 90, 97], ["Patients", "SPECIES", 0, 8], ["f.", "SPECIES", 119, 121], ["blood glucose", "TEST", 84, 97], ["drug adjustment", "TREATMENT", 102, 117]]], ["Hospitalised patients with severe disease need frequent blood glucose monitoring.", [["blood", "ANATOMY", 56, 61], ["glucose", "CHEMICAL", 62, 69], ["glucose", "CHEMICAL", 62, 69], ["patients", "ORGANISM", 13, 21], ["blood", "ORGANISM_SUBSTANCE", 56, 61], ["glucose", "SIMPLE_CHEMICAL", 62, 69], ["patients", "SPECIES", 13, 21], ["severe disease", "PROBLEM", 27, 41], ["frequent blood glucose monitoring", "TREATMENT", 47, 80], ["severe", "OBSERVATION_MODIFIER", 27, 33], ["disease", "OBSERVATION", 34, 41]]], ["Oral agents especially metformin and sodium glucose cotransporter-2 inhibitors need to be stopped. g.", [["Oral", "ANATOMY", 0, 4], ["metformin", "CHEMICAL", 23, 32], ["sodium glucose", "CHEMICAL", 37, 51], ["metformin", "CHEMICAL", 23, 32], ["sodium glucose", "CHEMICAL", 37, 51], ["metformin", "SIMPLE_CHEMICAL", 23, 32], ["sodium glucose cotransporter-2", "GENE_OR_GENE_PRODUCT", 37, 67], ["Oral agents", "TREATMENT", 0, 11], ["metformin", "TREATMENT", 23, 32], ["sodium glucose cotransporter", "TREATMENT", 37, 65]]], ["Insulin is the preferred agent for control of hyperglycemia in hospitalised sick patients.Unproven therapies and future directionsIn the absence of a specific antiviral drug, anecdotal use of drugs like lopinavir, ritonavir, interferon-1b, RNA polymerase inhibitor remdesivir, and chloroquine has been reported.", [["Insulin", "CHEMICAL", 0, 7], ["hyperglycemia", "DISEASE", 46, 59], ["lopinavir, ritonavir, interferon-1b", "CHEMICAL", 203, 238], ["remdesivir", "CHEMICAL", 265, 275], ["chloroquine", "CHEMICAL", 281, 292], ["lopinavir", "CHEMICAL", 203, 212], ["ritonavir", "CHEMICAL", 214, 223], ["remdesivir", "CHEMICAL", 265, 275], ["chloroquine", "CHEMICAL", 281, 292], ["Insulin", "GENE_OR_GENE_PRODUCT", 0, 7], ["patients", "ORGANISM", 81, 89], ["lopinavir", "SIMPLE_CHEMICAL", 203, 212], ["ritonavir", "SIMPLE_CHEMICAL", 214, 223], ["interferon-1b", "GENE_OR_GENE_PRODUCT", 225, 238], ["remdesivir", "SIMPLE_CHEMICAL", 265, 275], ["chloroquine", "SIMPLE_CHEMICAL", 281, 292], ["interferon", "PROTEIN", 225, 235], ["patients", "SPECIES", 81, 89], ["Insulin", "TREATMENT", 0, 7], ["hyperglycemia", "PROBLEM", 46, 59], ["Unproven therapies", "TREATMENT", 90, 108], ["a specific antiviral drug", "TREATMENT", 148, 173], ["drugs", "TREATMENT", 192, 197], ["lopinavir", "TREATMENT", 203, 212], ["ritonavir", "TREATMENT", 214, 223], ["interferon", "TREATMENT", 225, 235], ["1b", "TREATMENT", 236, 238], ["RNA polymerase inhibitor remdesivir", "TREATMENT", 240, 275], ["chloroquine", "TREATMENT", 281, 292], ["hyperglycemia", "OBSERVATION", 46, 59]]], ["2019-nCoV receptor binding site has a strong affinity with angiotensin converting enzyme 2 (ACE2) and inhibitors of the rennin angiotensin system may have a role in treating severe respiratory disease [13, 14] .", [["respiratory", "ANATOMY", 181, 192], ["angiotensin", "CHEMICAL", 59, 70], ["angiotensin", "CHEMICAL", 127, 138], ["respiratory disease", "DISEASE", 181, 200], ["angiotensin converting enzyme 2", "GENE_OR_GENE_PRODUCT", 59, 90], ["ACE2", "GENE_OR_GENE_PRODUCT", 92, 96], ["rennin angiotensin", "GENE_OR_GENE_PRODUCT", 120, 138], ["2019-nCoV receptor binding site", "DNA", 0, 31], ["angiotensin converting enzyme 2", "PROTEIN", 59, 90], ["ACE2", "PROTEIN", 92, 96], ["angiotensin converting enzyme", "TREATMENT", 59, 88], ["inhibitors", "TREATMENT", 102, 112], ["the rennin angiotensin system", "TREATMENT", 116, 145], ["severe respiratory disease", "PROBLEM", 174, 200], ["severe", "OBSERVATION_MODIFIER", 174, 180], ["respiratory disease", "OBSERVATION", 181, 200]]], ["Zinc nanoparticles were shown to have inhibitory effects on H1N1 viral load, though their effect in COVID-19 is unknown and untested [15] .", [["Zinc", "CHEMICAL", 0, 4], ["COVID-19", "CHEMICAL", 100, 108], ["Zinc", "CHEMICAL", 0, 4], ["Zinc nanoparticles", "SIMPLE_CHEMICAL", 0, 18], ["H1N1 viral", "ORGANISM", 60, 70], ["Zinc nanoparticles", "TREATMENT", 0, 18], ["inhibitory effects", "PROBLEM", 38, 56], ["H1N1 viral load", "PROBLEM", 60, 75], ["COVID", "TEST", 100, 105]]], ["Vitamin C supplementation has some role in prevention of pneumonia and its effect on COVID-19 needs evaluation [16] .", [["Vitamin C", "CHEMICAL", 0, 9], ["pneumonia", "DISEASE", 57, 66], ["Vitamin C", "CHEMICAL", 0, 9], ["Vitamin C", "SIMPLE_CHEMICAL", 0, 9], ["Vitamin C supplementation", "TREATMENT", 0, 25], ["pneumonia", "PROBLEM", 57, 66], ["COVID", "TEST", 85, 90], ["evaluation", "TEST", 100, 110], ["pneumonia", "OBSERVATION", 57, 66]]], ["Efforts to develop a vaccine are underway, which will be a major tool to contain this epidemic [17] .", [["a vaccine", "TREATMENT", 19, 28]]]], "PMC7335231": [["The tradeoff between environmental quality and economic growth is a global dilemma.", [["a global dilemma", "PROBLEM", 66, 82], ["global", "OBSERVATION_MODIFIER", 68, 74], ["dilemma", "OBSERVATION", 75, 82]]], ["Since the beginning of the industrial revolution from about 1760s, global economic growth has increased substantially at the cost of environmental degradation.", [["global economic growth", "PROBLEM", 67, 89], ["environmental degradation", "PROBLEM", 133, 158], ["global", "OBSERVATION_MODIFIER", 67, 73], ["economic", "OBSERVATION_MODIFIER", 74, 82], ["growth", "OBSERVATION_MODIFIER", 83, 89], ["increased", "OBSERVATION_MODIFIER", 94, 103], ["substantially", "OBSERVATION_MODIFIER", 104, 117], ["environmental degradation", "OBSERVATION", 133, 158]]], ["The basic reason behind environmental loss is the use of conventional energy sources such as coal and fossil fuels in the production processes.", [["coal", "CHEMICAL", 93, 97], ["environmental loss", "PROBLEM", 24, 42], ["coal and fossil fuels", "PROBLEM", 93, 114], ["fossil fuels", "OBSERVATION", 102, 114]]], ["Therefore, economic growth, energy use, and environmental degradation show an amalgamation of triumvirate complicated structures\u2014 trilemma.IntroductionThe relationship of fiscal instruments with environmental quality has attracted the attention of the environmental and energy economists in recent years.", [["trilemma", "PROBLEM", 130, 138], ["fiscal instruments", "TREATMENT", 171, 189], ["fiscal instruments", "OBSERVATION", 171, 189]]], ["The studies, however, are fairly limited in the existing empirical literature.", [["The studies", "TEST", 0, 11]]], ["The fiscal role for environmental quality can be both amplifying and mitigating CO2 emissions.", [["CO2", "CHEMICAL", 80, 83], ["CO2", "CHEMICAL", 80, 83], ["CO2", "SIMPLE_CHEMICAL", 80, 83], ["mitigating CO2 emissions", "PROBLEM", 69, 93]]], ["Few studies have considered government spending as a fiscal instrument to control the environmental quality (Frederik and Lundstr\u00f6m 2001; Bernauer and Koubi 2006; L\u00f3pez et al., 2011; Halkos and Paizanos 2013, 2016).", [["Few studies", "TEST", 0, 11], ["a fiscal instrument", "TREATMENT", 51, 70]]], ["First, the scale effect refers to the pressure on the environment because of high economic growth.", [["high economic growth", "PROBLEM", 77, 97]]], ["Physical capital-intensive inputs are switched with human capital-intensive inputs, which are less polluting.", [["human", "ORGANISM", 52, 57], ["human", "SPECIES", 52, 57], ["human", "SPECIES", 52, 57], ["less", "OBSERVATION_MODIFIER", 94, 98], ["polluting", "OBSERVATION_MODIFIER", 99, 108]]], ["Fourth, income effect indicates an increasing priority and the need for a better environment because of high-income status.", [["increasing", "OBSERVATION_MODIFIER", 35, 45]]], ["They concluded, \u201cEFR can lead to environmental improvement more efficiently and cost-effectively than traditional regulation.\u201dIntroductionIn an earlier study, Frederik and Lundstr\u00f6m (2001) explored the effects of economic freedom and government size on pollution using the data for high- and low-income countries.", [["traditional regulation", "TREATMENT", 102, 124], ["an earlier study", "TEST", 141, 157], ["economic freedom and government size", "TREATMENT", 213, 249], ["the data", "TEST", 269, 277], ["size", "OBSERVATION_MODIFIER", 245, 249]]], ["They found economic freedom increases emissions while government spending decreases emissions.", [["economic freedom increases emissions", "PROBLEM", 11, 47], ["economic", "OBSERVATION_MODIFIER", 11, 19], ["freedom", "OBSERVATION_MODIFIER", 20, 27], ["increases", "OBSERVATION_MODIFIER", 28, 37], ["emissions", "OBSERVATION_MODIFIER", 38, 47]]], ["Bernauer and Koubi (2006) also explored the impact of government size on the quality of the environment using a sample of 42 countries from 1971 to 1996.", [["size", "OBSERVATION_MODIFIER", 65, 69]]], ["Halkos and Paizanos (2013) investigated the effect of government expenditures on environmental quality employing a panel data set of 77 economies from 1980 to 2000.", [["a panel data", "TEST", 113, 125]]], ["The results demonstrated that government spending has an insignificant impact on CO2 emissions while it has a significant and negative effect on SO2 emissions.", [["CO2", "CHEMICAL", 81, 84], ["SO2", "CHEMICAL", 145, 148], ["CO2", "CHEMICAL", 81, 84], ["SO2", "CHEMICAL", 145, 148], ["CO2", "SIMPLE_CHEMICAL", 81, 84], ["SO2", "SIMPLE_CHEMICAL", 145, 148], ["CO2 emissions", "TREATMENT", 81, 94], ["insignificant", "OBSERVATION_MODIFIER", 57, 70], ["significant", "OBSERVATION_MODIFIER", 110, 121], ["negative effect", "OBSERVATION", 126, 141]]], ["The results revealed that the effect of SO2 changes from negative to positive as income increases.", [["SO2", "CHEMICAL", 40, 43], ["SO2", "CHEMICAL", 40, 43], ["SO2", "SIMPLE_CHEMICAL", 40, 43], ["SO2 changes", "PROBLEM", 40, 51]]], ["The empirical studies such as Lopez and Palacios (2010), Halkos and Paizanos (2016), and Katircioglu and Katircioglu (2018) have considered government spending and revenues as fiscal policy instruments in their empirical model.", [["The empirical studies", "TEST", 0, 21], ["Lopez and Palacios", "TREATMENT", 30, 48], ["Halkos", "TREATMENT", 57, 63], ["Paizanos", "TREATMENT", 68, 76], ["Katircioglu", "TREATMENT", 89, 100], ["fiscal policy instruments", "TREATMENT", 176, 201]]], ["One major limitation of these studies is that they neglected the asymmetric relationships between fiscal policy instruments and CO2 emissions.IntroductionRecently, Gerlagh et al. (2018) explored the role of fiscal policy in controlling carbon emissions for 15 European Union (EU) countries in the context of new passenger cars over the time span 2001\u20132010.", [["CO2", "CHEMICAL", 128, 131], ["CO2", "CHEMICAL", 128, 131], ["carbon", "CHEMICAL", 236, 242], ["CO2", "SIMPLE_CHEMICAL", 128, 131], ["these studies", "TEST", 24, 37], ["CO2 emissions", "TEST", 128, 141], ["asymmetric", "OBSERVATION_MODIFIER", 65, 75]]], ["They analyzed the impact of fiscal policy using a measure of the vehicle registration and annual road tax levels.", [["tax", "PROTEIN", 102, 105], ["fiscal policy", "TREATMENT", 28, 41], ["the vehicle registration", "TEST", 61, 85]]], ["Their findings suggest that registration taxes lowers carbon emissions.", [["carbon", "CHEMICAL", 54, 60], ["carbon", "SIMPLE_CHEMICAL", 54, 60], ["carbon emissions", "PROBLEM", 54, 70], ["carbon emissions", "OBSERVATION", 54, 70]]], ["However, the findings of their study cannot be generalized as they are limited to the car industry.", [["their study", "TEST", 25, 36]]], ["The empirical literature has neglected the dynamic relationships between fiscal policy instruments and CO2 emissions by incorporating both negative and positive components of fiscal policy instruments.", [["CO2", "CHEMICAL", 103, 106], ["CO2", "CHEMICAL", 103, 106], ["CO2", "SIMPLE_CHEMICAL", 103, 106], ["CO2 emissions", "TEST", 103, 116], ["fiscal policy instruments", "TREATMENT", 175, 200], ["positive components", "OBSERVATION_MODIFIER", 152, 171]]], ["Moreover, the evidence for the Asian region is overlooked in the existing literature.IntroductionSimilarly, in another recent study, Katircioglu and Katircioglu (2018) tested the importance of fiscal policy for environmental quality for Turkey over the period 1960\u20132013.", [["the Asian region", "PROBLEM", 27, 43], ["another recent study", "TEST", 111, 131]]], ["The empirical results, based on the linear ARDL model, reveal that fiscal aggregates help to lower carbon emissions implying that fiscal policy has a significant role in managing environmental quality in the context of Turkey.", [["carbon", "CHEMICAL", 99, 105], ["carbon", "CHEMICAL", 99, 105], ["the linear ARDL model", "TEST", 32, 53], ["fiscal aggregates", "PROBLEM", 67, 84], ["lower carbon emissions", "TREATMENT", 93, 115], ["significant", "OBSERVATION_MODIFIER", 150, 161]]], ["Yuelan et al. (2019) explored the nexus of fiscal policy instruments and environmental degradation for China over the period 1980\u20132016.", [["fiscal policy instruments", "TREATMENT", 43, 68]]], ["The empirical results of their study showed that fiscal policy instruments significantly increase environmental degradation in the long run.", [["their study", "TEST", 25, 36], ["fiscal policy instruments", "TREATMENT", 49, 74], ["increase", "OBSERVATION_MODIFIER", 89, 97], ["environmental degradation", "OBSERVATION", 98, 123]]], ["That is, expansionary fiscal policy compromises the environmental quality in the context of China.", [["environmental quality", "OBSERVATION", 52, 73]]], ["One limitation of these studies is that they assume a symmetric relationship between fiscal policy instruments and environmental quality.", [["these studies", "TEST", 18, 31], ["symmetric", "OBSERVATION_MODIFIER", 54, 63], ["fiscal policy", "OBSERVATION", 85, 98]]], ["Moreover, the findings of these studies cannot be generalized at a regional level as they are limited to country-specific experiences.IntroductionAsia is a rapidly growing region and millions of poor have been lifted from the poverty traps.", [["these studies", "TEST", 26, 39], ["a rapidly growing region", "PROBLEM", 154, 178], ["the poverty traps", "TREATMENT", 222, 239], ["rapidly", "OBSERVATION_MODIFIER", 156, 163], ["growing", "OBSERVATION_MODIFIER", 164, 171], ["millions", "OBSERVATION_MODIFIER", 183, 191]]], ["However, this growth is coming at the cost of environmental disruption.", [["this growth", "PROBLEM", 9, 20], ["environmental disruption", "PROBLEM", 46, 70], ["growth", "OBSERVATION_MODIFIER", 14, 20], ["environmental disruption", "OBSERVATION", 46, 70]]], ["Energy use, consumption of natural resources, and coupled emissions are also displaying similar trajectories as of economic growth.", [["natural resources", "TREATMENT", 27, 44]]], ["Oil consumption has increased by 92% between the years (1990\u20132010), and it is expected to increase by 44% from 2010 to 2030 (Asian Development Bank (ADB), 2011).", [["Oil", "CHEMICAL", 0, 3], ["Oil", "SIMPLE_CHEMICAL", 0, 3], ["increased", "OBSERVATION_MODIFIER", 20, 29]]], ["Asia as a region is responsible for about 40% of global greenhouse gas emissions, which can escalate up to 50% if sustainable measures are not adopted (Dulal et al. 2015).", [["global greenhouse gas emissions", "PROBLEM", 49, 80], ["gas emissions", "OBSERVATION", 67, 80]]], ["Thus, Asian economies are increasingly getting trapped in pollution-concentrated development routes.IntroductionThe dynamic relationships of economic growth, fiscal policy instruments, and environmental quality are neglected in the case of Asia in general and top polluting Asian economies in particular.", [["economic growth", "PROBLEM", 141, 156], ["fiscal policy instruments", "TREATMENT", 158, 183], ["economic", "OBSERVATION_MODIFIER", 141, 149], ["growth", "OBSERVATION_MODIFIER", 150, 156]]], ["There is the only study that explores the scope of fiscal policy instruments to manage the environmental quality of Asian countries.", [["fiscal policy instruments", "TREATMENT", 51, 76]]], ["Dulal et al. (2015) provided an exploratory analysis of fiscal policy and environmental quality.", [["an exploratory analysis", "TEST", 29, 52]]], ["The study provided facts about environmental changes in the region and concludes that the region is increasingly getting locked in carob-intensive development paths.IntroductionMoreover, Dulal et al. (2015) explored the scope of fiscal policy in helping the region to avoid the carbon-intensive paths and conclude that fiscal policy has a greater scope in the region, particularly carbon tax policy and taxation of the use of natural resources.", [["carbon", "CHEMICAL", 278, 284], ["carbon", "CHEMICAL", 381, 387], ["The study", "TEST", 0, 9], ["environmental changes in the region", "PROBLEM", 31, 66], ["fiscal policy", "TREATMENT", 229, 242], ["carbon tax policy", "TREATMENT", 381, 398], ["natural resources", "TREATMENT", 426, 443]]], ["However, fiscal policy instruments are not adapted to the required extent.", [["fiscal policy instruments", "TREATMENT", 9, 34]]], ["Dulal et al. (2015) emphasize the need for fiscal policy instruments to manage the environmental quality of the region.", [["fiscal policy instruments", "TREATMENT", 43, 68]]], ["However, this study is qualitative in its nature and does not provide any firm empirical evidence.", [["this study", "TEST", 9, 19]]], ["Therefore, the scope for empirical studies for the region is the need of the present time.", [["empirical studies", "TEST", 25, 42]]], ["Furthermore, the findings of these studies, however, neither certain nor can be generalized.", [["these studies", "TEST", 29, 42]]], ["These studies provide evidence based on a single country-specific experience.", [["These studies", "TEST", 0, 13]]], ["Moreover, these studies assume a linear relationship between fiscal policy instruments and environmental quality ignoring hidden nonlinear relationships.", [["these studies", "TEST", 10, 23], ["fiscal policy instruments", "TREATMENT", 61, 86]]], ["It is not necessary that both positive and negative shocks in fiscal policy instruments have linear effects on environmental quality.", [["fiscal policy instruments", "TREATMENT", 62, 87], ["not necessary", "UNCERTAINTY", 6, 19], ["linear", "OBSERVATION_MODIFIER", 93, 99]]], ["Therefore, it is important to estimate the asymmetric effects of changes in fiscal policy instruments on environmental quality.", [["asymmetric", "OBSERVATION_MODIFIER", 43, 53], ["fiscal policy", "OBSERVATION", 76, 89]]], ["Our study deviates from the entire empirical literature by arguing that the impacts of fiscal policy instruments on environmental quality could be asymmetric, therefore we applied the NARDL methodology in this analysis.IntroductionBased on the findings of the aforementioned studies, it can be inferred that fiscal policy has heterogeneous effects on environmental quality depending upon the kinds of pollutants and geographical locations and income groups of the countries.", [["Our study", "TEST", 0, 9], ["fiscal policy instruments", "TREATMENT", 87, 112], ["the NARDL methodology", "TREATMENT", 180, 201], ["this analysis", "TEST", 205, 218], ["the aforementioned studies", "TEST", 256, 282], ["impacts", "OBSERVATION_MODIFIER", 76, 83], ["fiscal policy", "OBSERVATION", 87, 100], ["asymmetric", "OBSERVATION_MODIFIER", 147, 157], ["heterogeneous", "OBSERVATION_MODIFIER", 326, 339]]], ["The present study aims to explore the dynamic relationships between fiscal policy instruments and CO2 emissions for the top ten pollution emitting Asian countries over the time span of 1981\u20132018.", [["CO2", "CHEMICAL", 98, 101], ["CO2", "CHEMICAL", 98, 101], ["CO2", "SIMPLE_CHEMICAL", 98, 101], ["The present study", "TEST", 0, 17], ["fiscal policy instruments", "TREATMENT", 68, 93], ["CO2 emissions", "TREATMENT", 98, 111]]], ["The scope of the present study is wider as few studies are available in the literature, which focuses on fiscal policy and environment.", [["the present study", "TEST", 13, 30], ["few studies", "TEST", 43, 54]]], ["The studies generally focus on government spending aspect of the fiscal policy; therefore, the studies with the focus on both government spending and revenue instruments are quite limited.", [["The studies", "TEST", 0, 11], ["the studies", "TEST", 91, 102], ["focus", "OBSERVATION_MODIFIER", 22, 27]]], ["The problem of ecological disruption as a result of GHG emissions can only be resolved with a suitable fiscal rejoinder.IntroductionThis study contributes to the literature in the following ways: First, this study controls the twin impact of both fiscal policy instruments namely government expenditures and government revenues.", [["ecological disruption", "PROBLEM", 15, 36], ["GHG emissions", "PROBLEM", 52, 65], ["a suitable fiscal rejoinder", "TREATMENT", 92, 119], ["This study", "TEST", 132, 142], ["this study", "TEST", 203, 213], ["ecological disruption", "OBSERVATION", 15, 36], ["GHG emissions", "OBSERVATION", 52, 65]]], ["Second, we use a novel approach of estimation that is asymmetric effects of fiscal policy instruments on environmental quality.", [["a novel approach", "TREATMENT", 15, 31], ["fiscal policy instruments", "TREATMENT", 76, 101], ["asymmetric", "OBSERVATION_MODIFIER", 54, 64], ["fiscal policy", "OBSERVATION", 76, 89]]], ["Third, this study provides an analysis of the top ten CO2 emitting Asian countries.IntroductionThe present study focuses exclusively on Malaysia, United Arab Emirates, Thailand, Indonesia, Turkey, Iran, Saudi Arabia, Japan, India, and China owing to the unique characteristics of these countries.", [["CO2", "CHEMICAL", 54, 57], ["this study", "TEST", 7, 17], ["an analysis", "TEST", 27, 38]]], ["These countries are the top ten carbon emitters from Asia and they are major sources of global CO2 emissions.", [["CO2", "CHEMICAL", 95, 98], ["carbon", "CHEMICAL", 32, 38], ["CO2", "CHEMICAL", 95, 98], ["CO2", "SIMPLE_CHEMICAL", 95, 98], ["the top ten carbon emitters", "TREATMENT", 20, 47], ["global CO2 emissions", "PROBLEM", 88, 108], ["CO2 emissions", "OBSERVATION", 95, 108]]], ["We consider these countries as an appropriate sample based on not only their significant share in global emissions but also the absolute size of their CO2 emissions.", [["CO2", "CHEMICAL", 151, 154], ["CO2", "CHEMICAL", 151, 154], ["CO2", "SIMPLE_CHEMICAL", 151, 154], ["size", "OBSERVATION_MODIFIER", 137, 141], ["CO2 emissions", "OBSERVATION", 151, 164]]], ["Therefore, these countries have a strong impact on world energy demand and expenditures and global ecological balance.", [["ecological balance", "OBSERVATION", 99, 117]]], ["Thus, it is imperative to provide separate empirical analysis for the top ten emitting countries from Asia.", [["separate empirical analysis", "TEST", 34, 61]]], ["In the existing literature, the role of fiscal policy instruments, particularly the twin effect of government expenditures and revenue, is less focused.", [["fiscal policy instruments", "TREATMENT", 40, 65]]], ["Moreover, the past literature has used symmetric modeling methods for empirical analysis providing conflicting results, whereas asymmetric modeling provides more comprehensive and authoritative results.", [["empirical analysis", "TEST", 70, 88]]], ["Thus, it is important to explore the asymmetric effects of fiscal policy instruments on environmental quality.", [["fiscal policy instruments", "TREATMENT", 59, 84], ["asymmetric", "OBSERVATION_MODIFIER", 37, 47]]], ["This research provides a robust empirical analysis of fiscal policy instruments and environmental pollution using time series annual data of the top ten pollution emitting courtiers from 1981 to 2018.IntroductionThe rest of the study is organized as follows: A discussion on methodology and model is provided in \u201cModel and methodology.\u201d", [["fiscal policy instruments", "TREATMENT", 54, 79], ["the study", "TEST", 224, 233]]], ["Finally, \u201cConclusion and policy implications\u201d concludes the study and offers policy implications.Data description ::: Model and methodologyThis study uses a dataset from 1981 to 2018 for the top ten carbon emitters from Asia regions, such as Malaysia, United Arab Emirates, Thailand, Indonesia, Turkey, Iran, Saudi Arabia, Japan, India, and China.", [["carbon", "CHEMICAL", 199, 205], ["the study", "TEST", 56, 65], ["This study", "TEST", 139, 149], ["the top ten carbon emitters", "TREATMENT", 187, 214]]], ["Definitions of CO2, Gexp, Grev, and EG are given in Table 1 and all data attained from the World Bank (2020).", [["CO2", "CHEMICAL", 15, 18], ["CO2", "CHEMICAL", 15, 18], ["CO2", "SIMPLE_CHEMICAL", 15, 18], ["CO2", "TEST", 15, 18], ["Gexp", "TEST", 20, 24], ["CO2", "OBSERVATION_MODIFIER", 15, 18]]], ["In the study, all indicators are taken non-logarithmic form except the variable of CO2, while we take the data of CO2 in logarithmic form in our estimation, and while CO2, Gexp, Grev, and EG summary statistics are given in Table 2 for selected Asian countries.", [["CO2", "CHEMICAL", 83, 86], ["CO2", "CHEMICAL", 114, 117], ["CO2", "CHEMICAL", 83, 86], ["CO2", "CHEMICAL", 114, 117], ["CO2", "CHEMICAL", 167, 170], ["CO2", "SIMPLE_CHEMICAL", 83, 86], ["CO2", "SIMPLE_CHEMICAL", 114, 117], ["CO2", "SIMPLE_CHEMICAL", 167, 170], ["the study", "TEST", 3, 12], ["our estimation", "TEST", 141, 155], ["CO2", "TEST", 167, 170]]], ["The statistics show that China is the highest carbon emitters with a value of 4,837,142 kt.", [["carbon", "CHEMICAL", 46, 52], ["a value", "TEST", 67, 74]]], ["While the UAE is 98,828 kt of carbon pollution producing, which is the smallest in our sample.", [["carbon", "CHEMICAL", 30, 36], ["carbon", "CHEMICAL", 30, 36], ["the UAE", "TEST", 6, 13], ["carbon pollution", "PROBLEM", 30, 46], ["carbon pollution", "OBSERVATION", 30, 46], ["smallest", "OBSERVATION_MODIFIER", 71, 79]]], ["Similarly, the mean values of Grev vary from 3.60 (UAE) to 37.62% (Saudi Arabia), which infers that Indonesia and UAE are at the lowest in Gexp and Grev.", [["the mean values", "TEST", 11, 26], ["UAE", "TEST", 51, 54], ["UAE", "TEST", 114, 117], ["mean", "OBSERVATION_MODIFIER", 15, 19], ["lowest", "OBSERVATION_MODIFIER", 129, 135]]], ["The statistic of EG shows that the minimum mean value (3.26%) belongs to Iran and the maximum mean value (9.56%) belongs to China in our sample.Empirical results and discussion ::: Model and methodologyWe begin by using the ADF and PP unit root statistics to estimate the extent to which the time series are non-stationary.", [["The statistic of EG", "TEST", 0, 19], ["the minimum mean value", "TEST", 31, 53], ["the maximum mean value", "TEST", 82, 104], ["PP unit root", "TREATMENT", 232, 244]]], ["The results are recapped in Table 3 and outcomes show that dependent, independent, and control variables are a mixture of I (0) and I (1), and none of the variables are integrated I (2).", [["dependent", "OBSERVATION_MODIFIER", 59, 68]]], ["The next step is to decide the appropriate number of lags for our analysis.", [["our analysis", "TEST", 62, 74]]], ["To that end, we have used the Akaike information criteria (AIC) and applied the maximum of four lags for the annual data in the case of each of our models.", [["the annual data", "TEST", 105, 120]]], ["In NARDL methodology, we adopted the general-to-specific modeling approach.Empirical results and discussion ::: Model and methodologyTable 5 reports the estimates of the asymmetric ARDL technique.", [["the asymmetric ARDL technique", "TREATMENT", 166, 195]]], ["In Table 5, panel A exhibits that the short-run outcome, we infer that positive shocks in government expenditure carry the favorable effects on the environmental quality of 6 economies (Malaysia, UAE, Turkey, Saudi Arabia, Japan, and China) by decreasing the CO2.", [["CO2", "CHEMICAL", 259, 262], ["CO2", "CHEMICAL", 259, 262], ["CO2", "SIMPLE_CHEMICAL", 259, 262], ["favorable", "OBSERVATION_MODIFIER", 123, 132]]], ["Furthermore, the negative shocks of government expenditures affect the climate of Thailand, Indonesia, Iran, and India positively, while the environment of the remaining 6 economies negatively by decreasing and increasing pollution, respectively, except the economy of Malaysia.Empirical results and discussion ::: Model and methodologyAlso, half of the selected economies, i.e., Malaysia, UAE, Saudi Arabia, Japan, and China get the environmental benefits, and the other half countries face the environmental deterioration, as the positive shocks in the collection of the government revenues tend to contract and expand the level of CO2 emissions, respectively.", [["CO2", "CHEMICAL", 634, 637], ["CO2", "CHEMICAL", 634, 637], ["CO2", "SIMPLE_CHEMICAL", 634, 637], ["the environmental deterioration", "PROBLEM", 492, 523], ["the positive shocks", "PROBLEM", 528, 547], ["decreasing", "OBSERVATION_MODIFIER", 196, 206], ["increasing", "OBSERVATION_MODIFIER", 211, 221], ["pollution", "OBSERVATION_MODIFIER", 222, 231], ["CO2 emissions", "OBSERVATION", 634, 647]]], ["Besides, the negative shocks in government revenues have a significantly negative impact on pollution in the case of Thailand, Indonesia, Turkey, and India by reducing carbon dioxide.", [["carbon dioxide", "CHEMICAL", 168, 182], ["carbon dioxide", "CHEMICAL", 168, 182], ["carbon dioxide", "SIMPLE_CHEMICAL", 168, 182], ["carbon dioxide", "TREATMENT", 168, 182]]], ["Interestingly, all the economies demonstrate the consensus on the unfriendly environmental effects of GDP growth on account of surging carbon emissions.Empirical results and discussion ::: Model and methodologyAs for as the long-run asymmetric effects of modeled regressors, panel B confirms that positive shocks in government expenditures harm the environment of 8 out of 10 economies.", [["GDP", "CHEMICAL", 102, 105], ["GDP", "CHEMICAL", 102, 105], ["carbon", "CHEMICAL", 135, 141], ["GDP", "SIMPLE_CHEMICAL", 102, 105], ["carbon", "SIMPLE_CHEMICAL", 135, 141], ["GDP growth", "PROBLEM", 102, 112], ["surging carbon emissions", "TREATMENT", 127, 151], ["panel B", "TEST", 275, 282], ["positive shocks", "PROBLEM", 297, 312], ["GDP growth", "OBSERVATION", 102, 112], ["positive shocks", "OBSERVATION", 297, 312]]], ["It indicates that 1% increase in government expenditure tends to increase CO2 emissions by 0.172% in Malaysia, 0.231% in UAE, 0.307% in Thailand, 0.471% in Indonesia, 0.178% in Turkey, 0.093% in Iran, 0.366% in India, and 0.188% in China.", [["CO2", "CHEMICAL", 74, 77], ["CO2", "CHEMICAL", 74, 77], ["CO2", "SIMPLE_CHEMICAL", 74, 77], ["1% increase in government expenditure", "PROBLEM", 18, 55], ["increase CO2 emissions", "PROBLEM", 65, 87], ["increase", "OBSERVATION_MODIFIER", 21, 29]]], ["These findings are in line with the results of Halkos and Paizanos (2016) and Yuelan et al. (2019) who noted the possible reason is that government expenditure of these economies are invested in such economic projects that consume the fossil fuel-based energy excessively which results in an enormous amount of carbon dioxide emissions.", [["carbon dioxide", "CHEMICAL", 311, 325], ["carbon dioxide", "CHEMICAL", 311, 325], ["carbon dioxide", "SIMPLE_CHEMICAL", 311, 325], ["carbon dioxide emissions", "TREATMENT", 311, 335], ["carbon dioxide", "OBSERVATION", 311, 325]]], ["The possible reason is that government consumption improvs the physical infrastructure including roads, transportation, and housing societies that increase carbon pollution.", [["carbon", "CHEMICAL", 156, 162], ["carbon", "CHEMICAL", 156, 162], ["carbon", "SIMPLE_CHEMICAL", 156, 162], ["carbon pollution", "TREATMENT", 156, 172], ["possible", "UNCERTAINTY", 4, 12], ["carbon pollution", "OBSERVATION", 156, 172]]], ["This also implies that government consumption increases urbanization that is one of the sources of carbon pollution.", [["carbon", "CHEMICAL", 99, 105], ["carbon", "SIMPLE_CHEMICAL", 99, 105], ["carbon pollution", "TREATMENT", 99, 115], ["carbon pollution", "OBSERVATION", 99, 115]]], ["The results also infer that government spending leads to domestic private consumption with the investment that also increases environmental pollution.", [["the investment", "TREATMENT", 91, 105], ["increases", "OBSERVATION_MODIFIER", 116, 125], ["environmental pollution", "OBSERVATION", 126, 149]]], ["Furthermore, the economy of Japan gets benefitted due to the upward trend of government expenditures as it diminishes the CO2 by 0.352%.", [["CO2", "CHEMICAL", 122, 125], ["CO2", "CHEMICAL", 122, 125], ["CO2", "SIMPLE_CHEMICAL", 122, 125], ["the CO2", "TEST", 118, 125]]], ["This implies that Japanese consumption most on the human capital activities includes health and education sectors that are small emitters of carbon compared to physical capital infrastructure.", [["carbon", "CHEMICAL", 141, 147], ["carbon", "CHEMICAL", 141, 147], ["human", "ORGANISM", 51, 56], ["human", "SPECIES", 51, 56], ["human", "SPECIES", 51, 56], ["Japanese consumption", "PROBLEM", 18, 38], ["small emitters of carbon", "PROBLEM", 123, 147], ["small", "OBSERVATION_MODIFIER", 123, 128], ["capital infrastructure", "OBSERVATION", 169, 191]]], ["Besides, the Saudi Arabian economy\u2019s response remains insignificant.Empirical results and discussion ::: Model and methodologyConversely, the negative shocks in government expenditure carry an adverse impact on environmental pollution in the case of 7 out of 10 countries.", [["insignificant", "OBSERVATION_MODIFIER", 54, 67]]], ["It implies that a 1% decrease in government expenditure leads to a reduction in the ratio of CO2 by 0.062% in Malaysia, 0.181% in UAE, 0.092% in Thailand, 0.280% in Indonesia, 0.042% in Turkey, 0.031% in Iran, and 0.178% in India.", [["CO2", "CHEMICAL", 93, 96], ["CO2", "CHEMICAL", 93, 96], ["CO2", "SIMPLE_CHEMICAL", 93, 96], ["a 1% decrease in government expenditure", "PROBLEM", 16, 55], ["a reduction", "TREATMENT", 65, 76], ["CO2", "TEST", 93, 96], ["decrease", "OBSERVATION_MODIFIER", 21, 29], ["reduction", "OBSERVATION_MODIFIER", 67, 76]]], ["Moreover, this finding is also consistent with Katircioglu and Katircioglu (2018) and Chan (2020), who found that a contractionary fiscal policy could decrease environmental pollution.", [["a contractionary fiscal policy", "TREATMENT", 114, 144], ["consistent with", "UNCERTAINTY", 31, 46], ["decrease", "OBSERVATION_MODIFIER", 151, 159], ["environmental pollution", "OBSERVATION", 160, 183]]], ["The Japanese economy has to endure environmental loss as negative shocks in government expenditures result in an increase in carbon dioxide by 0.178%.", [["carbon dioxide", "CHEMICAL", 125, 139], ["carbon dioxide", "CHEMICAL", 125, 139], ["carbon dioxide", "SIMPLE_CHEMICAL", 125, 139], ["environmental loss", "PROBLEM", 35, 53], ["an increase in carbon dioxide", "TREATMENT", 110, 139], ["increase", "OBSERVATION_MODIFIER", 113, 121], ["carbon dioxide", "OBSERVATION", 125, 139]]], ["In contrast, the climate of two economies, i.e., Saudi Arabia and China, show no association with the negative shocks.", [["two", "OBSERVATION_MODIFIER", 28, 31], ["economies", "OBSERVATION", 32, 41], ["no association with", "UNCERTAINTY", 78, 97]]], ["The results also show that a positive shock of government spending is more effective in the environment in magnitude compared to a negative shock.Empirical results and discussion ::: Model and methodologyFurthermore, the positive shocks in government revenues show a positive association with pollution in 8 out of 10 economies.", [["shock", "DISEASE", 38, 43], ["shock", "DISEASE", 140, 145], ["a positive shock of government", "PROBLEM", 27, 57], ["a negative shock", "PROBLEM", 129, 145], ["positive", "OBSERVATION_MODIFIER", 29, 37], ["shock", "OBSERVATION", 38, 43], ["more effective", "OBSERVATION_MODIFIER", 70, 84], ["shock", "OBSERVATION", 140, 145], ["positive", "OBSERVATION", 267, 275]]], ["It implies that 1% increase in government revenues causes to emit CO2 by 0.281% in Malaysia, 0.043% in UAE, 0.226% in Thailand, 0.236% in Indonesia, 0.266% in Turkey, 0.138% in Iran, 0.208% in India, and 0.207% in China.", [["CO2", "CHEMICAL", 66, 69], ["CO2", "CHEMICAL", 66, 69], ["CO2", "SIMPLE_CHEMICAL", 66, 69], ["emit CO2", "TEST", 61, 69], ["increase", "OBSERVATION_MODIFIER", 19, 27]]], ["The possible reason is that the increasing ratio of taxes to generate the revenues forces the producers to use traditional methods of production.", [["the increasing ratio of taxes", "TREATMENT", 28, 57], ["traditional methods of production", "TREATMENT", 111, 144], ["possible", "UNCERTAINTY", 4, 12]]], ["These production methods require fossil fuel based-energy intensively, as a result, CO2 emissions rise in these economies.", [["CO2", "CHEMICAL", 84, 87], ["CO2", "CHEMICAL", 84, 87], ["CO2", "SIMPLE_CHEMICAL", 84, 87], ["CO2 emissions", "TEST", 84, 97], ["rise", "OBSERVATION_MODIFIER", 98, 102], ["economies", "OBSERVATION_MODIFIER", 112, 121]]], ["Also, higher government income levels, which are usually linked with increased government spending, enhance the public infrastructure that is not better for environmental quality.", [["higher", "OBSERVATION_MODIFIER", 6, 12], ["increased", "OBSERVATION_MODIFIER", 69, 78], ["government", "OBSERVATION", 79, 89]]], ["This finding is consistent with Yuelan et al. (2019), who noted that government revenue initially increases environmental pollution.", [["consistent with", "UNCERTAINTY", 16, 31], ["increases", "OBSERVATION_MODIFIER", 98, 107], ["environmental pollution", "OBSERVATION", 108, 131]]], ["A positive government revenue shock improves consumption and increases carbon pollution.", [["shock", "DISEASE", 30, 35], ["carbon", "CHEMICAL", 71, 77], ["carbon", "SIMPLE_CHEMICAL", 71, 77], ["carbon pollution", "TREATMENT", 71, 87], ["positive", "OBSERVATION_MODIFIER", 2, 10], ["government", "OBSERVATION_MODIFIER", 11, 21], ["revenue shock", "OBSERVATION", 22, 35], ["increases", "OBSERVATION_MODIFIER", 61, 70], ["carbon pollution", "OBSERVATION", 71, 87]]], ["In contrast, the economy of Japan gains environmental advantages since the upward trend in government revenues contracts the ratio of CO2 emissions.Empirical results and discussion ::: Model and methodologyThe negative shocks in government revenues, in contrast, ameliorate the deleterious repercussions of pollution in 6 of concerned economies.", [["CO2", "CHEMICAL", 134, 137], ["CO2", "CHEMICAL", 134, 137], ["CO2", "SIMPLE_CHEMICAL", 134, 137], ["CO2 emissions", "OBSERVATION", 134, 147], ["negative", "OBSERVATION_MODIFIER", 210, 218], ["shocks", "OBSERVATION", 219, 225]]], ["It signifies that carbon emissions decline on account of a downward trend in government revenues by 0.100% in Malaysia, 0.008% in UAE, 0.115% in Thailand, 0.154% in Indonesia, 0.012% in Iran, and 0.083% China.", [["carbon", "CHEMICAL", 18, 24], ["carbon", "CHEMICAL", 18, 24], ["carbon emissions", "PROBLEM", 18, 34], ["carbon emissions", "OBSERVATION", 18, 34]]], ["Only the Japanese economy enjoys the environmental benefits as negative shocks in government revenue decrease the amount of CO2 by 0.095%.", [["CO2", "CHEMICAL", 124, 127], ["CO2", "CHEMICAL", 124, 127], ["CO2", "SIMPLE_CHEMICAL", 124, 127], ["CO2", "TEST", 124, 127], ["amount", "OBSERVATION_MODIFIER", 114, 120]]], ["Moreover, a lower government income tax revenue uniquely decreases the government\u2019s spending that reduces carbon emissions.", [["carbon", "CHEMICAL", 106, 112], ["carbon", "SIMPLE_CHEMICAL", 106, 112], ["tax", "PROTEIN", 36, 39], ["carbon emissions", "OBSERVATION", 106, 122]]], ["With lower government revenues, the emission level responds less to the government spending negative shock; therefore, it is easier for the management to maintain the carbon emissions target.", [["shock", "DISEASE", 101, 106], ["carbon", "CHEMICAL", 167, 173], ["the management", "TREATMENT", 136, 150], ["the carbon emissions target", "TREATMENT", 163, 190], ["lower", "OBSERVATION_MODIFIER", 5, 10], ["government revenues", "OBSERVATION", 11, 30], ["shock", "OBSERVATION", 101, 106], ["carbon emissions", "OBSERVATION", 167, 183]]], ["We also suggested that increasing fiscal revenues with affecting its public spending structure is not neutral for the environment in Asian economies.", [["increasing", "OBSERVATION_MODIFIER", 23, 33]]], ["Again, all the economies demonstrate the consensus on the unfriendly environmental effects of GDP growth on account of surging carbon emissions in the long run.Empirical results and discussion ::: Model and methodologyBeyond that, we report the outcomes of some diagnostic tests in panel C. The results also conclude that ECMt-1 statistics of all sampled economies are significantly negative.", [["GDP", "CHEMICAL", 94, 97], ["GDP", "CHEMICAL", 94, 97], ["carbon", "CHEMICAL", 127, 133], ["GDP", "SIMPLE_CHEMICAL", 94, 97], ["carbon", "SIMPLE_CHEMICAL", 127, 133], ["ECMt-1", "GENE_OR_GENE_PRODUCT", 322, 328], ["GDP growth", "PROBLEM", 94, 104], ["surging carbon emissions", "TREATMENT", 119, 143], ["some diagnostic tests", "TEST", 257, 278], ["ECMt", "TEST", 322, 326], ["all sampled economies", "TEST", 343, 364], ["GDP growth", "OBSERVATION", 94, 104]]], ["It indicates that the adjustment rate towards the long-run equilibrium is 47% in Malaysia, 63% in UAE, 81% in Thailand, 40% in Indonesia, 70% in Turkey, 53% in Iran, 73% in Saudi Arabia, 80% in Japan, 50% in India, and 91% in China.", [["the adjustment rate", "TEST", 18, 37], ["UAE", "TEST", 98, 101], ["Thailand", "TEST", 110, 118], ["Indonesia", "TEST", 127, 136], ["Iran", "TEST", 160, 164], ["Saudi Arabia", "TEST", 173, 185], ["Japan", "TEST", 194, 199], ["India", "TEST", 208, 213]]], ["The LM and LM test with the structural break and RESET tests are also deployed to determine the autocorrelation and model specification, respectively.", [["LM", "MULTI-TISSUE_STRUCTURE", 4, 6], ["The LM and LM test", "TEST", 0, 18], ["RESET tests", "TEST", 49, 60], ["LM", "ANATOMY", 4, 6], ["LM", "ANATOMY", 11, 13]]], ["The findings suggest that all models of the selected sample are robust as the statistics of the LM and RESET tests are insignificant.", [["LM", "MULTI-TISSUE_STRUCTURE", 96, 98], ["RESET tests", "TEST", 103, 114], ["LM", "ANATOMY", 96, 98], ["insignificant", "OBSERVATION_MODIFIER", 119, 132]]], ["To check the stability of the NARDL estimates, we apply CUSUM and CUSUMQ tests that confirm the stability of the parameters of most models.", [["CUSUM and CUSUMQ tests", "TEST", 56, 78]]], ["The short- and long-run asymmetries are further supported by the Wald test of fiscal policy instruments.", [["The short- and long-run asymmetries", "PROBLEM", 0, 35], ["fiscal policy instruments", "TREATMENT", 78, 103], ["short", "OBSERVATION_MODIFIER", 4, 9]]], ["The results show that short- and long-run asymmetries exist in both variables in some selected economies.", [["short- and long-run asymmetries", "PROBLEM", 22, 53], ["short", "OBSERVATION_MODIFIER", 22, 27], ["both", "ANATOMY_MODIFIER", 63, 67], ["selected", "OBSERVATION_MODIFIER", 86, 94], ["economies", "OBSERVATION", 95, 104]]], ["The asymmetry curves show the nonlinear mixture of the dynamic multipliers due to positive and negative shocks of the government expenditure and revenue variables (Fig. 1).Conclusion and policy implicationsFiscal policy instruments are said to have positive or negative effects on environmental quality, depending on the public sector spending and tax revenues.", [["tax", "PROTEIN", 348, 351], ["The asymmetry curves", "TEST", 0, 20]]], ["However, due to changes in their expectations, the impacts of fiscal policy instruments on the environment could be asymmetric.", [["fiscal policy instruments", "TREATMENT", 62, 87], ["asymmetric", "OBSERVATION_MODIFIER", 116, 126]]], ["Therefore, the study examines the asymmetric effects of fiscal policy instruments on environmental pollution by using the NARDL approaches for a dataset covering the 1980\u20132018 period for Malaysia, UAE, Thailand, Indonesia, Turkey, Iran, Saudi Arabia, Japan, India, and China.Conclusion and policy implicationsThe outcome of asymmetric ARDL exhibits that positive shock of government expenditure has a positive effect on the environmental pollution in the proposed economies, including Malaysia, UAE, Thailand, Indonesia, Turkey, Iran, India, and China.", [["shock", "DISEASE", 363, 368], ["the study", "TEST", 11, 20], ["fiscal policy instruments", "TREATMENT", 56, 81], ["asymmetric ARDL", "PROBLEM", 324, 339], ["positive shock of government expenditure", "PROBLEM", 354, 394], ["asymmetric", "OBSERVATION_MODIFIER", 34, 44], ["asymmetric", "OBSERVATION_MODIFIER", 324, 334], ["positive", "OBSERVATION_MODIFIER", 354, 362], ["shock", "OBSERVATION", 363, 368], ["positive effect", "OBSERVATION_MODIFIER", 401, 416]]], ["However, the adverse shocks decline the carbon pollution in these economies.", [["carbon", "CHEMICAL", 40, 46], ["carbon", "CHEMICAL", 40, 46], ["the adverse shocks", "PROBLEM", 9, 27], ["the carbon pollution", "TREATMENT", 36, 56], ["carbon pollution", "OBSERVATION", 40, 56]]], ["While Japan gets environmental improvements through the decline in carbon emissions when the government expenditure trends to increases over time.", [["carbon", "CHEMICAL", 67, 73], ["carbon", "SIMPLE_CHEMICAL", 67, 73], ["carbon emissions", "TREATMENT", 67, 83]]], ["While the Japanese government expenditure negative shocks also have a positive influence on carbon emissions.", [["carbon", "CHEMICAL", 92, 98], ["carbon", "SIMPLE_CHEMICAL", 92, 98], ["a positive influence on carbon emissions", "PROBLEM", 68, 108], ["carbon emissions", "OBSERVATION", 92, 108]]], ["Our results have revealed that the positive shock of government revenue enhances the environmental pollution of eight countries (Malaysia, UAE, Thailand, Indonesia, Turkey, Iran, India, and China).", [["shock", "DISEASE", 44, 49], ["positive", "OBSERVATION_MODIFIER", 35, 43], ["shock", "OBSERVATION_MODIFIER", 44, 49]]], ["In contrast, the negative shocks of government revenues carry favorable impacts on the environment quality of these eight economies.", [["favorable", "OBSERVATION_MODIFIER", 62, 71]]], ["While the Japanese government\u2019s positive and negative shocks in revenues have similar results on environments as in the case of government expenditure, the findings also revealed that government expenditure outcomes are also maintained in Malaysia, UAE, Thailand, Indonesia, Turkey, Iran, India, and China, means that a lower (higher) government income tax revenue uniquely decreases (increase) the government\u2019s spending that reduces (increase) the carbon emissions.", [["carbon", "CHEMICAL", 449, 455], ["tax", "PROTEIN", 353, 356], ["the carbon emissions", "TREATMENT", 445, 465], ["decreases", "OBSERVATION_MODIFIER", 374, 383], ["carbon emissions", "OBSERVATION", 449, 465]]], ["However, fiscal policy instruments in Saudi Arabia\u2019s economy have an insignificant influence on environmental pollution.", [["insignificant", "OBSERVATION_MODIFIER", 69, 82]]], ["Overall, the asymmetric findings are also country-specific, and in general, carbon pollution could be attributed to fiscal policy phenomena in the proposed economies.Conclusion and policy implicationsBased on these findings, regarding public spending, Asian economics should devote revenues to green public goods which are completely environmental-friendly.", [["carbon", "CHEMICAL", 76, 82], ["carbon", "SIMPLE_CHEMICAL", 76, 82], ["carbon pollution", "PROBLEM", 76, 92], ["fiscal policy phenomena", "PROBLEM", 116, 139], ["asymmetric", "OBSERVATION_MODIFIER", 13, 23], ["findings", "OBSERVATION", 24, 32], ["carbon pollution", "OBSERVATION", 76, 92], ["fiscal policy", "OBSERVATION", 116, 129]]], ["The Asian economies should minimize the carbon emissions through fiscal policy instruments as well as monetary policy because fiscal policy is not a specific solution.", [["carbon", "CHEMICAL", 40, 46], ["The Asian economies", "TREATMENT", 0, 19], ["the carbon emissions", "TREATMENT", 36, 56], ["fiscal policy instruments", "TREATMENT", 65, 90]]], ["At the time of fiscal policy, Asian economies set up long-term environmental policies by considering the government expenditure and revenue.", [["fiscal policy", "TREATMENT", 15, 28]]], ["Fiscal policies must be independent in Asian economies because efficient fiscal policies can help to minimize environmental pollution.", [["efficient fiscal policies", "TREATMENT", 63, 88]]], ["Asian economies should introduce green energy in public transportation and physical capital that is normally small carbon emitters.", [["carbon", "CHEMICAL", 115, 121], ["normally small carbon emitters", "PROBLEM", 100, 130], ["small", "OBSERVATION_MODIFIER", 109, 114], ["carbon emitters", "OBSERVATION", 115, 130]]], ["In sum, the importance of fiscal policies is strongly emphasized further in the context of climate change.", [["fiscal policies", "TREATMENT", 26, 41]]], ["Public spending will be increased sharply in many countries during previous years in response to the coronavirus that Asian economies must consider environmental quality.", [["coronavirus", "ORGANISM", 101, 112], ["the coronavirus", "PROBLEM", 97, 112]]], ["The governments in the Asian region need to heavily invest in human capital, offer concessional bank lending to green economic activities, increase clean infrastructure investment and provide tax incentives to capital markets, and increase consumer financing so that technical and market barriers are sufficiently eased.", [["human", "ORGANISM", 62, 67], ["human", "SPECIES", 62, 67], ["human", "SPECIES", 62, 67], ["technical and market barriers", "TREATMENT", 267, 296]]], ["Households, especially the poor ones and producers who are more carbon emitters, will need some sort of support to assistance from fiscal policy instruments.", [["carbon", "CHEMICAL", 64, 70], ["carbon emitters", "TREATMENT", 64, 79], ["fiscal policy instruments", "TREATMENT", 131, 156]]], ["Also, the Japanese government should maintain the emphasis on public spending on human capital goods leads to a greater reduction of carbon emissions than aggregate spending, for both consumption- and production-generated emissions.", [["carbon", "CHEMICAL", 133, 139], ["carbon", "CHEMICAL", 133, 139], ["human", "ORGANISM", 81, 86], ["carbon", "SIMPLE_CHEMICAL", 133, 139], ["human", "SPECIES", 81, 86], ["human", "SPECIES", 81, 86], ["a greater reduction of carbon emissions", "TREATMENT", 110, 149]]]], "PMC7266130": [["Research publication is slow ::: Main textThe current system for publication of peer-reviewed research is slow.", [["slow", "OBSERVATION_MODIFIER", 106, 110]]], ["However, in the light of COVID-19, it is very clear that the delays caused by standard workflows, which are both appropriately rigorous and inappropriately bureaucratic, are slowing the translation of new research evidence into practice, and that lives are being lost in those lost days, weeks and months.Research publication is slow ::: Main textA now familiar example is a key paper on the effectiveness of face masks [1], for which Nature Medicine achieved what would have, in other times, been considered a sprightly turnaround, but which resulted in a 1-month delay between receipt of the paper and its publication.", [["COVID", "TEST", 25, 30], ["inappropriately bureaucratic", "PROBLEM", 140, 168], ["face masks", "TREATMENT", 409, 419], ["clear", "OBSERVATION", 46, 51], ["new", "OBSERVATION_MODIFIER", 201, 204]]], ["On the other hand, the growing interest in \u2018living\u2019 continually updated evidence reviews does seem to have taken off in an environment where so little is certain and new evidence is available every day.Research publication is noisy ::: Main textOver the first few months of 2020, there has been an initially small, but dizzyingly rapid production of primary research and reviews of research related to COVID-19.", [["COVID-19", "CHEMICAL", 402, 410], ["COVID-19", "DNA", 402, 410], ["COVID", "TEST", 402, 407], ["small", "OBSERVATION_MODIFIER", 308, 313]]], ["These research studies have been broadly disseminated through the usual research publication systems as well as through social media, clinical networks and other channels.", [["These research studies", "TEST", 0, 22]]], ["We need better strategies to remove the noise from our research publication and dissemination systems, and we need them now.", [["the noise", "PROBLEM", 36, 45], ["dissemination systems", "TEST", 80, 101]]], ["Simple flags for identifying research that has been peer reviewed or accessible, curated collections of rapid systematic reviews would be useful steps in the right direction.There is a desire for research ::: Main textHaving been increasingly disheartened by the cynical attitudes towards \u2018experts\u2019 and \u2018evidence\u2019 so sadly ubiquitous in the pre-COVID-19 world, it has been hugely encouraging to see the widespread demand for research evidence to guide health decision-making at all levels, from individual patients to global multi-laterals.There is a desire for research ::: Main textThis presents a huge opportunity for the research community to demonstrate their ability and willingness to engage, and it has been encouraging to see our colleagues step up and into the conversation.", [["patients", "ORGANISM", 506, 514], ["patients", "SPECIES", 506, 514], ["Simple flags", "PROBLEM", 0, 12], ["rapid systematic reviews", "TEST", 104, 128], ["flags", "OBSERVATION", 7, 12], ["right", "ANATOMY_MODIFIER", 158, 163]]], ["There is no doubting the real-world impact of research on decision-making in the shadow of COVID-19, even if it will be months before we see the publication metrics.There is a desire for research ::: Main textThe real challenge will be converting these acute \u2018evidence hunger pangs\u2019 into an ongoing appetite in our governments, health systems and others to fund and use research evidence to guide decision-making beyond the pandemic.", [["pangs", "DISEASE", 276, 281], ["COVID", "TEST", 91, 96], ["no", "UNCERTAINTY", 9, 11]]], ["To achieve this, we need to ensure that we capture data and stories of the impact of research on decision-making during the current crisis, so we can build on this momentum following the pandemic.Researchers are collaborators ::: Main textNever before have so many researchers asked for access to pre-publication data from their colleagues on the other side of the globe and received a rapid and resounding \u2018yes\u2019.", [["pre-publication", "DISEASE", 297, 312], ["the pandemic", "PROBLEM", 183, 195], ["pre-publication data", "TEST", 297, 317], ["globe", "ANATOMY", 365, 370]]], ["COVID-19 has provided an undeniable imperative to put aside concerns of being pipped to the publishing post or to the funder\u2019s wallet, to collaborate in the service of the global, common and immediate good.Researchers are collaborators ::: Main textAs elsewhere, our challenge as a research community is to translate this willingness to share beyond the bubble produced by this pandemic and beyond the espoused rhetoric; to build and implement models for research funding, conduct and publication that reward true collaboration and acknowledge the reality that the partnerships required for successful collaborative research are complex and time consuming as well as, ultimately, incredibly rewarding.It is all one evidence ecosystem ::: Main textThe line between research and practice has always been marked in fuzzy pencil and COVID has taken a big smudgy eraser to that already unclear demarcation.", [["research funding", "TREATMENT", 455, 471], ["The line", "TREATMENT", 747, 755], ["a big smudgy eraser", "TREATMENT", 845, 864], ["good", "OBSERVATION_MODIFIER", 201, 205], ["bubble", "OBSERVATION", 354, 360], ["line", "OBSERVATION", 751, 755], ["marked", "OBSERVATION_MODIFIER", 802, 808], ["fuzzy pencil", "OBSERVATION", 812, 824], ["demarcation", "OBSERVATION", 889, 900]]], ["A novel virus, an unprecedented health emergency, a non-existent evidence base.", [["A novel virus", "PROBLEM", 0, 13], ["virus", "OBSERVATION", 8, 13], ["base", "ANATOMY_MODIFIER", 74, 78]]], ["In this evidence-free zone, when does a clinical hunch, a series of cases, the experience of a hospital for a month, become the best available evidence?", [["free zone", "OBSERVATION", 17, 26]]], ["Hydroxychloroquine, which was touted early in the outbreak as a revolutionary treatment, is looking less and less promising as rigorous trials emerge [2] and clinical experience has been key in identifying that the symptoms of COVID-19 may deteriorate rapidly on days 6\u201310 of illness, life-saving information for ensuring patients are appropriately monitored even if apparently well [3].", [["Hydroxychloroquine", "CHEMICAL", 0, 18], ["COVID", "DISEASE", 227, 232], ["illness", "DISEASE", 276, 283], ["Hydroxychloroquine", "CHEMICAL", 0, 18], ["COVID-19", "CHEMICAL", 227, 235], ["Hydroxychloroquine", "SIMPLE_CHEMICAL", 0, 18], ["patients", "ORGANISM", 322, 330], ["patients", "SPECIES", 322, 330], ["Hydroxychloroquine", "TREATMENT", 0, 18], ["a revolutionary treatment", "TREATMENT", 62, 87], ["the symptoms", "PROBLEM", 211, 223], ["COVID", "TEST", 227, 232], ["illness", "PROBLEM", 276, 283]]], ["Vital knowledge about COVID-19 has been produced along the entire research spectrum from the very fundamental, \u2018basic\u2019 research to the most hands-on clinician researcher; the engine rooms of translation have been the multidisciplinary networks of clinical specialists, policy-makers and researchers in formal discussion lists, on knowledge translation platforms and in professional societies.", [["COVID", "TEST", 22, 27]]], ["As is always true, and is even more so now, there is no us and them, we are all us.Conclusion: the possibilities ::: Main textIt has already become a clich\u00e9 that COVID-19 presents us with a pivotal moment; there is no question that many decisions made now will have a huge impact on history, for better or for worse.", [["no", "UNCERTAINTY", 53, 55], ["no question", "UNCERTAINTY", 215, 226]]], ["This crucible of COVID-19 highlights the fundamental need to institutionalize the use of research evidence in policy decisions at a time of crisis, and beyond.", [["COVID", "TEST", 17, 22], ["crisis", "PROBLEM", 140, 146]]]], "PMC7279229": [], "f19fb35c6648929cd986ba0e0513f423d09ae5b1": [["Have more confidence in your stability data: Two points to consider K. De Vore (Irvine, CA, USABioanalytical ApplicationsEvaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I", [["serum", "ANATOMY", 216, 221], ["osteoporosis", "DISEASE", 181, 193], ["serum", "ORGANISM_SUBSTANCE", 216, 221], ["osteocalcin", "GENE_OR_GENE_PRODUCT", 222, 233], ["collagen I", "GENE_OR_GENE_PRODUCT", 238, 248], ["modal damping factor", "PROTEIN", 135, 155], ["serum osteocalcin", "PROTEIN", 216, 233], ["collagen I", "PROTEIN", 238, 248], ["modal damping factor", "PROBLEM", 135, 155], ["a diagnostic tool", "TEST", 159, 176], ["osteoporosis", "PROBLEM", 181, 193], ["serum osteocalcin", "TEST", 216, 233]]]], "PMC7543614": [["We provide an overview of COVID-19 informatics resources, including data specifications for COVID-19 clinical encounters, laboratory results, cause-of-death certification, PH surveillance, and emergency operations.", [["death", "DISEASE", 151, 156], ["PH surveillance", "TEST", 172, 187], ["emergency operations", "TREATMENT", 193, 213]]], ["The scope of the review is (1) to demonstrate the CDC COVID-19 Information Management Repository\u2019s ability to categorize and manage critical COVID-19 informatics documentation and standards; and (2) to describe COVID-19 data exchange standards, forms, and specifications.MATERIALS AND METHODSThe Repository (Figure 1) is the product of collaboration among the CDC COVID-19 IMS; CDC EOC\u2019s Situational Awareness Team; CDC\u2019s Center for Surveillance, Epidemiology, and Laboratory Services; and other CDC centers participating in the COVID-19 response.MATERIALS AND METHODSThe Repository is publicly available, distributed through the CDC\u2019s Public Health Information Network Vocabulary Access and Distribution System (PHIN VADS; see Figure 1).1 PHIN VADS is a web-based enterprise vocabulary and information management system for accessing, searching, and distributing vocabularies, terminology, and data standards used in PH and clinical care practice.", [["critical COVID", "TEST", 132, 146], ["COVID", "TEST", 211, 216], ["the COVID", "TEST", 525, 534], ["System (PHIN VADS", "TREATMENT", 705, 722]]], ["PHIN VADS promotes the use of semantically interoperable information sources to support consistent communication among PH partners.2 The Repository can be accessed via the PHIN VADS homepage or the \u201cCDC COVID-19 Surveillance and Data Analytics\u201d3 page within Additional Information Resources on the primary CDC \u201cCoronavirus (COVID-19)\u201d web page.", [["PHIN VADS", "TREATMENT", 0, 9], ["the PHIN VADS homepage", "TREATMENT", 168, 190]]], ["Within the Repository, essential COVID-19 data management and data definition sources are divided into 6 Sections (Table 1).MATERIALS AND METHODSIn this review, we describe 5 sections (1.2-1.6) within the Repository that address specific COVID-19 information management use cases.", [["essential COVID-19 data management", "TREATMENT", 23, 57]]], ["Additionally, we provide references to documents included in the General Resources (Section 1.1) that address information exchange needs across specific use cases.MATERIALS AND METHODSPrimary standard development and standard implementation organizations that collaborate with the CDC and contribute to the CDC COVID-19 Repository and data interoperability tasks are presented in Table 2.MATERIALS AND METHODSThe CDC\u2019s COVID-19 IMS Data Team and EOC Situational Awareness informaticians developed ongoing communications with these organizations to assure that (1) essential elements of COVID-19 information exchange are included in the data harmonization and standardization process; and (2) these organizations provide the most recent data standard and specifications to the Repository management team.", [["the CDC COVID", "TEST", 303, 316], ["COVID", "TEST", 419, 424], ["COVID", "TEST", 586, 591]]], ["As of 2 May 2020, the Repository contained 53 reference sources, all included in the present review.Applying the NEMSIS standard for collection and analysis of pre-hospital emergency care information (repository section 1.2) ::: RESULTSThe National Emergency Medical Services Information System (NEMSIS) provides a framework for collecting, storing, and sharing standardized EMS data from states nationwide.4 NEMSIS develops and manages the national universal standard for the collection and transmission of EMS operations and patient care data.", [["patient", "ORGANISM", 527, 534], ["patient", "SPECIES", 527, 534], ["the NEMSIS standard", "TREATMENT", 109, 128], ["EMS operations", "TREATMENT", 508, 522], ["patient care data", "TEST", 527, 544]]], ["The Office of the National Coordinator for Health Information Technology (ONC) 2020 Interoperability Standards Advisory (ISA) recommends the \u201cNEMSIS data standard version 3.4\u201d5 as a primary national standard for representing health-care data for emergency medical services.6CSTE COVID-19 case definition and national notification ::: Analyzing and reporting a COVID-19 clinical encounter (repository section 1.3) ::: RESULTSOn 5 May 2020, the Council of State and Territorial Epidemiologists (CSTE) released the \u201cstandardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19) Interim-20-ID-01.\u201d7 This provides criteria for case ascertainment (clinical, laboratory, epidemiologic, vital records, and other criteria for case reporting), as well as case classifications (confirmed, probable) for the COVID-19 case definition (Figure 2).CSTE COVID-19 case definition and national notification ::: Analyzing and reporting a COVID-19 clinical encounter (repository section 1.3) ::: RESULTSThis COVID-19 case definition and case classification serves as a foundation for COVID-19 cases\u2019 codification via the data standards described above.ICD-10-CM COVID-19 codes ::: Analyzing and reporting a COVID-19 clinical encounter (repository section 1.3) ::: RESULTSThe International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) is a coding system based on the World Health Organization\u2019s (WHO\u2019s) ICD-10, modified for US clinical use by the Department of Health and Human Services (spearheaded by the CDC\u2019s National Center for Health Statistics and Centers for Medicare and Medicaid Services [CMS]) and used by physicians and other health-care providers to classify and code all diagnoses, symptoms, and procedures recorded in conjunction with hospital care in the United States.8 Epidemiologists and data analysts use ICD-10-CM codes for tracking and analyzing COVID-19 morbidity.", [["coronavirus disease", "DISEASE", 596, 615], ["Human", "ORGANISM", 1535, 1540], ["Human", "SPECIES", 1535, 1540], ["novel coronavirus disease", "PROBLEM", 590, 615], ["COVID", "TEST", 617, 622], ["the COVID", "TEST", 844, 853], ["COVID", "TEST", 1115, 1120], ["ICD", "TEST", 1183, 1186], ["Diseases", "PROBLEM", 1338, 1346], ["Tenth Revision", "TREATMENT", 1348, 1362], ["Clinical Modification (ICD", "TREATMENT", 1364, 1390], ["ICD", "TREATMENT", 1466, 1469], ["symptoms", "PROBLEM", 1759, 1767], ["procedures", "TREATMENT", 1773, 1783], ["ICD", "TREATMENT", 1888, 1891], ["analyzing COVID", "TEST", 1921, 1936], ["10-CM", "OBSERVATION_MODIFIER", 1187, 1192], ["Diseases", "OBSERVATION", 1338, 1346]]], ["Since 20 February 2020, following WHO COVID-19 recommendations, the CDC and CMS twice released COVID-19 ICD-10-CM guidance:", [["CM", "DISEASE", 111, 113], ["ICD", "TREATMENT", 104, 107]]]], "PMC7149820": [["IntroductionThe variant 1 of the human bocavirus (HBoV-1) that causes respiratory infections in primates and humans belongs to the family of Parvoviridae, subfamily Parvovirinae, genus Bocaparvovirus, was discovered originally in 2005 by Tobias Allander1 and his team and represents together with the strains HBoV-3 and the gorilla bocavirus the species Primate bocaparvovirus 1.2", [["respiratory", "ANATOMY", 70, 81], ["respiratory infections", "DISEASE", 70, 92], ["human", "ORGANISM", 33, 38], ["bocavirus", "GENE_OR_GENE_PRODUCT", 39, 48], ["HBoV-1", "ORGANISM", 50, 56], ["primates", "ORGANISM", 96, 104], ["humans", "ORGANISM", 109, 115], ["Parvoviridae", "GENE_OR_GENE_PRODUCT", 141, 153], ["subfamily Parvovirinae", "ORGANISM", 155, 177], ["HBoV-3", "ORGANISM", 309, 315], ["gorilla bocavirus", "ORGANISM", 324, 341], ["Primate bocaparvovirus", "ORGANISM", 354, 376], ["human", "SPECIES", 33, 38], ["humans", "SPECIES", 109, 115], ["gorilla bocavirus", "SPECIES", 324, 341], ["human bocavirus", "SPECIES", 33, 48], ["HBoV-1", "SPECIES", 50, 56], ["humans", "SPECIES", 109, 115], ["HBoV-3", "SPECIES", 309, 315], ["Primate bocaparvovirus", "SPECIES", 354, 376], ["the human bocavirus (HBoV", "TREATMENT", 29, 54], ["respiratory infections", "PROBLEM", 70, 92], ["Parvoviridae", "TREATMENT", 141, 153], ["the strains HBoV", "TEST", 297, 313], ["the gorilla bocavirus the species", "PROBLEM", 320, 353], ["bocaparvovirus", "TEST", 362, 376], ["respiratory", "ANATOMY", 70, 81], ["infections", "OBSERVATION", 82, 92], ["gorilla bocavirus", "ANATOMY", 324, 341]]]], "PMC7263071": [["IntroductionCOVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) [1].", [["respiratory", "ANATOMY", 26, 37], ["respiratory disease", "DISEASE", 26, 45], ["SARS-CoV-2", "ORGANISM", 77, 87], ["coronavirus", "SPECIES", 64, 75], ["IntroductionCOVID", "TEST", 0, 17], ["a respiratory disease", "PROBLEM", 24, 45], ["a novel coronavirus", "PROBLEM", 56, 75], ["respiratory disease", "OBSERVATION", 26, 45]]], ["Two other coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle Eastern respiratory syndrome coronavirus (MERS- CoV) had been identified in 2002 and 2012 [4].", [["acute respiratory syndrome coronavirus", "DISEASE", 32, 70], ["SARS-CoV)", "DISEASE", 72, 81], ["Middle Eastern respiratory syndrome coronavirus", "DISEASE", 86, 133], ["severe acute respiratory syndrome coronavirus", "ORGANISM", 25, 70], ["SARS-CoV", "ORGANISM", 72, 80], ["Middle Eastern respiratory syndrome coronavirus", "ORGANISM", 86, 133], ["MERS- CoV", "ORGANISM", 135, 144], ["syndrome coronavirus", "SPECIES", 113, 133], ["severe acute respiratory syndrome coronavirus", "SPECIES", 25, 70], ["SARS-CoV", "SPECIES", 72, 80], ["Middle Eastern respiratory syndrome coronavirus", "SPECIES", 86, 133], ["MERS- CoV", "SPECIES", 135, 144], ["Two other coronaviruses", "PROBLEM", 0, 23], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 25, 70], ["Middle Eastern respiratory syndrome coronavirus", "PROBLEM", 86, 133], ["coronaviruses", "OBSERVATION", 10, 23], ["severe", "OBSERVATION_MODIFIER", 25, 31], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["respiratory syndrome coronavirus", "OBSERVATION", 38, 70], ["Middle", "ANATOMY_MODIFIER", 86, 92], ["respiratory syndrome", "OBSERVATION", 101, 121]]], ["While both of these caused significant outbreaks of disease, they were more lethal and less transmissible, and did not cause pandemics.IntroductionSARS-CoV-2 has already spread through most of the world.", [["IntroductionSARS-CoV-2", "CHEMICAL", 135, 157], ["disease", "PROBLEM", 52, 59], ["pandemics", "PROBLEM", 125, 134], ["IntroductionSARS", "TEST", 135, 151], ["significant", "OBSERVATION_MODIFIER", 27, 38], ["outbreaks", "OBSERVATION_MODIFIER", 39, 48], ["disease", "OBSERVATION", 52, 59]]], ["And most countries have restricted travel, closed large parts of industry, restructured their economies, and focussed their efforts on its control.", [["large", "OBSERVATION_MODIFIER", 50, 55]]], ["By the 29th April, 3 053 457 cases of COVID-19 had been confirmed by testing and 214 862 of those individuals had died [5].", [["COVID", "TEST", 38, 43]]], ["Cases have been reported in 207 countries.IntroductionVarious measures have been adopted to control the spread of the virus.", [["IntroductionVarious measures", "TREATMENT", 42, 70], ["the virus", "PROBLEM", 114, 123]]], ["The most stringent of these have been termed \u201clockdown\u201d, and almost entirely restricted people to their own homes.", [["people", "ORGANISM", 88, 94], ["people", "SPECIES", 88, 94], ["most stringent", "OBSERVATION_MODIFIER", 4, 18]]], ["At the end of April, some European countries began to try relaxing some of restrictions, but, in late-May, there continue to be large numbers of mortalities in most parts of the world [5].", [["large numbers of mortalities", "PROBLEM", 128, 156], ["large", "OBSERVATION_MODIFIER", 128, 133], ["numbers", "OBSERVATION_MODIFIER", 134, 141], ["mortalities", "OBSERVATION", 145, 156]]], ["We therefore need to understand both the transmissibility of the virus and the effectiveness of the social distancing and lockdown measures that have been taken.", [["the virus", "PROBLEM", 61, 70], ["lockdown measures", "TREATMENT", 122, 139]]], ["The difference between the initial spread of the virus, before the restrictions were imposed, and its spread under lockdown gives an estimate of how effective lockdown measures have been.", [["the virus", "PROBLEM", 45, 54], ["effective lockdown measures", "TREATMENT", 149, 176], ["difference", "OBSERVATION_MODIFIER", 4, 14], ["virus", "OBSERVATION", 49, 54]]], ["It can also suggest how far those measures can be relaxed without a resurgence of infection.IntroductionThis paper uses publically available data from multiple countries to model the spread of SARS-CoV-2, both before and under the lockdown, and estimate the scope for relaxing the current restrictions.Data ::: MethodsData on the numbers of new confirmed cases of COVID-19, and numbers of deaths reported for people known to have COVID-19, are available from the European Centre for Disease Prevention and Control (ECDC) website (www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-COVID-19-19-cases-worldwide).", [["infection", "DISEASE", 82, 91], ["SARS", "DISEASE", 193, 197], ["deaths", "DISEASE", 389, 395], ["people", "ORGANISM", 409, 415], ["people", "SPECIES", 409, 415], ["SARS-CoV", "SPECIES", 193, 201], ["infection", "PROBLEM", 82, 91], ["COVID", "TEST", 364, 369], ["COVID", "TEST", 430, 435], ["Disease Prevention", "TREATMENT", 483, 501], ["infection", "OBSERVATION", 82, 91]]], ["Mortality data was used for countries that had reported at least 100 deaths, and numbers of cases for those where at least 1000 confirmed cases had been reported.", [["deaths", "DISEASE", 69, 75], ["Mortality data", "TEST", 0, 14]]], ["The pattern of arrival of infectious individuals determines the course of the initial stages of outbreaks, therefore days before a total of 10 deaths or 100 cases had been reported in each country were discarded.", [["deaths", "DISEASE", 143, 149], ["infectious individuals", "PROBLEM", 26, 48], ["infectious", "OBSERVATION", 26, 36]]], ["That left 89 countries with sufficient data for further consideration.Data ::: MethodsBoth these types of data have important limitations: varying proportions of infections and deaths were not recorded, in each country and over time.", [["infections", "DISEASE", 162, 172], ["deaths", "DISEASE", 177, 183], ["infections", "PROBLEM", 162, 172], ["infections", "OBSERVATION", 162, 172]]], ["But they do provide a large, stable, and standardised source of information that covers most countries.", [["large", "OBSERVATION_MODIFIER", 22, 27], ["stable", "OBSERVATION_MODIFIER", 29, 35]]], ["Confirmed cases are individuals who have tested positive for SARS-CoV-2.", [["SARS", "DISEASE", 61, 65], ["SARS-CoV-2", "ORGANISM", 61, 71], ["SARS-CoV", "SPECIES", 61, 69], ["SARS", "PROBLEM", 61, 65], ["CoV", "TEST", 66, 69]]], ["Unfortunately, no country has managed complete and continuous testing, and limitations and changes in testing strategies make this data particularly problematic.", [["continuous testing", "TEST", 51, 69], ["changes in testing strategies", "TEST", 91, 120]]], ["Data are skewed towards hospitalised cases and asymptomatic or paucisymptomatic cases, in particular, will be underreported.", [["asymptomatic", "PROBLEM", 47, 59], ["paucisymptomatic cases", "PROBLEM", 63, 85]]], ["The mortality data have an intrinsic lag that reduces their sensitivity to recent changes.", [["an intrinsic lag", "PROBLEM", 24, 40]]], ["Nevertheless, most countries have systematic testing of hospitalised cases and most mortality occurs in hospitals, so disease specific mortality is potentially less biased than confirmed cases.", [["systematic testing", "TEST", 34, 52], ["disease specific mortality", "PROBLEM", 118, 144]]], ["Data for each included country were examined for inconsistencies and artefacts.", [["artefacts", "PROBLEM", 69, 78]]], ["The data for China on 18th April showed a spike that appears to be an artefact of redefinition, and was also discarded.", [["a spike", "PROBLEM", 40, 47], ["appears to be", "UNCERTAINTY", 53, 66], ["artefact", "OBSERVATION", 70, 78]]], ["Iran reported nothing on the 4th April and a spike on the 5th, so those reports were split evenly across the 2 days.Structure of the models ::: MethodsThe number of people a directly transmitted disease will infect each day is proportional to the number of infectious people multiplied by the number of susceptible people.", [["people", "ORGANISM", 165, 171], ["people", "ORGANISM", 268, 274], ["people", "ORGANISM", 315, 321], ["people", "SPECIES", 165, 171], ["people", "SPECIES", 268, 274], ["people", "SPECIES", 315, 321], ["a spike", "PROBLEM", 43, 50], ["Methods", "TREATMENT", 144, 151], ["a directly transmitted disease", "PROBLEM", 172, 202], ["infectious", "OBSERVATION", 257, 267]]], ["While the absolute numbers of COVID-19 cases and deaths are shocking, the daily numbers are very small proportions of each country's population and, therefore, the numbers of susceptible individuals are almost constant.", [["deaths", "DISEASE", 49, 55], ["COVID", "TEST", 30, 35], ["the daily numbers", "TEST", 70, 87], ["susceptible individuals", "PROBLEM", 175, 198], ["very", "OBSERVATION_MODIFIER", 92, 96], ["small", "OBSERVATION_MODIFIER", 97, 102], ["susceptible", "OBSERVATION_MODIFIER", 175, 186], ["individuals", "OBSERVATION", 187, 198], ["almost", "OBSERVATION_MODIFIER", 203, 209], ["constant", "OBSERVATION_MODIFIER", 210, 218]]], ["This means that, during periods of constant behaviour, exponential trajectories can be expected.", [["constant behaviour", "PROBLEM", 35, 53], ["exponential trajectories", "PROBLEM", 55, 79]]], ["And this should hold whether the daily numbers were increasing or decreasing.Structure of the models ::: MethodsEach country introduced restrictions in a different pattern, so rather than attempting to interpret those rules, and how people responded to them, the data were used to identify periods of steady increase and decline.", [["people", "ORGANISM", 233, 239], ["people", "SPECIES", 233, 239], ["MethodsEach country", "TREATMENT", 105, 124], ["the data", "TEST", 259, 267], ["steady increase", "PROBLEM", 301, 316], ["decreasing", "OBSERVATION_MODIFIER", 66, 76], ["steady", "OBSERVATION_MODIFIER", 301, 307], ["increase", "OBSERVATION", 308, 316]]], ["This required identifying, and discarding, the transitional period where the data were affected by both the original, pre-lockdown, and modified, lockdown behaviour.Structure of the models ::: MethodsThe data were loaded into R 3.6.1 (R Core Team 2019) [9] and mortality and cases from each country were analysed separately.", [["Methods", "TREATMENT", 193, 200], ["The data", "TEST", 200, 208]]], ["Preliminary examination of the data showed that residuals around models fitted to almost all the datasets were overdispersed relative to the Poisson distribution.", [["Preliminary examination of the data", "TEST", 0, 35], ["residuals around models", "PROBLEM", 48, 71], ["residuals", "OBSERVATION", 48, 57]]], ["All the models therefore used the negative binomial error family, with a log link function.Exponential models ::: MethodsTo find the best representation of the initial, exponential growth, phase, a pair of generalised linear models were fitted for each combination of start and finish date at least 10 days apart such that the finish date was no later than 5 days before the day that the maximum number of events was observed.", [["Methods", "TREATMENT", 114, 121], ["a pair of generalised linear models", "PROBLEM", 196, 231]]], ["The 5 day interval was chosen after exploration of the Spanish and Italian data, where tight lockdowns were associated with obvious changes in the trajectory.", [["exploration", "TEST", 36, 47], ["obvious changes in the trajectory", "PROBLEM", 124, 157]]], ["These changes were particularly visible because of the large numbers of infections in those countries at that time.", [["infections", "DISEASE", 72, 82], ["infections", "PROBLEM", 72, 82], ["large", "OBSERVATION_MODIFIER", 55, 60], ["numbers", "OBSERVATION_MODIFIER", 61, 68], ["infections", "OBSERVATION", 72, 82]]], ["Adjusting this interval changes the estimates, and estimability, of individual countries' trajectories but produces similar overall patternsExponential models ::: MethodsThe first model, of each pair, simply contained a linear term for time.", [["Methods", "TREATMENT", 163, 170], ["linear", "OBSERVATION_MODIFIER", 220, 226]]], ["The second model contained both linear and quadratic terms for time.", [["both", "OBSERVATION_MODIFIER", 27, 31], ["linear", "OBSERVATION_MODIFIER", 32, 38], ["quadratic", "OBSERVATION_MODIFIER", 43, 52]]], ["Exploratory analyses using AIC [11] showed this selected very short intervals, and the small sample correction, AICc, worsens this problem.", [["Exploratory analyses", "TEST", 0, 20], ["AIC", "TEST", 27, 30], ["the small sample correction", "TREATMENT", 83, 110], ["small", "OBSERVATION_MODIFIER", 87, 92]]], ["In BIC the penalty for additional parameters is proportional to the natural logarithm of the number of datapoints, so it is less eager to increase the complexity of models as sample size increases.Exponential models ::: MethodsLinear models were considered potential representations of the initial exponential growth phase if they:; 1) had positive point estimates of slope; and 2) had BIC lower than their parallel quadratic model.", [["MethodsLinear models", "TREATMENT", 220, 240], ["BIC lower than their parallel quadratic model", "PROBLEM", 386, 431], ["number", "OBSERVATION_MODIFIER", 93, 99], ["size", "OBSERVATION_MODIFIER", 182, 186], ["increases", "OBSERVATION_MODIFIER", 187, 196]]], ["If multiple models satisfied these criteria, the model where BIC was furthest below that of its quadratic equivalent was used.Exponential models ::: MethodsFor the exponential period under lockdown, the model was chosen in a similar way, but with its data not beginning before 5 days after the finish of the first exponential period.", [["the model where BIC", "TREATMENT", 45, 64]]], ["No requirement was placed on the slope of the second exponential period, so this could be negative or positive.", [["requirement", "OBSERVATION_MODIFIER", 3, 14], ["positive", "OBSERVATION", 102, 110]]], ["It could even be larger than that for the first period, if that produced a better fit to the data.", [["larger", "OBSERVATION_MODIFIER", 17, 23]]], ["One exponential period was identified in the case data from 19 countries, and two exponential periods for 68 others.", [["exponential", "OBSERVATION_MODIFIER", 4, 15]]], ["For the mortality data, these numbers were 1 and 53.Model checking ::: MethodsTo provide a visual check on these models, a generalised additive model (GAM) of the whole trajectory was also fitted [12].", [["the mortality data", "TEST", 4, 22], ["these numbers", "TEST", 24, 37], ["Methods", "TREATMENT", 71, 78], ["a visual check", "TEST", 89, 103], ["a generalised additive model (GAM) of the whole trajectory", "TREATMENT", 121, 179]]], ["In most cases, the ends of this curve are similar to the exponential models.", [["this curve", "TEST", 27, 37]]], ["It should be noted that GAMs favour steady change and curvature, while many of the changes in behaviour were quite sudden.", [["GAMs", "SIMPLE_CHEMICAL", 24, 28], ["steady change and curvature", "PROBLEM", 36, 63], ["curvature", "OBSERVATION_MODIFIER", 54, 63]]], ["For a few countries the mismatch between the GAM and exponential models gave, subjectively, cause for concern.", [["GAM", "DNA", 45, 48], ["mismatch", "OBSERVATION", 24, 32]]], ["These are indicated in the figures.Model checking ::: MethodsThe slopes, and confidence intervals around them, are of limited direct use.", [["Methods", "TREATMENT", 54, 61], ["slopes", "OBSERVATION_MODIFIER", 65, 71]]], ["However, dividing the natural logarithm of 2 by them gives the doubling time of epidemic growth or halving time of its decay.Reproduction (R) number ::: MethodsR0, the basic reproduction number for the disease, is the expected number of people one infected person would pass the disease to in a na\u00efve population.", [["people", "ORGANISM", 237, 243], ["MethodsR0", "PROTEIN", 153, 162], ["people", "SPECIES", 237, 243], ["person", "SPECIES", 257, 263], ["epidemic growth", "PROBLEM", 80, 95], ["MethodsR0", "TREATMENT", 153, 162], ["the disease", "PROBLEM", 198, 209], ["the disease", "PROBLEM", 275, 286], ["disease", "OBSERVATION", 202, 209], ["infected", "OBSERVATION", 248, 256]]], ["It is critical to disease spread: above 1 an epidemic will accelerate, below that the outbreak will fade away.", [["disease", "OBSERVATION", 18, 25]]], ["This approach requires an estimated distribution for the serial interval of infection.", [["infection", "DISEASE", 76, 85], ["infection", "PROBLEM", 76, 85], ["infection", "OBSERVATION", 76, 85]]], ["The lognormal with mean 4 days and standard deviation of 2.9 days calculated by Nishiura, Linton and Akhmetzhanov [15] was used for this.", [["Linton", "TREATMENT", 90, 96], ["Akhmetzhanov", "TREATMENT", 101, 113]]], ["While changing this distribution changes the individual estimated values for R0, the relationship between the estimates before and under lockdown is relatively insensitive to plausible choices.Estimates of the effect of \u201clockdown\u201d ::: MethodsMost discussion of R considers it as either indicating whether a disease outbreak will grow or fade away.", [["a disease outbreak", "PROBLEM", 305, 323], ["disease", "OBSERVATION", 307, 314]]], ["At best the size of R is used as an indication of these changes.", [["these changes", "PROBLEM", 50, 63], ["size", "OBSERVATION_MODIFIER", 12, 16]]], ["However, it is also a measure of how frequently individuals come into sufficiently close contact to pass the disease.", [["the disease", "PROBLEM", 105, 116], ["disease", "OBSERVATION", 109, 116]]], ["The difference between the value of R and 1 therefore contains information on how much behaviour needs to change to stop the spread of a disease, or how much restrictions on contact between individuals can be relaxed without causing a resurgence in infections.Estimates of the effect of \u201clockdown\u201d ::: MethodsFour estimates of the scope for relaxing lockdown were then considered (table 1).", [["infections", "DISEASE", 249, 259], ["a disease", "PROBLEM", 135, 144], ["infections", "PROBLEM", 249, 259], ["relaxing lockdown", "TREATMENT", 341, 358], ["infections", "OBSERVATION", 249, 259]]], ["It is the proportion that contact under lockdown could be increased without causing a resurgence of the epidemic.", [["the epidemic", "PROBLEM", 100, 112]]]], "PMC7172049": [["IntroductionThe respiratory and the intestinal tract are entry sites that are used frequently by microorganisms to invade a host.", [["respiratory", "ANATOMY", 16, 27], ["intestinal tract", "ANATOMY", 36, 52], ["respiratory and the intestinal tract", "DISEASE", 16, 52], ["intestinal tract", "ORGAN", 36, 52], ["the intestinal tract", "TREATMENT", 32, 52], ["respiratory", "ANATOMY", 16, 27], ["intestinal tract", "ANATOMY", 36, 52]]], ["In both cases, epithelial cells lining the lumen are a primary target site for successful infection.", [["epithelial cells", "ANATOMY", 15, 31], ["lumen", "ANATOMY", 43, 48], ["infection", "DISEASE", 90, 99], ["epithelial cells", "CELL", 15, 31], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 43, 48], ["epithelial cells", "CELL_TYPE", 15, 31], ["epithelial cells lining the lumen", "TREATMENT", 15, 48], ["successful infection", "PROBLEM", 79, 99], ["epithelial cells", "OBSERVATION", 15, 31], ["lumen", "ANATOMY_MODIFIER", 43, 48], ["successful", "OBSERVATION_MODIFIER", 79, 89], ["infection", "OBSERVATION", 90, 99]]], ["The intestinal epithelium comprises a variety of cell types that have differentiated into specialized cells to fulfill different functions, e.g. enterocytes, goblet cells, M cells, and others.", [["intestinal epithelium", "ANATOMY", 4, 25], ["cell", "ANATOMY", 49, 53], ["cells", "ANATOMY", 102, 107], ["enterocytes", "ANATOMY", 145, 156], ["goblet cells", "ANATOMY", 158, 170], ["M cells", "ANATOMY", 172, 179], ["intestinal epithelium", "TISSUE", 4, 25], ["cell types", "CELL", 49, 59], ["cells", "CELL", 102, 107], ["enterocytes", "CELL", 145, 156], ["goblet cells", "CELL", 158, 170], ["M cells", "CELL", 172, 179], ["enterocytes", "CELL_TYPE", 145, 156], ["goblet cells", "CELL_TYPE", 158, 170], ["M cells", "CELL_TYPE", 172, 179], ["The intestinal epithelium", "PROBLEM", 0, 25], ["goblet cells", "TEST", 158, 170], ["intestinal epithelium", "ANATOMY", 4, 25], ["variety", "OBSERVATION_MODIFIER", 38, 45], ["cell types", "OBSERVATION", 49, 59], ["specialized cells", "OBSERVATION", 90, 107], ["enterocytes", "ANATOMY", 145, 156], ["goblet cells", "OBSERVATION", 158, 170]]], ["In addition, non-epithelial cells, such as intraepithelial lymphocytes are present within the epithelial layer.", [["non-epithelial cells", "ANATOMY", 13, 33], ["intraepithelial lymphocytes", "ANATOMY", 43, 70], ["epithelial layer", "ANATOMY", 94, 110], ["non-epithelial cells", "CELL", 13, 33], ["intraepithelial lymphocytes", "CELL", 43, 70], ["epithelial layer", "TISSUE", 94, 110], ["non-epithelial cells", "CELL_TYPE", 13, 33], ["intraepithelial lymphocytes", "CELL_TYPE", 43, 70], ["non-epithelial cells", "PROBLEM", 13, 33], ["intraepithelial lymphocytes", "PROBLEM", 43, 70], ["non-epithelial cells", "OBSERVATION", 13, 33], ["intraepithelial lymphocytes", "OBSERVATION", 43, 70], ["epithelial", "ANATOMY_MODIFIER", 94, 104], ["layer", "ANATOMY_MODIFIER", 105, 110]]], ["There are no immortalized cell lines that reflect all the functions of well-differentiated epithelial cells.", [["cell lines", "ANATOMY", 26, 36], ["epithelial cells", "ANATOMY", 91, 107], ["cell lines", "CELL", 26, 36], ["epithelial cells", "CELL", 91, 107], ["immortalized cell lines", "CELL_LINE", 13, 36], ["differentiated epithelial cells", "CELL_TYPE", 76, 107], ["immortalized cell lines", "PROBLEM", 13, 36], ["no", "UNCERTAINTY", 10, 12], ["immortalized cell lines", "OBSERVATION", 13, 36], ["well-differentiated", "OBSERVATION_MODIFIER", 71, 90], ["epithelial cells", "OBSERVATION", 91, 107]]], ["Primary cells are a more promising culture system to analyze the characteristics of these cells.", [["Primary cells", "ANATOMY", 0, 13], ["cells", "ANATOMY", 90, 95], ["Primary cells", "CELL", 0, 13], ["cells", "CELL", 90, 95], ["Primary cells", "CELL_TYPE", 0, 13], ["culture system", "TEST", 35, 49], ["these cells", "PROBLEM", 84, 95]]], ["Cultures of primary intestinal epithelial cells are difficult to prepare and often have a limited time of viability that is not sufficient for infection experiments (Bjerknes and Cheng, 1981, Cano-Gauci et al., 1993, Lotz et al., 2006).", [["intestinal epithelial cells", "ANATOMY", 20, 47], ["infection", "DISEASE", 143, 152], ["intestinal epithelial cells", "CELL", 20, 47], ["primary intestinal epithelial cells", "CELL_TYPE", 12, 47], ["Cultures", "TEST", 0, 8], ["primary intestinal epithelial cells", "PROBLEM", 12, 47], ["infection experiments", "PROBLEM", 143, 164], ["primary", "OBSERVATION_MODIFIER", 12, 19], ["intestinal", "ANATOMY", 20, 30], ["epithelial cells", "OBSERVATION", 31, 47], ["not sufficient for", "UNCERTAINTY", 124, 142], ["infection", "OBSERVATION", 143, 152]]], ["For physiological studies, the Ussing chamber has proven to be a valuable device to measure the flow of ions across the epithelium (He et al., 2013).", [["epithelium", "ANATOMY", 120, 130], ["epithelium", "TISSUE", 120, 130], ["physiological studies", "TEST", 4, 25], ["the Ussing chamber", "TREATMENT", 27, 45], ["a valuable device", "TREATMENT", 63, 80], ["flow", "OBSERVATION", 96, 100], ["epithelium", "ANATOMY_MODIFIER", 120, 130]]], ["The large volume and the constant exchange of the solutions applied, render this system not practicable for infection experiments.", [["infection", "DISEASE", 108, 117], ["The large volume", "TREATMENT", 0, 16], ["the solutions", "TREATMENT", 46, 59], ["this system", "TREATMENT", 76, 87], ["infection experiments", "PROBLEM", 108, 129], ["large", "OBSERVATION_MODIFIER", 4, 9], ["volume", "OBSERVATION_MODIFIER", 10, 16], ["constant", "OBSERVATION_MODIFIER", 25, 33], ["infection", "OBSERVATION", 108, 117]]], ["Furthermore, the cells are functional only for a limited time.IntroductionWhile infection studies with differentiated intestinal epithelial cells are still a challenging task, there has been progress in recent years in the analysis of respiratory tract infections.", [["cells", "ANATOMY", 17, 22], ["intestinal epithelial cells", "ANATOMY", 118, 145], ["respiratory tract", "ANATOMY", 235, 252], ["infection", "DISEASE", 80, 89], ["respiratory tract infections", "DISEASE", 235, 263], ["cells", "CELL", 17, 22], ["intestinal epithelial cells", "CELL", 118, 145], ["respiratory tract", "ORGANISM_SUBDIVISION", 235, 252], ["intestinal epithelial cells", "CELL_TYPE", 118, 145], ["infection studies", "TEST", 80, 97], ["differentiated intestinal epithelial cells", "PROBLEM", 103, 145], ["respiratory tract infections", "PROBLEM", 235, 263], ["intestinal", "ANATOMY", 118, 128], ["epithelial cells", "OBSERVATION", 129, 145], ["respiratory tract", "ANATOMY", 235, 252], ["infections", "OBSERVATION", 253, 263]]], ["Filter-grown airway epithelial cells may differentiate into specialized cells such as ciliated cells or mucus-producing cells, when maintained under air-liquid-interface (ALI) conditions (Slepushkin et al., 2001).", [["airway epithelial cells", "ANATOMY", 13, 36], ["cells", "ANATOMY", 72, 77], ["ciliated cells", "ANATOMY", 86, 100], ["mucus", "ANATOMY", 104, 109], ["cells", "ANATOMY", 120, 125], ["ALI", "DISEASE", 171, 174], ["airway epithelial cells", "CELL", 13, 36], ["cells", "CELL", 72, 77], ["ciliated cells", "CELL", 86, 100], ["mucus", "CELL", 104, 109], ["cells", "CELL", 120, 125], ["Filter-grown airway epithelial cells", "CELL_LINE", 0, 36], ["specialized cells", "CELL_TYPE", 60, 77], ["ciliated cells", "CELL_TYPE", 86, 100], ["mucus-producing cells", "CELL_TYPE", 104, 125], ["Filter", "TREATMENT", 0, 6], ["grown airway epithelial cells", "PROBLEM", 7, 36], ["ciliated cells", "PROBLEM", 86, 100], ["mucus-producing cells", "PROBLEM", 104, 125], ["airway epithelial cells", "OBSERVATION", 13, 36], ["ciliated cells", "OBSERVATION", 86, 100], ["producing cells", "OBSERVATION", 110, 125]]], ["This system has been used for human cells and cells from other species (Goris et al., 2009).", [["cells", "ANATOMY", 36, 41], ["cells", "ANATOMY", 46, 51], ["human", "ORGANISM", 30, 35], ["cells", "CELL", 36, 41], ["cells", "CELL", 46, 51], ["human cells", "CELL_TYPE", 30, 41], ["human", "SPECIES", 30, 35], ["human", "SPECIES", 30, 35], ["human cells and cells", "TREATMENT", 30, 51]]], ["An alternative culture system for differentiated respiratory epithelial cells is provided by precision-cut lung slices (PCLS), where the epithelial cells are maintained in their original setting (Fisher et al., 1994, AbdEl Rahman et al., 2010, Meng et al., 2013).", [["respiratory epithelial cells", "ANATOMY", 49, 77], ["lung slices", "ANATOMY", 107, 118], ["PCLS", "ANATOMY", 120, 124], ["epithelial cells", "ANATOMY", 137, 153], ["respiratory epithelial cells", "CELL", 49, 77], ["lung slices", "MULTI-TISSUE_STRUCTURE", 107, 118], ["epithelial cells", "CELL", 137, 153], ["differentiated respiratory epithelial cells", "CELL_TYPE", 34, 77], ["epithelial cells", "CELL_TYPE", 137, 153], ["An alternative culture system", "TEST", 0, 29], ["differentiated respiratory epithelial cells", "PROBLEM", 34, 77], ["the epithelial cells", "PROBLEM", 133, 153], ["respiratory epithelial cells", "OBSERVATION", 49, 77], ["lung", "ANATOMY", 107, 111], ["epithelial cells", "OBSERVATION", 137, 153]]], ["In addition to mucus production and ciliary activity, this culture system provides an additional feature of the airway, bronchoconstriction (Martin et al., 1996).", [["mucus", "ANATOMY", 15, 20], ["ciliary", "ANATOMY", 36, 43], ["culture system", "ANATOMY", 59, 73], ["airway", "ANATOMY", 112, 118], ["mucus", "TISSUE", 15, 20], ["ciliary", "MULTI-TISSUE_STRUCTURE", 36, 43], ["airway", "MULTI-TISSUE_STRUCTURE", 112, 118], ["mucus production", "PROBLEM", 15, 31], ["ciliary activity", "PROBLEM", 36, 52], ["this culture system", "TEST", 54, 73], ["bronchoconstriction", "PROBLEM", 120, 139], ["mucus production", "OBSERVATION", 15, 31], ["ciliary activity", "OBSERVATION", 36, 52], ["airway", "ANATOMY", 112, 118]]], ["As submucosal cells are also present in precision-cut lung slices, they can be included in the investigation (Goris et al., 2009, Punyadarsaniya et al., 2011).IntroductionThere is no culture system for differentiated intestinal epithelial cells that is similar to the air-liquid-interface system.", [["submucosal cells", "ANATOMY", 3, 19], ["lung slices", "ANATOMY", 54, 65], ["intestinal epithelial cells", "ANATOMY", 217, 244], ["submucosal cells", "CELL", 3, 19], ["lung slices", "MULTI-TISSUE_STRUCTURE", 54, 65], ["intestinal epithelial cells", "CELL", 217, 244], ["submucosal cells", "CELL_TYPE", 3, 19], ["intestinal epithelial cells", "CELL_TYPE", 217, 244], ["submucosal cells", "PROBLEM", 3, 19], ["culture system", "TEST", 183, 197], ["differentiated intestinal epithelial cells", "PROBLEM", 202, 244], ["submucosal cells", "OBSERVATION", 3, 19], ["lung", "ANATOMY", 54, 58], ["no", "UNCERTAINTY", 180, 182], ["intestinal", "ANATOMY", 217, 227], ["epithelial cells", "OBSERVATION", 228, 244], ["interface system", "OBSERVATION", 279, 295]]], ["However, it has been shown that precision-cut intestinal slices (PCIS) can be used for physiological measurements (De Kanter et al., 2005) providing results that are similar to those obtained with the Ussing chamber (Van de Kerkhof et al., 2006).", [["intestinal slices", "ANATOMY", 46, 63], ["PCIS", "ANATOMY", 65, 69], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 46, 63], ["precision-cut intestinal slices (PCIS", "TREATMENT", 32, 69], ["intestinal slices", "ANATOMY", 46, 63]]], ["This study shows that precision-cut intestinal slices can be used to analyze virus infections.Ethics statement ::: Materials and methodsA study approval from an ethics committee was not required, since working with avian embryos is currently not regulated by legislation as animal experiment in Germany (http://www.bmelv.de/SharedDocs/Rechtsgrundlagen/T/Tierschutzgesetz.html), (as confirmed by the animal welfare official of the University of Veterinary Medicine Hannover).", [["intestinal slices", "ANATOMY", 36, 53], ["embryos", "ANATOMY", 221, 228], ["infections", "DISEASE", 83, 93], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 36, 53], ["avian", "ORGANISM", 215, 220], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 221, 228], ["This study", "TEST", 0, 10], ["precision-cut intestinal slices", "TREATMENT", 22, 53], ["analyze virus infections", "PROBLEM", 69, 93], ["A study", "TEST", 136, 143], ["intestinal", "ANATOMY", 36, 46]]], ["Protocols for working with embryonated eggs were in accordance with the European Union Legislation (http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32005L0094:EN:NOT).", [["Protocols", "TREATMENT", 0, 9], ["embryonated eggs", "TREATMENT", 27, 43]]], ["Embryos used for precision cut-intestinal slice preparation did not undergo any procedures prior to being killed by decapitation.Precision-cut intestinal slices (PCIS) preparation ::: Materials and methodsPrecision-cut intestinal slices were prepared from 20-day-old specific pathogen free (SPF) chicken embryos.", [["Embryos", "ANATOMY", 0, 7], ["intestinal slice", "ANATOMY", 31, 47], ["intestinal slices", "ANATOMY", 143, 160], ["PCIS", "ANATOMY", 162, 166], ["intestinal slices", "ANATOMY", 219, 236], ["embryos", "ANATOMY", 304, 311], ["Embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 0, 7], ["intestinal", "MULTI-TISSUE_STRUCTURE", 31, 41], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 143, 160], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 219, 236], ["chicken", "ORGANISM", 296, 303], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 304, 311], ["chicken", "SPECIES", 296, 303], ["chicken", "SPECIES", 296, 303], ["precision cut-intestinal slice preparation", "TREATMENT", 17, 59], ["any procedures", "TREATMENT", 76, 90], ["intestinal", "ANATOMY", 31, 41], ["intestinal slices", "ANATOMY", 143, 160], ["intestinal", "ANATOMY", 219, 229]]], ["This time point was chosen to reduce the risk of contamination from the bacterial microbiota encountered after animals have hatched.", [["contamination", "PROBLEM", 49, 62], ["the bacterial microbiota", "PROBLEM", 68, 92], ["contamination", "OBSERVATION", 49, 62], ["bacterial microbiota", "OBSERVATION", 72, 92]]], ["The embryos were killed by decapitation.", [["embryos", "ANATOMY", 4, 11], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 4, 11], ["embryos", "ANATOMY", 4, 11]]], ["A needle covered with a micropipette tip was inserted carefully into the intestinal lumen to wash away the intestinal content 3 times by phosphate-buffered saline (PBS) pH 7.5 containing NaCl 8.00 g/l (AppliChem, Darmstadt, Germany) KCl 0.20 g/l (AppliChem, Darmstadt, Germany)Na2HPO4 1.15 g/l (Merck, Darmstadt, Germany) KH2PO4 0.20 g/l (Merck, Darmstadt, Germany)MgCl2\u00d7 6H2O 0.10 g/l (Merck, Darmstadt, Germany) CaCl2\u00d7 2H2O 0.13 g/l (Merck, Darmstadt, Germany).", [["intestinal lumen", "ANATOMY", 73, 89], ["intestinal", "ANATOMY", 107, 117], ["phosphate", "CHEMICAL", 137, 146], ["NaCl", "CHEMICAL", 187, 191], ["KCl", "CHEMICAL", 233, 236], ["MgCl2", "CHEMICAL", 365, 370], ["CaCl2", "CHEMICAL", 414, 419], ["phosphate", "CHEMICAL", 137, 146], ["NaCl", "CHEMICAL", 187, 191], ["KCl", "CHEMICAL", 233, 236], ["Na2HPO4", "CHEMICAL", 277, 284], ["MgCl2", "CHEMICAL", 365, 370], ["6H2O", "CHEMICAL", 372, 376], ["CaCl2", "CHEMICAL", 414, 419], ["2H2O", "CHEMICAL", 421, 425], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 73, 89], ["intestinal", "ORGAN", 107, 117], ["phosphate-buffered saline", "SIMPLE_CHEMICAL", 137, 162], ["A needle", "TREATMENT", 0, 8], ["a micropipette tip", "TREATMENT", 22, 40], ["the intestinal lumen", "TREATMENT", 69, 89], ["phosphate-buffered saline (PBS", "TREATMENT", 137, 167], ["pH", "TEST", 169, 171], ["NaCl", "TREATMENT", 187, 191], ["AppliChem", "TREATMENT", 202, 211], ["Darmstadt", "TREATMENT", 213, 222], ["KCl", "TREATMENT", 233, 236], ["Na2HPO4", "TEST", 277, 284], ["Merck", "TEST", 295, 300], ["Darmstadt", "TEST", 302, 311], ["KH2PO4", "TEST", 322, 328], ["Merck", "TEST", 339, 344], ["Darmstadt", "TEST", 346, 355], ["MgCl2", "TEST", 365, 370], ["Merck", "TEST", 387, 392], ["Darmstadt", "TEST", 394, 403], ["CaCl2", "TEST", 414, 419], ["intestinal", "ANATOMY", 73, 83], ["lumen", "ANATOMY_MODIFIER", 84, 89], ["intestinal", "ANATOMY", 107, 117]]], ["The method used was similar to that described by de Graaf et al. (2010) with slight modifications: (i) for protection of the intestinal tissue, the intestinal contents were removed by washing without applying forceps (ii) a device described for the preparation of precision-cut lung slices (Punyadarsaniya et al., 2011) was used; it can be filled with five pieces of intestine.Precision-cut intestinal slices (PCIS) preparation ::: Materials and methodsThe intestine (jejunum) was cut into pieces about 1 inch in length.", [["intestinal tissue", "ANATOMY", 125, 142], ["intestinal", "ANATOMY", 148, 158], ["lung slices", "ANATOMY", 278, 289], ["intestine", "ANATOMY", 367, 376], ["intestinal slices", "ANATOMY", 391, 408], ["PCIS", "ANATOMY", 410, 414], ["intestine", "ANATOMY", 457, 466], ["jejunum", "ANATOMY", 468, 475], ["intestinal tissue", "TISSUE", 125, 142], ["intestinal", "ORGAN", 148, 158], ["lung slices", "MULTI-TISSUE_STRUCTURE", 278, 289], ["intestine", "ORGAN", 367, 376], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 391, 408], ["intestine", "ORGAN", 457, 466], ["jejunum", "ORGAN", 468, 475], ["The method", "TREATMENT", 0, 10], ["the intestinal tissue", "PROBLEM", 121, 142], ["forceps (ii) a device", "TREATMENT", 209, 230], ["intestinal tissue", "ANATOMY", 125, 142], ["intestinal", "ANATOMY", 148, 158], ["lung", "ANATOMY", 278, 282], ["intestine", "ANATOMY", 367, 376], ["intestinal slices", "ANATOMY", 391, 408], ["intestine", "ANATOMY", 457, 466], ["jejunum", "ANATOMY", 468, 475]]], ["After having closed one end of the intestine with the help of a thread, the intestine was filled gently with low-melting-point agarose (agarose LM GQT; GERBU, Gaiberg, Germany) to stabilize the intestinal tissue.", [["intestine", "ANATOMY", 35, 44], ["intestine", "ANATOMY", 76, 85], ["intestinal tissue", "ANATOMY", 194, 211], ["intestine", "ORGAN", 35, 44], ["intestine", "ORGAN", 76, 85], ["agarose", "SIMPLE_CHEMICAL", 127, 134], ["intestinal tissue", "TISSUE", 194, 211], ["low-melting-point agarose", "TREATMENT", 109, 134], ["the intestinal tissue", "PROBLEM", 190, 211], ["intestine", "ANATOMY", 35, 44], ["intestine", "ANATOMY", 76, 85], ["intestinal tissue", "ANATOMY", 194, 211]]], ["For solidification, the sample was put on ice.", [["solidification", "PROBLEM", 4, 18], ["solidification", "OBSERVATION", 4, 18]]], ["The samples were arranged in a straight position about 1 cm in length and \u2013 after removal of the thread by cutting \u2013 5 pieces of intestine were put into the cool tissue holding adapter of a Krumdieck tissue slicer (TSE systems, Bad Homburg, Germany, model MD4000-01).", [["samples", "ANATOMY", 4, 11], ["intestine", "ANATOMY", 129, 138], ["tissue", "ANATOMY", 162, 168], ["tissue", "ANATOMY", 200, 206], ["intestine", "ORGAN", 129, 138], ["tissue", "TISSUE", 162, 168], ["Krumdieck tissue", "TISSUE", 190, 206], ["The samples", "TEST", 0, 11], ["removal", "TREATMENT", 82, 89], ["the thread", "TREATMENT", 93, 103], ["cutting \u2013 5 pieces of intestine", "TREATMENT", 107, 138], ["a Krumdieck tissue slicer", "TREATMENT", 188, 213], ["intestine", "ANATOMY", 129, 138], ["cool tissue", "OBSERVATION", 157, 168]]], ["The space between the intestine and the walls of the adapter were filled with low-melting-point agarose.", [["intestine", "ANATOMY", 22, 31], ["intestine", "ORGAN", 22, 31], ["agarose", "SIMPLE_CHEMICAL", 96, 103], ["low-melting-point agarose", "TREATMENT", 78, 103], ["space", "ANATOMY_MODIFIER", 4, 9], ["intestine", "ANATOMY", 22, 31], ["walls", "ANATOMY_MODIFIER", 40, 45], ["low-melting", "OBSERVATION_MODIFIER", 78, 89]]], ["After solidification, the intestine was cut with the Krumdieck tissue slicer into slices approximately 250 \u03bcm thick with a cycle speed of 60 slices/min.", [["intestine", "ANATOMY", 26, 35], ["tissue", "ANATOMY", 63, 69], ["slices", "ANATOMY", 82, 88], ["intestine", "ORGAN", 26, 35], ["Krumdieck tissue slicer", "TISSUE", 53, 76], ["intestine", "ANATOMY", 26, 35]]], ["Precision-cut intestinal slices were incubated in 1 ml of RPMI 1640 medium (Invitrogen/Gibco, Darmstadt, Germany) containing antibiotics and antimycotics; Amphotericin B 2.5 mg/l (Sigma-Aldrich, Munich, Germany), Clotrimazole 1 mg/l (Sigma-Aldrich, Munich, Germany), Enrofloxacin 10 mg/l (Baytril\u00ae, Bayer, Leverkusen, Germany), Kanamycin 50 mg/l (Roth, Karlsruh, Germany), Penicillin 0.06 g/l (Sigma-Aldrich, Munich, Germany), Streptomycin 0.05 g/l (Sigma-Aldrich, Munich, Germany) per slice in a 24-well plate at 37 \u00b0C and 5% CO2.", [["intestinal slices", "ANATOMY", 14, 31], ["Amphotericin B", "CHEMICAL", 155, 169], ["Clotrimazole", "CHEMICAL", 213, 225], ["Enrofloxacin", "CHEMICAL", 267, 279], ["Kanamycin", "CHEMICAL", 328, 337], ["Penicillin", "CHEMICAL", 373, 383], ["Streptomycin", "CHEMICAL", 427, 439], ["CO2", "CHEMICAL", 527, 530], ["Amphotericin B", "CHEMICAL", 155, 169], ["Clotrimazole", "CHEMICAL", 213, 225], ["Enrofloxacin", "CHEMICAL", 267, 279], ["Kanamycin", "CHEMICAL", 328, 337], ["Penicillin", "CHEMICAL", 373, 383], ["Streptomycin", "CHEMICAL", 427, 439], ["CO2", "CHEMICAL", 527, 530], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 14, 31], ["antimycotics", "SIMPLE_CHEMICAL", 141, 153], ["Amphotericin B", "SIMPLE_CHEMICAL", 155, 169], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 180, 193], ["Clotrimazole", "SIMPLE_CHEMICAL", 213, 225], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 234, 247], ["Enrofloxacin", "SIMPLE_CHEMICAL", 267, 279], ["Kanamycin", "SIMPLE_CHEMICAL", 328, 337], ["Penicillin", "SIMPLE_CHEMICAL", 373, 383], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 394, 407], ["Streptomycin", "SIMPLE_CHEMICAL", 427, 439], ["CO2", "SIMPLE_CHEMICAL", 527, 530], ["Invitrogen/Gibco", "TREATMENT", 76, 92], ["Darmstadt", "TREATMENT", 94, 103], ["antibiotics", "TREATMENT", 125, 136], ["antimycotics", "TREATMENT", 141, 153], ["Amphotericin B", "TREATMENT", 155, 169], ["Clotrimazole", "TREATMENT", 213, 225], ["Enrofloxacin", "TREATMENT", 267, 279], ["Baytril\u00ae", "TREATMENT", 289, 297], ["Kanamycin", "TREATMENT", 328, 337], ["Penicillin", "TREATMENT", 373, 383], ["Streptomycin", "TREATMENT", 427, 439], ["intestinal slices", "ANATOMY", 14, 31]]], ["The medium was changed every hour during the first 2 h and once after 24 h to remove the agarose before slices were used for infection.", [["slices", "ANATOMY", 104, 110], ["infection", "DISEASE", 125, 134], ["agarose", "SIMPLE_CHEMICAL", 89, 96], ["the agarose before slices", "TREATMENT", 85, 110], ["infection", "PROBLEM", 125, 134], ["medium", "OBSERVATION_MODIFIER", 4, 10], ["infection", "OBSERVATION", 125, 134]]], ["The integrity of the cells in precision-cut intestinal slices was determined by applying a Live/Dead viability/cytotoxicity assay kit (Fluo Probes, Rockford, USA, FP-BE4710).", [["cells", "ANATOMY", 21, 26], ["intestinal slices", "ANATOMY", 44, 61], ["cells", "CELL", 21, 26], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 44, 61], ["a Live/Dead viability", "TREATMENT", 89, 110], ["integrity", "OBSERVATION_MODIFIER", 4, 13], ["cells", "ANATOMY", 21, 26], ["intestinal slices", "ANATOMY", 44, 61]]], ["For this purpose, the slices were washed with PBS and incubated with calcein AM (1 \u03bcM) and ethidium bromide (EthD-1; 2 \u03bcM) for 30 min.", [["slices", "ANATOMY", 22, 28], ["calcein", "CHEMICAL", 69, 76], ["ethidium bromide", "CHEMICAL", 91, 107], ["EthD-1", "CHEMICAL", 109, 115], ["calcein AM", "CHEMICAL", 69, 79], ["ethidium bromide", "CHEMICAL", 91, 107], ["EthD-1", "CHEMICAL", 109, 115], ["calcein AM", "SIMPLE_CHEMICAL", 69, 79], ["ethidium bromide", "SIMPLE_CHEMICAL", 91, 107], ["PBS", "TREATMENT", 46, 49], ["calcein AM", "TREATMENT", 69, 79], ["ethidium bromide", "TREATMENT", 91, 107]]], ["The former compound is converted into a green-fluorescent dye which is retained by intact cells.", [["cells", "ANATOMY", 90, 95], ["green-fluorescent dye", "SIMPLE_CHEMICAL", 40, 61], ["cells", "CELL", 90, 95], ["intact cells", "CELL_TYPE", 83, 95], ["a green-fluorescent dye", "PROBLEM", 38, 61], ["intact cells", "OBSERVATION", 83, 95]]], ["Ethidium bromide stains the DNA of cells which have lost the plasma membrane integrity.", [["cells", "ANATOMY", 35, 40], ["plasma membrane", "ANATOMY", 61, 76], ["Ethidium bromide", "CHEMICAL", 0, 16], ["Ethidium bromide", "CHEMICAL", 0, 16], ["Ethidium bromide", "SIMPLE_CHEMICAL", 0, 16], ["DNA", "CELLULAR_COMPONENT", 28, 31], ["cells", "CELL", 35, 40], ["plasma membrane", "CELLULAR_COMPONENT", 61, 76], ["Ethidium bromide", "TREATMENT", 0, 16], ["the DNA of cells", "PROBLEM", 24, 40], ["plasma membrane integrity", "OBSERVATION", 61, 86]]], ["After incubation, slices were washed with PBS and embedded in Mowiol resin prior to analysis by a Leica TCS SP5 AOBS confocal laser scanning microscope using wavelengths of 488, 561, 405 (excitation) and 570,520, 421 nm (emission) for detection of the green fluorescence of FITC, the red fluorescence of Cy3, and the blue fluorescence of DAPI.Virus propagation ::: Materials and methodsAn avian influenza virus of the H9N2 subtype was used in this study: A/chicken/Saudi Arabia/CP7/98 (LPAI).", [["slices", "ANATOMY", 18, 24], ["influenza virus", "DISEASE", 395, 410], ["FITC", "CHEMICAL", 274, 278], ["DAPI", "CHEMICAL", 338, 342], ["FITC", "SIMPLE_CHEMICAL", 274, 278], ["Cy3", "SIMPLE_CHEMICAL", 304, 307], ["DAPI", "SIMPLE_CHEMICAL", 338, 342], ["Virus", "ORGANISM", 343, 348], ["avian influenza virus", "ORGANISM", 389, 410], ["H9N2", "ORGANISM", 418, 422], ["chicken", "ORGANISM", 457, 464], ["Saudi Arabia", "ORGANISM", 465, 477], ["CP7/98", "ORGANISM", 478, 484], ["LPAI", "ORGANISM", 486, 490], ["FITC", "PROTEIN", 274, 278], ["avian influenza virus", "SPECIES", 389, 410], ["chicken", "SPECIES", 457, 464], ["chicken", "SPECIES", 457, 464], ["Saudi Arabia/CP7/98 (LPAI", "SPECIES", 465, 490], ["slices", "TEST", 18, 24], ["PBS", "TREATMENT", 42, 45], ["embedded in Mowiol resin", "TREATMENT", 50, 74], ["analysis", "TEST", 84, 92], ["a Leica TCS", "TEST", 96, 107], ["the green fluorescence of FITC", "PROBLEM", 248, 278], ["the red fluorescence of Cy3", "TEST", 280, 307], ["the blue fluorescence of DAPI", "PROBLEM", 313, 342], ["An avian influenza virus", "PROBLEM", 386, 410], ["the H9N2 subtype", "PROBLEM", 414, 430], ["influenza virus", "OBSERVATION", 395, 410]]], ["Virus stocks were grown in 10-days old specific pathogen-free embryonated chicken eggs (VALO Biomedia, Cuxhaven, Germany).", [["eggs", "ANATOMY", 82, 86], ["Virus", "ORGANISM", 0, 5], ["chicken", "ORGANISM", 74, 81], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 82, 86], ["chicken", "SPECIES", 74, 81], ["chicken", "SPECIES", 74, 81], ["Virus stocks", "TREATMENT", 0, 12], ["old specific pathogen", "PROBLEM", 35, 56], ["free embryonated chicken eggs", "TREATMENT", 57, 86]]], ["The allantoic cavity of the egg was inoculated with 100 \u03bcl of virus solution (virus stock 1:100 in PBS).", [["allantoic cavity", "ANATOMY", 4, 20], ["egg", "ANATOMY", 28, 31], ["allantoic cavity", "MULTI-TISSUE_STRUCTURE", 4, 20], ["egg", "ORGANISM_SUBSTANCE", 28, 31], ["virus solution (virus stock", "TREATMENT", 62, 89], ["allantoic", "OBSERVATION_MODIFIER", 4, 13], ["cavity", "OBSERVATION_MODIFIER", 14, 20], ["egg", "ANATOMY", 28, 31]]], ["The inoculated eggs were kept at 37 \u00b0C for up to three days in an egg incubator.", [["eggs", "ANATOMY", 15, 19], ["The inoculated eggs", "TREATMENT", 0, 19], ["an egg incubator", "TREATMENT", 63, 79]]], ["Chorioallantoic fluid was collected and clarified by low-speed centrifugation (450 \u00d7g, 15 min).", [["Chorioallantoic fluid", "ANATOMY", 0, 21], ["Chorioallantoic fluid", "ORGANISM_SUBSTANCE", 0, 21], ["Chorioallantoic fluid", "TEST", 0, 21], ["fluid", "OBSERVATION", 16, 21]]], ["Virus stocks were stored at \u221280 \u00b0C.Virus infection ::: Materials and methodsPrecision-cut intestinal slices were washed twice with PBS and infected with 500 \u03bcl of the viral dilution in RPMI medium.", [["intestinal slices", "ANATOMY", 90, 107], ["Virus infection", "DISEASE", 35, 50], ["Virus", "ORGANISM", 0, 5], ["Virus", "ORGANISM", 35, 40], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 90, 107], ["Virus stocks", "TREATMENT", 0, 12], ["Virus infection", "PROBLEM", 35, 50], ["methodsPrecision-cut intestinal slices", "TREATMENT", 69, 107], ["PBS", "TREATMENT", 131, 134], ["the viral dilution in RPMI medium", "TREATMENT", 163, 196], ["infection", "OBSERVATION", 41, 50], ["intestinal", "ANATOMY", 90, 100], ["viral dilution", "OBSERVATION", 167, 181], ["RPMI medium", "OBSERVATION", 185, 196]]], ["For immunostaining, the slices were infected with 105pfu/ml (1:10 dilution of stock virus) for 2 h.", [["slices", "ANATOMY", 24, 30], ["immunostaining", "TEST", 4, 18], ["stock virus", "TREATMENT", 78, 89]]], ["Inoculums were removed and precision-cut intestinal slices were washed 3 times with PBS before a final volume of 1 ml of RPMI medium was added.", [["intestinal slices", "ANATOMY", 41, 58], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 41, 58], ["precision-cut intestinal slices", "TREATMENT", 27, 58], ["PBS", "TREATMENT", 84, 87], ["RPMI medium", "TREATMENT", 121, 132]]], ["The slices were incubated in 5% CO2 at 37 \u00b0C for up to 1 day which allowed more than one round of infection.", [["slices", "ANATOMY", 4, 10], ["CO2", "CHEMICAL", 32, 35], ["infection", "DISEASE", 98, 107], ["CO2", "CHEMICAL", 32, 35], ["slices", "MULTI-TISSUE_STRUCTURE", 4, 10], ["CO2", "SIMPLE_CHEMICAL", 32, 35], ["5% CO2", "TREATMENT", 29, 35], ["infection", "PROBLEM", 98, 107], ["infection", "OBSERVATION", 98, 107]]], ["All experiments were performed with at least six slices.Preparation of cryosections ::: Materials and methodsPrecision-cut intestinal slices were mounted with tissue-freezing medium (Jung, Heidelberg, Germany) on a small filter paper and put into in liquid nitrogen and then stored at \u221280 \u00b0C. Slices were cut by a cryostat (Reichert-Jung, Nu\u00dfloch, Germany).", [["cryosections", "ANATOMY", 71, 83], ["intestinal slices", "ANATOMY", 123, 140], ["tissue", "ANATOMY", 159, 165], ["Slices", "ANATOMY", 293, 299], ["nitrogen", "CHEMICAL", 257, 265], ["cryosections", "TISSUE", 71, 83], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 123, 140], ["tissue", "TISSUE", 159, 165], ["Slices", "MULTI-TISSUE_STRUCTURE", 293, 299], ["methodsPrecision-cut intestinal slices", "TREATMENT", 102, 140], ["a small filter paper", "TREATMENT", 213, 233], ["liquid nitrogen", "TREATMENT", 250, 265], ["intestinal slices", "ANATOMY", 123, 140], ["small filter", "OBSERVATION", 215, 227]]], ["The sections (10 \u03bcm thick) were dried overnight at room temperature and kept frozen at \u221220 \u00b0C until staining.Immunofluorescence analysis of cryosections ::: Materials and methodsSamples were fixed with 3% paraformaldehyde for 20 min.", [["sections", "ANATOMY", 4, 12], ["cryosections", "ANATOMY", 140, 152], ["paraformaldehyde", "CHEMICAL", 205, 221], ["sections", "MULTI-TISSUE_STRUCTURE", 4, 12], ["paraformaldehyde", "SIMPLE_CHEMICAL", 205, 221], ["The sections", "TEST", 0, 12], ["Immunofluorescence analysis", "TEST", 109, 136], ["methodsSamples", "TREATMENT", 171, 185], ["3% paraformaldehyde", "TREATMENT", 202, 221]]], ["The sections were washed 3 times with phosphate-buffered saline minus (PBSM) pH 7.5 containing NaCl 8.00 g/l (AppliChem, Darmstadt, Germany) KCl 0.20 g/l (AppliChem, Darmstadt, Germany) Na2HPO4 1.15 g/l (Merck, Darmstadt, Germany) KH2PO4 0.20 g/l (Merck, Darmstadt, Germany) followed by permeabilization with 0.2% Triton X-100 for 5 min.", [["sections", "ANATOMY", 4, 12], ["phosphate", "CHEMICAL", 38, 47], ["NaCl", "CHEMICAL", 95, 99], ["KCl", "CHEMICAL", 141, 144], ["Triton X-100", "CHEMICAL", 314, 326], ["phosphate", "CHEMICAL", 38, 47], ["NaCl", "CHEMICAL", 95, 99], ["KCl", "CHEMICAL", 141, 144], ["Na2HPO4", "CHEMICAL", 186, 193], ["sections", "MULTI-TISSUE_STRUCTURE", 4, 12], ["phosphate-buffered saline", "SIMPLE_CHEMICAL", 38, 63], ["Triton X-100", "SIMPLE_CHEMICAL", 314, 326], ["The sections", "TEST", 0, 12], ["phosphate", "TEST", 38, 47], ["PBSM", "TEST", 71, 75], ["pH", "TEST", 77, 79], ["NaCl", "TEST", 95, 99], ["AppliChem", "TREATMENT", 110, 119], ["Darmstadt", "TREATMENT", 121, 130], ["KCl", "TREATMENT", 141, 144], ["Na2HPO4", "TEST", 186, 193], ["KH2PO4", "TEST", 231, 237]]], ["A solution of 1% bovine serum albumin was used as diluent for all antibodies that were incubated with the sections for 1 h at room temperature in a humid chamber.", [["serum", "ANATOMY", 24, 29], ["sections", "ANATOMY", 106, 114], ["bovine", "ORGANISM", 17, 23], ["serum", "ORGANISM_SUBSTANCE", 24, 29], ["albumin", "GENE_OR_GENE_PRODUCT", 30, 37], ["antibodies", "PROTEIN", 66, 76], ["bovine", "SPECIES", 17, 23], ["bovine", "SPECIES", 17, 23], ["A solution", "TREATMENT", 0, 10], ["1% bovine serum albumin", "TREATMENT", 14, 37], ["a humid chamber", "TREATMENT", 146, 161]]], ["After the last incubation step, the sections were washed three times with PBS and once with distilled water to remove precipitates that may have been formed during the freezing period.", [["sections", "ANATOMY", 36, 44], ["the sections", "TREATMENT", 32, 44], ["PBS", "TREATMENT", 74, 77]]], ["The slices were embedded in Mowiol and stored at 4 \u00b0C until examination under the confocal microscope.Immunofluorescence analysis of cryosections ::: Materials and methodsA monoclonal antibody against the influenza A virus nucleoprotein (NP) (AbDSeroTec, D\u00fcsseldorf, Germany).) at a 1:750 dilution was used for detection of infected cells.", [["slices", "ANATOMY", 4, 10], ["cryosections", "ANATOMY", 133, 145], ["cells", "ANATOMY", 333, 338], ["slices", "MULTI-TISSUE_STRUCTURE", 4, 10], ["Mowiol", "SIMPLE_CHEMICAL", 28, 34], ["influenza A virus", "ORGANISM", 205, 222], ["cells", "CELL", 333, 338], ["methodsA monoclonal antibody", "PROTEIN", 164, 192], ["infected cells", "CELL_TYPE", 324, 338], ["influenza A virus", "SPECIES", 205, 222], ["influenza A virus", "SPECIES", 205, 222], ["examination", "TEST", 60, 71], ["the confocal microscope", "TEST", 78, 101], ["Immunofluorescence analysis", "TEST", 102, 129], ["Materials", "TEST", 150, 159], ["methodsA monoclonal antibody", "TEST", 164, 192], ["infected cells", "PROBLEM", 324, 338], ["infected cells", "OBSERVATION", 324, 338]]], ["The secondary antibody consisted of FITC-labeled anti-mouse IgG (Sigma-Aldrich, Munich, Germany) at a 1:500 dilution.Immunofluorescence analysis of cryosections ::: Materials and methodsFITC-labeled Sambucus nigra agglutinin (SNA)(Vector laboratories, Burlungame, USA) at a dilution of 1:200 was used to detect \u03b12,6-linked sialic acids and biotinylated Maackia amurensis agglutinin II (MAAII) at a dilution of 1:100 was used to visualize \u03b12,3-linked sialic acids after pretreatment with the Avidin/Biotin Blocking kit (both from Vector Laboratories,Burlungame, USA).", [["cryosections", "ANATOMY", 148, 160], ["sialic acids", "CHEMICAL", 323, 335], ["Maackia amurensis agglutinin II", "CHEMICAL", 353, 384], ["MAAII", "CHEMICAL", 386, 391], ["sialic acids", "CHEMICAL", 450, 462], ["FITC", "CHEMICAL", 36, 40], ["sialic acids", "CHEMICAL", 323, 335], ["sialic acids", "CHEMICAL", 450, 462], ["FITC", "SIMPLE_CHEMICAL", 36, 40], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 65, 78], ["Sambucus nigra agglutinin", "ORGANISM", 199, 224], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 311, 335], ["Maackia amurensis agglutinin II", "GENE_OR_GENE_PRODUCT", 353, 384], ["MAAII", "SIMPLE_CHEMICAL", 386, 391], ["\u03b12,3-linked sialic acids", "SIMPLE_CHEMICAL", 438, 462], ["Avidin", "SIMPLE_CHEMICAL", 491, 497], ["Biotin", "GENE_OR_GENE_PRODUCT", 498, 504], ["FITC-labeled anti-mouse IgG", "PROTEIN", 36, 63], ["\u03b12,6", "PROTEIN", 311, 315], ["biotinylated Maackia amurensis agglutinin II", "PROTEIN", 340, 384], ["MAAII", "PROTEIN", 386, 391], ["\u03b12,3", "PROTEIN", 438, 442], ["Avidin", "PROTEIN", 491, 497], ["Sambucus nigra", "SPECIES", 199, 213], ["Maackia amurensis", "SPECIES", 353, 370], ["Sambucus nigra", "SPECIES", 199, 213], ["Maackia amurensis", "SPECIES", 353, 370], ["The secondary antibody", "TEST", 0, 22], ["FITC", "TEST", 36, 40], ["Immunofluorescence analysis", "TEST", 117, 144], ["Materials", "TEST", 165, 174], ["methodsFITC", "TEST", 179, 190], ["sialic acids", "TEST", 323, 335], ["the Avidin/Biotin Blocking kit", "TREATMENT", 487, 517]]], ["Streptavidin-Cy3 (Sigma-Aldrich, Munich, Germany) at a dilution of 1:500 was used to visualize binding of biotinylated reagents.Immunofluorescence analysis of cryosections ::: Materials and methodsFor detection of microvilli, a goat anti-ezrin (Santa Cruz Biotechnology, Heidelberg, Germany) antibody was used at a 1:200 dilution followed by incubation with a Cy3-labeled mouse anti-goat IgG (Sigma-Aldrich, Munich, Germany) as secondary antibody at a dilution of 1:500.Immunofluorescence analysis of cryosections ::: Materials and methodsNuclei of cells were stained by incubation with DAPI (4\u2032,6\u2032-diamidino-2-phenylindole) for 15 min (37 \u00b0C).Neuraminidase treatment ::: Materials and methodsThe precision-cut intestinal slices were washed with RPMI medium 3 times to remove mucus.", [["cryosections", "ANATOMY", 159, 171], ["microvilli", "ANATOMY", 214, 224], ["cryosections", "ANATOMY", 501, 513], ["cells", "ANATOMY", 549, 554], ["intestinal slices", "ANATOMY", 711, 728], ["mucus", "ANATOMY", 776, 781], ["Streptavidin-Cy3", "CHEMICAL", 0, 16], ["DAPI", "CHEMICAL", 587, 591], ["4\u2032,6\u2032-diamidino-2-phenylindole", "CHEMICAL", 593, 623], ["Streptavidin-Cy3", "CHEMICAL", 0, 16], ["DAPI", "CHEMICAL", 587, 591], ["4\u2032,6\u2032-diamidino-2-phenylindole", "CHEMICAL", 593, 623], ["Streptavidin-Cy3", "SIMPLE_CHEMICAL", 0, 16], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 18, 31], ["microvilli", "CELLULAR_COMPONENT", 214, 224], ["goat", "ORGANISM", 228, 232], ["anti-ezrin", "SIMPLE_CHEMICAL", 233, 243], ["Cy3", "SIMPLE_CHEMICAL", 360, 363], ["mouse", "ORGANISM", 372, 377], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 393, 406], ["cells", "CELL", 549, 554], ["DAPI", "SIMPLE_CHEMICAL", 587, 591], ["4\u2032,6\u2032-diamidino-2-phenylindole", "SIMPLE_CHEMICAL", 593, 623], ["Neuraminidase", "SIMPLE_CHEMICAL", 644, 657], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 711, 728], ["mucus", "ORGANISM_SUBSTANCE", 776, 781], ["goat anti-ezrin", "PROTEIN", 228, 243], ["Santa Cruz Biotechnology, Heidelberg, Germany) antibody", "PROTEIN", 245, 300], ["Cy3-labeled mouse anti-goat IgG", "PROTEIN", 360, 391], ["goat", "SPECIES", 228, 232], ["mouse", "SPECIES", 372, 377], ["goat", "SPECIES", 228, 232], ["mouse", "SPECIES", 372, 377], ["Streptavidin", "TEST", 0, 12], ["biotinylated reagents", "TREATMENT", 106, 127], ["Immunofluorescence analysis", "TEST", 128, 155], ["a Cy3", "TEST", 358, 363], ["Immunofluorescence analysis", "TEST", 470, 497], ["DAPI", "TEST", 587, 591], ["diamidino", "TREATMENT", 599, 608], ["Neuraminidase treatment", "TREATMENT", 644, 667], ["The precision-cut intestinal slices", "TREATMENT", 693, 728], ["RPMI medium", "TREATMENT", 746, 757], ["mucus", "PROBLEM", 776, 781], ["intestinal slices", "ANATOMY", 711, 728]]], ["Washed precision-cut intestinal slices were treated with neuraminidase (NA) type V from Clostridium perfringens (Sigma/Aldrich, Munich, Germany) at 50 mU/ring and incubated for 2 h at 37 \u00b0C. After removal of the NA solution, precision-cut intestinal slices were washed three times with PBS and then embedded with tissue-freezing medium (Jung, Heidelberg, Germany) to generate cryosections and perform lectin staining.Precision-cut intestinal slices (PCIS), a model system for differentiated avian intestinal epithelium cells ::: ResultsA culture system was established for differentiated intestinal epithelial cells from the chicken intestine.", [["intestinal slices", "ANATOMY", 21, 38], ["intestinal slices", "ANATOMY", 239, 256], ["tissue", "ANATOMY", 313, 319], ["cryosections", "ANATOMY", 376, 388], ["intestinal slices", "ANATOMY", 431, 448], ["PCIS", "ANATOMY", 450, 454], ["intestinal epithelium cells", "ANATOMY", 497, 524], ["intestinal epithelial cells", "ANATOMY", 588, 615], ["intestine", "ANATOMY", 633, 642], ["NA", "CHEMICAL", 72, 74], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 21, 38], ["Clostridium perfringens", "ORGANISM", 88, 111], ["Sigma/Aldrich", "ORGANISM", 113, 126], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 239, 256], ["tissue", "TISSUE", 313, 319], ["lectin", "GENE_OR_GENE_PRODUCT", 401, 407], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 431, 448], ["avian", "ORGANISM", 491, 496], ["intestinal epithelium cells", "CELL", 497, 524], ["intestinal epithelial cells", "CELL", 588, 615], ["chicken", "ORGANISM", 625, 632], ["intestine", "ORGAN", 633, 642], ["lectin", "PROTEIN", 401, 407], ["differentiated avian intestinal epithelium cells", "CELL_TYPE", 476, 524], ["intestinal epithelial cells", "CELL_TYPE", 588, 615], ["Clostridium perfringens", "SPECIES", 88, 111], ["chicken", "SPECIES", 625, 632], ["Clostridium perfringens", "SPECIES", 88, 111], ["chicken", "SPECIES", 625, 632], ["cut intestinal slices", "TREATMENT", 17, 38], ["neuraminidase", "TREATMENT", 57, 70], ["Clostridium perfringens", "PROBLEM", 88, 111], ["the NA solution", "TREATMENT", 208, 223], ["precision-cut intestinal slices", "TREATMENT", 225, 256], ["PBS", "TREATMENT", 286, 289], ["tissue-freezing medium", "TREATMENT", 313, 335], ["lectin staining", "TEST", 401, 416], ["a model system", "TEST", 457, 471], ["ResultsA culture system", "TEST", 529, 552], ["differentiated intestinal epithelial cells", "PROBLEM", 573, 615], ["intestinal slices", "ANATOMY", 21, 38], ["intestinal", "ANATOMY", 239, 249], ["lectin staining", "OBSERVATION", 401, 416], ["intestinal slices", "ANATOMY", 431, 448], ["intestinal", "ANATOMY", 497, 507], ["epithelium cells", "OBSERVATION", 508, 524], ["intestinal epithelial cells", "OBSERVATION", 588, 615], ["chicken intestine", "ANATOMY", 625, 642]]], ["Precision-cut intestinal slices were prepared from 20 days-old chicken embryos.", [["intestinal slices", "ANATOMY", 14, 31], ["embryos", "ANATOMY", 71, 78], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 14, 31], ["chicken", "ORGANISM", 63, 70], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 71, 78], ["chicken", "SPECIES", 63, 70], ["chicken", "SPECIES", 63, 70], ["Precision-cut intestinal slices", "TREATMENT", 0, 31], ["intestinal slices", "ANATOMY", 14, 31]]], ["Precision-cut intestinal slices were analyzed by light microscopy to visualize the morphology of the intestinal slice at day 1 and day 4 after preparation (Fig. 1A and C).", [["intestinal slices", "ANATOMY", 14, 31], ["intestinal slice", "ANATOMY", 101, 117], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 14, 31], ["intestinal slice", "MULTI-TISSUE_STRUCTURE", 101, 117], ["light microscopy", "TEST", 49, 65], ["intestinal slices", "ANATOMY", 14, 31], ["intestinal slice", "ANATOMY", 101, 117]]], ["To determine whether precision-cut intestinal slices from chicken intestine are a suitable culture system for infection studies, the vitality of the epithelial cells had to be determined.Precision-cut intestinal slices (PCIS), a model system for differentiated avian intestinal epithelium cells ::: ResultsThe viability of the cells of precision-cut intestinal slices was analyzed by a live/dead viability/cytotoxicity assay.", [["intestinal slices", "ANATOMY", 35, 52], ["intestine", "ANATOMY", 66, 75], ["epithelial cells", "ANATOMY", 149, 165], ["intestinal slices", "ANATOMY", 201, 218], ["PCIS", "ANATOMY", 220, 224], ["intestinal epithelium cells", "ANATOMY", 267, 294], ["cells", "ANATOMY", 327, 332], ["intestinal slices", "ANATOMY", 350, 367], ["infection", "DISEASE", 110, 119], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 35, 52], ["chicken", "ORGANISM", 58, 65], ["intestine", "ORGAN", 66, 75], ["epithelial cells", "CELL", 149, 165], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 201, 218], ["avian", "ORGANISM", 261, 266], ["intestinal epithelium cells", "CELL", 267, 294], ["cells", "CELL", 327, 332], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 350, 367], ["epithelial cells", "CELL_TYPE", 149, 165], ["differentiated avian intestinal epithelium cells", "CELL_TYPE", 246, 294], ["chicken", "SPECIES", 58, 65], ["chicken", "SPECIES", 58, 65], ["chicken intestine", "PROBLEM", 58, 75], ["a suitable culture system", "TEST", 80, 105], ["infection studies", "TEST", 110, 127], ["the epithelial cells", "PROBLEM", 145, 165], ["a model system", "TEST", 227, 241], ["cytotoxicity assay", "TEST", 406, 424], ["intestine", "ANATOMY", 66, 75], ["epithelial cells", "OBSERVATION", 149, 165], ["intestinal slices", "ANATOMY", 201, 218], ["intestinal", "ANATOMY", 267, 277], ["epithelium cells", "OBSERVATION", 278, 294], ["viability", "OBSERVATION_MODIFIER", 310, 319], ["intestinal slices", "ANATOMY", 350, 367]]], ["As shown in Fig. 1, the epithelial lining of the intestine consisted of viable cells (green) when analyzed at 1 and 4 days post-preparation (Fig. 1B and D).", [["epithelial lining", "ANATOMY", 24, 41], ["intestine", "ANATOMY", 49, 58], ["cells", "ANATOMY", 79, 84], ["epithelial lining", "TISSUE", 24, 41], ["intestine", "ORGAN", 49, 58], ["cells", "CELL", 79, 84], ["viable cells", "CELL_TYPE", 72, 84], ["viable cells", "PROBLEM", 72, 84], ["epithelial", "ANATOMY_MODIFIER", 24, 34], ["lining", "ANATOMY_MODIFIER", 35, 41], ["intestine", "ANATOMY", 49, 58], ["viable cells", "OBSERVATION", 72, 84]]], ["The distribution of the red stain indicates that only very few cells of the epithelial lining were dead.Expression of sialic acid ::: ResultsSialic acids are the crucial receptor determinant for the entry of influenza viruses.", [["cells", "ANATOMY", 63, 68], ["epithelial lining", "ANATOMY", 76, 93], ["sialic acid", "CHEMICAL", 118, 129], ["ResultsSialic acids", "CHEMICAL", 134, 153], ["influenza viruses", "DISEASE", 208, 225], ["sialic acid", "CHEMICAL", 118, 129], ["ResultsSialic acids", "CHEMICAL", 134, 153], ["cells", "CELL", 63, 68], ["epithelial lining", "TISSUE", 76, 93], ["sialic acid", "SIMPLE_CHEMICAL", 118, 129], ["ResultsSialic acids", "SIMPLE_CHEMICAL", 134, 153], ["influenza viruses", "ORGANISM", 208, 225], ["the red stain", "TEST", 20, 33], ["ResultsSialic acids", "TREATMENT", 134, 153], ["influenza viruses", "PROBLEM", 208, 225], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["red stain", "OBSERVATION", 24, 33], ["very", "OBSERVATION_MODIFIER", 54, 58], ["few", "OBSERVATION_MODIFIER", 59, 62], ["cells", "OBSERVATION", 63, 68], ["epithelial lining", "OBSERVATION", 76, 93], ["influenza viruses", "OBSERVATION", 208, 225]]], ["Therefore, precision-cut intestinal slices were analyzed for the expression of sialic acids on the epithelial cells.", [["intestinal slices", "ANATOMY", 25, 42], ["epithelial cells", "ANATOMY", 99, 115], ["sialic acids", "CHEMICAL", 79, 91], ["sialic acids", "CHEMICAL", 79, 91], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 25, 42], ["sialic acids", "SIMPLE_CHEMICAL", 79, 91], ["epithelial cells", "CELL", 99, 115], ["epithelial cells", "CELL_TYPE", 99, 115], ["precision-cut intestinal slices", "TREATMENT", 11, 42], ["sialic acids", "TEST", 79, 91], ["sialic acids", "OBSERVATION", 79, 91], ["epithelial cells", "OBSERVATION", 99, 115]]], ["Cryosections from precision-cut intestinal slices were stained with sialic acid-specific lectins: S. nigra agglutinin (SNA) and M. amurensis agglutinin (MAA) typeII.", [["Cryosections", "ANATOMY", 0, 12], ["intestinal slices", "ANATOMY", 32, 49], ["Cryosections", "TISSUE", 0, 12], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 32, 49], ["sialic acid-specific lectins", "GENE_OR_GENE_PRODUCT", 68, 96], ["S. nigra agglutinin", "ORGANISM", 98, 117], ["SNA", "GENE_OR_GENE_PRODUCT", 119, 122], ["M. amurensis", "ORGANISM", 128, 140], ["agglutinin", "GENE_OR_GENE_PRODUCT", 141, 151], ["MAA", "SIMPLE_CHEMICAL", 153, 156], ["sialic acid-specific lectins", "PROTEIN", 68, 96], ["S. nigra agglutinin", "PROTEIN", 98, 117], ["SNA", "PROTEIN", 119, 122], ["M. amurensis agglutinin (MAA) typeII", "PROTEIN", 128, 164], ["S. nigra", "SPECIES", 98, 106], ["M. amurensis", "SPECIES", 128, 140], ["S. nigra", "SPECIES", 98, 106], ["M. amurensis", "SPECIES", 128, 140], ["Cryosections", "TEST", 0, 12], ["precision", "TEST", 18, 27], ["cut intestinal slices", "TEST", 28, 49], ["sialic acid-specific lectins", "TEST", 68, 96], ["M. amurensis agglutinin (MAA) typeII", "TREATMENT", 128, 164], ["intestinal slices", "ANATOMY", 32, 49]]], ["The former lectin recognizes \u03b12,6-linked sialic acids, the latter \u03b12,3-linked sialic acids.", [["sialic acids", "CHEMICAL", 41, 53], ["sialic acids", "CHEMICAL", 78, 90], ["sialic acids", "CHEMICAL", 41, 53], ["sialic acids", "CHEMICAL", 78, 90], ["lectin", "GENE_OR_GENE_PRODUCT", 11, 17], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 29, 53], ["\u03b12,3-linked sialic acids", "SIMPLE_CHEMICAL", 66, 90], ["lectin", "PROTEIN", 11, 17], ["\u03b12,6", "PROTEIN", 29, 33], ["\u03b12,3", "PROTEIN", 66, 70], ["sialic acids", "TEST", 41, 53], ["sialic acids", "OBSERVATION", 78, 90]]], ["As shown in Fig. 2A, the cells stained by the two lectins have a different distribution.", [["cells", "ANATOMY", 25, 30], ["cells", "CELL", 25, 30], ["lectins", "GENE_OR_GENE_PRODUCT", 50, 57], ["lectins", "PROTEIN", 50, 57], ["the cells", "TEST", 21, 30], ["different", "OBSERVATION_MODIFIER", 65, 74], ["distribution", "OBSERVATION_MODIFIER", 75, 87]]], ["Cells stained by SNA (green) were found predominantly in subepithelial regions.", [["Cells", "ANATOMY", 0, 5], ["subepithelial regions", "ANATOMY", 57, 78], ["Cells", "CELL", 0, 5], ["SNA", "GENE_OR_GENE_PRODUCT", 17, 20], ["subepithelial regions", "TISSUE", 57, 78], ["SNA", "PROTEIN", 17, 20], ["Cells", "TEST", 0, 5], ["SNA", "TEST", 17, 20], ["SNA", "ANATOMY", 17, 20], ["predominantly", "OBSERVATION_MODIFIER", 40, 53], ["subepithelial", "ANATOMY_MODIFIER", 57, 70], ["regions", "ANATOMY_MODIFIER", 71, 78]]], ["This result suggests that \u03b12,6-linked sialic acids are more prominent at the lamina propria that consists of connective tissue.", [["lamina propria", "ANATOMY", 77, 91], ["connective tissue", "ANATOMY", 109, 126], ["sialic acids", "CHEMICAL", 38, 50], ["sialic acids", "CHEMICAL", 38, 50], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 26, 50], ["lamina propria", "TISSUE", 77, 91], ["connective tissue", "TISSUE", 109, 126], ["\u03b12,6-linked sialic acids", "PROBLEM", 26, 50], ["connective tissue", "PROBLEM", 109, 126], ["sialic acids", "OBSERVATION", 38, 50], ["more prominent", "OBSERVATION_MODIFIER", 55, 69], ["lamina", "ANATOMY_MODIFIER", 77, 83], ["propria", "ANATOMY_MODIFIER", 84, 91], ["connective tissue", "OBSERVATION", 109, 126]]], ["Cells visualized by MAA staining (red) were readily detectable along the epithelial cells lining the intestinal lumen.", [["Cells", "ANATOMY", 0, 5], ["epithelial cells", "ANATOMY", 73, 89], ["intestinal lumen", "ANATOMY", 101, 117], ["Cells", "CELL", 0, 5], ["MAA", "SIMPLE_CHEMICAL", 20, 23], ["epithelial cells", "CELL", 73, 89], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 101, 117], ["epithelial cells", "CELL_TYPE", 73, 89], ["MAA staining", "TEST", 20, 32], ["epithelial cells", "OBSERVATION", 73, 89], ["intestinal", "ANATOMY", 101, 111], ["lumen", "ANATOMY_MODIFIER", 112, 117]]], ["This finding indicates that \u03b12,3-linked sialic acids are present on the luminal surface of the epithelium.", [["luminal surface", "ANATOMY", 72, 87], ["epithelium", "ANATOMY", 95, 105], ["sialic acids", "CHEMICAL", 40, 52], ["luminal", "CHEMICAL", 72, 79], ["sialic acids", "CHEMICAL", 40, 52], ["\u03b12,3-linked sialic acids", "SIMPLE_CHEMICAL", 28, 52], ["luminal surface", "CELLULAR_COMPONENT", 72, 87], ["epithelium", "TISSUE", 95, 105], ["\u03b12,3-linked sialic acids", "PROBLEM", 28, 52], ["sialic acids", "OBSERVATION", 40, 52], ["luminal", "ANATOMY_MODIFIER", 72, 79], ["surface", "ANATOMY_MODIFIER", 80, 87], ["epithelium", "ANATOMY_MODIFIER", 95, 105]]], ["Pretreatment of precision-cut intestinal slices by neuraminidase from C. perfringens abolished lectin-specific staining (compare Fig. 2A and B) indicating that binding of both MAAII and SNA was sialic acid-dependent.Virus infection of precision-cut intestinal slices (PCIS) ::: ResultsFor analysis of the infection of differentiated chicken intestinal epithelial cells, an avian virus of the H9N2 subtype (strain A/chicken/SaudiArabia/CP7/98) was chosen.", [["intestinal slices", "ANATOMY", 30, 47], ["intestinal slices", "ANATOMY", 249, 266], ["intestinal epithelial cells", "ANATOMY", 341, 368], ["Virus infection", "DISEASE", 216, 231], ["infection", "DISEASE", 305, 314], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 30, 47], ["neuraminidase", "GENE_OR_GENE_PRODUCT", 51, 64], ["C. perfringens", "ORGANISM", 70, 84], ["lectin", "GENE_OR_GENE_PRODUCT", 95, 101], ["B", "GENE_OR_GENE_PRODUCT", 141, 142], ["MAAII", "GENE_OR_GENE_PRODUCT", 176, 181], ["SNA", "GENE_OR_GENE_PRODUCT", 186, 189], ["sialic acid-dependent", "SIMPLE_CHEMICAL", 194, 215], ["Virus", "ORGANISM", 216, 221], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 249, 266], ["chicken", "ORGANISM", 333, 340], ["intestinal epithelial cells", "CELL", 341, 368], ["H9N2", "ORGANISM", 392, 396], ["chicken", "ORGANISM", 415, 422], ["SaudiArabia", "ORGANISM", 423, 434], ["neuraminidase", "PROTEIN", 51, 64], ["lectin", "PROTEIN", 95, 101], ["B", "PROTEIN", 141, 142], ["MAAII", "PROTEIN", 176, 181], ["SNA", "PROTEIN", 186, 189], ["differentiated chicken intestinal epithelial cells", "CELL_TYPE", 318, 368], ["C. perfringens", "SPECIES", 70, 84], ["chicken", "SPECIES", 333, 340], ["chicken", "SPECIES", 415, 422], ["C. perfringens", "SPECIES", 70, 84], ["chicken", "SPECIES", 333, 340], ["A/chicken/SaudiArabia/CP7/98", "SPECIES", 413, 441], ["precision", "TEST", 16, 25], ["neuraminidase", "PROBLEM", 51, 64], ["C. perfringens", "PROBLEM", 70, 84], ["lectin", "TEST", 95, 101], ["sialic acid-dependent", "PROBLEM", 194, 215], ["Virus infection", "PROBLEM", 216, 231], ["analysis", "TEST", 289, 297], ["the infection", "PROBLEM", 301, 314], ["differentiated chicken intestinal epithelial cells", "PROBLEM", 318, 368], ["an avian virus", "PROBLEM", 370, 384], ["the H9N2 subtype", "PROBLEM", 388, 404], ["A/chicken/SaudiArabia/CP7", "TREATMENT", 413, 438], ["intestinal slices", "ANATOMY", 30, 47], ["SNA", "ANATOMY", 186, 189], ["sialic acid-dependent", "OBSERVATION", 194, 215], ["infection", "OBSERVATION", 222, 231], ["intestinal slices", "ANATOMY", 249, 266], ["infection", "OBSERVATION", 305, 314], ["intestinal epithelial cells", "OBSERVATION", 341, 368]]], ["Most avian viruses have a preference for \u03b12,3-linked sialic acids (Rogers and Paulson, 1983).", [["\u03b12,3-linked sialic acids", "CHEMICAL", 41, 65], ["sialic acids", "CHEMICAL", 53, 65], ["\u03b12,3-linked sialic acids", "SIMPLE_CHEMICAL", 41, 65], ["viruses", "OBSERVATION", 11, 18]]], ["Avian influenza viruses of the H9N2 subtype have been reported to bind both \u03b12,3- and \u03b12,6-linked sialic acids (Matrosovich et al., 2001, Punyadarsaniya et al., 2011).", [["influenza viruses", "DISEASE", 6, 23], ["sialic acids", "CHEMICAL", 98, 110], ["sialic acids", "CHEMICAL", 98, 110], ["Avian influenza viruses", "ORGANISM", 0, 23], ["H9N2", "ORGANISM", 31, 35], ["\u03b12,3", "SIMPLE_CHEMICAL", 76, 80], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 86, 110], ["\u03b12,6", "PROTEIN", 86, 90], ["Avian influenza viruses", "SPECIES", 0, 23], ["H9N2", "SPECIES", 31, 35], ["Avian influenza viruses", "PROBLEM", 0, 23], ["the H9N2 subtype", "PROBLEM", 27, 43]]], ["Strains containing a leucine rather than a glutamine at position 226 of the hemagglutinin, even have a preference for \u03b12,6-linked sialic acids (Matrosovich et al., 2001).", [["leucine", "CHEMICAL", 21, 28], ["glutamine", "CHEMICAL", 43, 52], ["sialic acids", "CHEMICAL", 130, 142], ["leucine", "CHEMICAL", 21, 28], ["glutamine", "CHEMICAL", 43, 52], ["sialic acids", "CHEMICAL", 130, 142], ["leucine", "AMINO_ACID", 21, 28], ["glutamine", "AMINO_ACID", 43, 52], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 118, 142], ["hemagglutinin", "PROTEIN", 76, 89], ["\u03b12,6", "PROTEIN", 118, 122], ["Strains", "PROBLEM", 0, 7], ["a leucine", "TREATMENT", 19, 28], ["a glutamine", "TREATMENT", 41, 52], ["the hemagglutinin", "TREATMENT", 72, 89]]], ["The receptor binding activity of the H9N2 virus hemagglutinin used in this study is able to bind to both \u03b12,3- and \u03b12,6-linked sialic acids as indicated by glycan array analysis (Punyadarsaniya et al., 2011).Virus infection of precision-cut intestinal slices (PCIS) ::: ResultsTo detect infected cells, cryosections of chicken precision-cut intestinal slices were stained for the presence of viral antigen using an antibody directed against the nucleoprotein (Fig. 2C, green).", [["intestinal slices", "ANATOMY", 241, 258], ["cells", "ANATOMY", 296, 301], ["cryosections", "ANATOMY", 303, 315], ["intestinal slices", "ANATOMY", 341, 358], ["sialic acids", "CHEMICAL", 127, 139], ["Virus infection", "DISEASE", 208, 223], ["sialic acids", "CHEMICAL", 127, 139], ["H9N2 virus hemagglutinin", "ORGANISM", 37, 61], ["\u03b12,6-linked sialic acids", "SIMPLE_CHEMICAL", 115, 139], ["Virus", "ORGANISM", 208, 213], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 241, 258], ["cells", "CELL", 296, 301], ["chicken", "ORGANISM", 319, 326], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 341, 358], ["\u03b12,3- and \u03b12,6-linked sialic acids", "PROTEIN", 105, 139], ["infected cells", "CELL_TYPE", 287, 301], ["viral antigen", "PROTEIN", 392, 405], ["nucleoprotein", "PROTEIN", 445, 458], ["Fig. 2C, green", "PROTEIN", 460, 474], ["H9N2 virus hemagglutinin", "SPECIES", 37, 61], ["chicken", "SPECIES", 319, 326], ["H9N2 virus", "SPECIES", 37, 47], ["chicken", "SPECIES", 319, 326], ["the H9N2 virus hemagglutinin", "TREATMENT", 33, 61], ["this study", "TEST", 70, 80], ["sialic acids", "TREATMENT", 127, 139], ["glycan array analysis", "TEST", 156, 177], ["Virus infection", "PROBLEM", 208, 223], ["infected cells", "PROBLEM", 287, 301], ["chicken precision", "TEST", 319, 336], ["viral antigen", "PROBLEM", 392, 405], ["an antibody", "TREATMENT", 412, 423], ["infection", "OBSERVATION", 214, 223], ["intestinal slices", "ANATOMY", 241, 258], ["infected cells", "OBSERVATION", 287, 301], ["intestinal slices", "ANATOMY", 341, 358]]], ["For comparison, the cryosections were stained in parallel for the presence of ezrin at the surface of the epithelium (Fig. 2C, red).", [["cryosections", "ANATOMY", 20, 32], ["surface", "ANATOMY", 91, 98], ["epithelium", "ANATOMY", 106, 116], ["ezrin", "GENE_OR_GENE_PRODUCT", 78, 83], ["surface", "CELLULAR_COMPONENT", 91, 98], ["epithelium", "TISSUE", 106, 116], ["ezrin", "PROTEIN", 78, 83], ["the cryosections", "TEST", 16, 32], ["ezrin", "PROBLEM", 78, 83], ["ezrin", "OBSERVATION", 78, 83], ["surface", "ANATOMY_MODIFIER", 91, 98], ["epithelium", "ANATOMY_MODIFIER", 106, 116]]], ["The infection by H9N2 virus was limited to the epithelial cells lining the intestinal lumen.", [["epithelial cells", "ANATOMY", 47, 63], ["intestinal lumen", "ANATOMY", 75, 91], ["infection", "DISEASE", 4, 13], ["H9N2 virus", "ORGANISM", 17, 27], ["epithelial cells", "CELL", 47, 63], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 75, 91], ["epithelial cells", "CELL_TYPE", 47, 63], ["H9N2 virus", "SPECIES", 17, 27], ["H9N2 virus", "SPECIES", 17, 27], ["The infection", "PROBLEM", 0, 13], ["H9N2 virus", "PROBLEM", 17, 27], ["infection", "OBSERVATION", 4, 13], ["epithelial cells", "OBSERVATION", 47, 63], ["intestinal", "ANATOMY", 75, 85], ["lumen", "ANATOMY_MODIFIER", 86, 91]]], ["Co-staining of the cryosections for the presence of viral antigen and ezrin revealed that the virus was able to infect villous cells (Fig. 2C).", [["cryosections", "ANATOMY", 19, 31], ["villous cells", "ANATOMY", 119, 132], ["cryosections", "MULTI-TISSUE_STRUCTURE", 19, 31], ["ezrin", "GENE_OR_GENE_PRODUCT", 70, 75], ["villous cells", "CELL", 119, 132], ["Fig. 2C", "CELL", 134, 141], ["viral antigen", "PROTEIN", 52, 65], ["ezrin", "PROTEIN", 70, 75], ["villous cells", "CELL_TYPE", 119, 132], ["the cryosections", "TEST", 15, 31], ["viral antigen", "PROBLEM", 52, 65], ["ezrin", "PROBLEM", 70, 75], ["the virus", "PROBLEM", 90, 99]]], ["The uninfected precision-cut intestinal slices were used as a control (Fig. 2D).", [["intestinal slices", "ANATOMY", 29, 46], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 29, 46], ["The uninfected precision-cut intestinal slices", "TREATMENT", 0, 46], ["uninfected", "OBSERVATION_MODIFIER", 4, 14], ["precision", "OBSERVATION_MODIFIER", 15, 24], ["intestinal slices", "ANATOMY", 29, 46]]], ["Virus released into the supernatant was determined by plaque titration and found to increase from 103pfu/ml at 24 hpi to 104pfu/ml at 48 hpi.DiscussionIn this study, a culture system for chicken intestinal epithelial cells was introduced that is suitable for infection studies.", [["supernatant", "ANATOMY", 24, 35], ["plaque", "ANATOMY", 54, 60], ["intestinal epithelial cells", "ANATOMY", 195, 222], ["infection", "DISEASE", 259, 268], ["Virus", "ORGANISM", 0, 5], ["chicken", "ORGANISM", 187, 194], ["intestinal epithelial cells", "CELL", 195, 222], ["chicken intestinal epithelial cells", "CELL_TYPE", 187, 222], ["chicken", "SPECIES", 187, 194], ["chicken", "SPECIES", 187, 194], ["Virus", "PROBLEM", 0, 5], ["plaque titration", "TEST", 54, 70], ["this study", "TEST", 154, 164], ["a culture system", "TEST", 166, 182], ["chicken intestinal epithelial cells", "PROBLEM", 187, 222], ["infection studies", "TEST", 259, 276], ["plaque", "OBSERVATION", 54, 60], ["increase", "OBSERVATION_MODIFIER", 84, 92], ["intestinal", "ANATOMY", 195, 205], ["epithelial cells", "OBSERVATION", 206, 222]]], ["In previous reports, different approaches have been applied to analyze the infection of intestinal epithelial cells (IEC).", [["intestinal epithelial cells", "ANATOMY", 88, 115], ["IEC", "ANATOMY", 117, 120], ["infection", "DISEASE", 75, 84], ["intestinal epithelial cells", "CELL", 88, 115], ["IEC", "CELL", 117, 120], ["intestinal epithelial cells", "CELL_TYPE", 88, 115], ["IEC", "CELL_TYPE", 117, 120], ["different approaches", "TREATMENT", 21, 41], ["the infection of intestinal epithelial cells", "PROBLEM", 71, 115], ["infection", "OBSERVATION", 75, 84], ["intestinal epithelial cells", "OBSERVATION", 88, 115]]], ["In contrast to respiratory epithelial cells, IEC cultures are more difficult to establish.", [["respiratory epithelial cells", "ANATOMY", 15, 43], ["IEC cultures", "ANATOMY", 45, 57], ["respiratory epithelial cells", "CELL", 15, 43], ["IEC cultures", "CELL", 45, 57], ["respiratory epithelial cells", "CELL_TYPE", 15, 43], ["IEC cultures", "CELL_LINE", 45, 57], ["respiratory epithelial cells", "TEST", 15, 43], ["IEC cultures", "TEST", 45, 57], ["respiratory epithelial cells", "OBSERVATION", 15, 43]]], ["Thus, the culture systems introduced so far have all some shortcomings, e.g. a short life span, or the selection of only some specialized cells such as crypt cells (Bjerknes and Cheng, 1981, Cano-Gauci et al., 1993, Lotz et al., 2006).", [["cells", "ANATOMY", 138, 143], ["crypt cells", "ANATOMY", 152, 163], ["cells", "CELL", 138, 143], ["crypt cells", "CELL", 152, 163], ["crypt cells", "CELL_TYPE", 152, 163], ["the culture systems", "TEST", 6, 25], ["a short life span", "PROBLEM", 77, 94], ["some specialized cells", "PROBLEM", 121, 143], ["crypt cells", "PROBLEM", 152, 163], ["crypt cells", "OBSERVATION", 152, 163]]], ["Precision-cut intestinal slices are an interesting alternative as their preparation is comparably easy providing a large number of slices.", [["intestinal slices", "ANATOMY", 14, 31], ["slices", "ANATOMY", 131, 137], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 14, 31], ["Precision-cut intestinal slices", "TREATMENT", 0, 31], ["intestinal slices", "ANATOMY", 14, 31], ["large", "OBSERVATION_MODIFIER", 115, 120]]], ["Furthermore, the epithelial cells lining the intestinal lumen remain viable for up to 4 days, a life span long enough for virus infections.", [["epithelial cells", "ANATOMY", 17, 33], ["intestinal lumen", "ANATOMY", 45, 61], ["infections", "DISEASE", 128, 138], ["epithelial cells", "CELL", 17, 33], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 45, 61], ["epithelial cells", "CELL_TYPE", 17, 33], ["the epithelial cells", "TREATMENT", 13, 33], ["virus infections", "PROBLEM", 122, 138], ["epithelial cells", "OBSERVATION", 17, 33], ["intestinal", "ANATOMY", 45, 55], ["lumen", "ANATOMY_MODIFIER", 56, 61]]], ["The feasibility of this approach has been demonstrated with the avian influenza virus of the H9N2 subtype.", [["avian influenza virus", "ORGANISM", 64, 85], ["H9N2", "ORGANISM", 93, 97], ["avian influenza virus", "SPECIES", 64, 85], ["H9N2", "SPECIES", 93, 97], ["this approach", "TREATMENT", 19, 32], ["the avian influenza virus", "PROBLEM", 60, 85], ["the H9N2 subtype", "PROBLEM", 89, 105], ["H9N2 subtype", "OBSERVATION", 93, 105]]], ["While influenza virus infections in many cases are restricted to the respiratory tract, infection of Mallard duck by influenza viruses is a typical lower intestinal infection (Fran\u00e7a et al., 2012).", [["respiratory tract", "ANATOMY", 69, 86], ["intestinal", "ANATOMY", 154, 164], ["influenza virus infections", "DISEASE", 6, 32], ["infection", "DISEASE", 88, 97], ["influenza viruses", "DISEASE", 117, 134], ["intestinal infection", "DISEASE", 154, 174], ["influenza virus", "ORGANISM", 6, 21], ["respiratory tract", "ORGANISM_SUBDIVISION", 69, 86], ["Mallard duck", "ORGANISM", 101, 113], ["influenza viruses", "ORGANISM", 117, 134], ["intestinal", "ORGAN", 154, 164], ["influenza virus", "SPECIES", 6, 21], ["Mallard duck", "SPECIES", 101, 113], ["influenza virus", "SPECIES", 6, 21], ["Mallard duck", "SPECIES", 101, 113], ["influenza virus infections", "PROBLEM", 6, 32], ["the respiratory tract", "PROBLEM", 65, 86], ["infection", "PROBLEM", 88, 97], ["Mallard duck", "PROBLEM", 101, 113], ["influenza viruses", "PROBLEM", 117, 134], ["a typical lower intestinal infection", "PROBLEM", 138, 174], ["respiratory tract", "ANATOMY", 69, 86], ["infection", "OBSERVATION", 88, 97], ["Mallard duck", "OBSERVATION", 101, 113], ["influenza viruses", "OBSERVATION", 117, 134], ["typical", "OBSERVATION_MODIFIER", 140, 147], ["lower", "ANATOMY_MODIFIER", 148, 153], ["intestinal", "ANATOMY", 154, 164], ["infection", "OBSERVATION", 165, 174]]], ["Therefore, it will be interesting to use precision-cut intestinal slices from duck intestines for infection studies.", [["intestinal slices", "ANATOMY", 55, 72], ["intestines", "ANATOMY", 83, 93], ["infection", "DISEASE", 98, 107], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 55, 72], ["duck", "ORGANISM", 78, 82], ["intestines", "ORGAN", 83, 93], ["duck", "SPECIES", 78, 82], ["infection studies", "TEST", 98, 115], ["intestinal", "ANATOMY", 55, 65], ["intestines", "ANATOMY", 83, 93], ["infection", "OBSERVATION", 98, 107]]], ["In this study, the infection system was established for the chicken intestine, because the chicken is used routinely in the laboratory tests, e.g. for preparation of chicken embryo kidney cells.", [["intestine", "ANATOMY", 68, 77], ["embryo kidney cells", "ANATOMY", 174, 193], ["infection", "DISEASE", 19, 28], ["chicken", "ORGANISM", 60, 67], ["intestine", "ORGAN", 68, 77], ["chicken", "ORGANISM", 91, 98], ["chicken", "ORGANISM", 166, 173], ["embryo kidney cells", "CELL", 174, 193], ["chicken embryo kidney cells", "CELL_TYPE", 166, 193], ["chicken", "SPECIES", 60, 67], ["chicken", "SPECIES", 91, 98], ["chicken", "SPECIES", 166, 173], ["chicken", "SPECIES", 60, 67], ["chicken", "SPECIES", 91, 98], ["chicken", "SPECIES", 166, 173], ["this study", "TEST", 3, 13], ["the infection system", "PROBLEM", 15, 35], ["the chicken intestine", "PROBLEM", 56, 77], ["the laboratory tests", "TEST", 120, 140], ["preparation of chicken embryo kidney cells", "TREATMENT", 151, 193], ["infection", "OBSERVATION", 19, 28], ["intestine", "ANATOMY", 68, 77], ["kidney", "ANATOMY", 181, 187]]], ["Future work will include the preparation of precision-cut intestinal slices from other avian species.", [["intestinal slices", "ANATOMY", 58, 75], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 58, 75], ["other avian species", "PROBLEM", 81, 100], ["intestinal", "ANATOMY", 58, 68]]], ["The preparation method for precision-cut intestinal slices reported in this study is limited by the organ size.", [["intestinal slices", "ANATOMY", 41, 58], ["organ", "ANATOMY", 100, 105], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 41, 58], ["organ", "ORGAN", 100, 105], ["precision-cut intestinal slices", "TEST", 27, 58], ["this study", "TEST", 71, 81], ["organ", "ANATOMY", 100, 105], ["size", "OBSERVATION_MODIFIER", 106, 110]]], ["It is expected that this technique can also be applied to the intestinal tissue from small mammalian species e.g. from mice and bats.", [["intestinal tissue", "ANATOMY", 62, 79], ["intestinal tissue", "TISSUE", 62, 79], ["mice", "ORGANISM", 119, 123], ["mice", "SPECIES", 119, 123], ["mice", "SPECIES", 119, 123], ["this technique", "TREATMENT", 20, 34], ["small mammalian species", "PROBLEM", 85, 108], ["intestinal tissue", "ANATOMY", 62, 79], ["small", "OBSERVATION_MODIFIER", 85, 90], ["mammalian species", "OBSERVATION", 91, 108]]], ["Thus, precision-cut intestinal slices promise to be a valuable culture system for infection studies with enteric viruses.Author contributionsConceived and designed the experiments: DP, GH; Performed the experiments: DP; Analyzed the data: DP, GH, CW, AKW, SR, MA, HN; Contributed reagents/materials/analysis tools: CW, AKW, SR, MA, HN; Wrote the paper: DP,GH.", [["intestinal slices", "ANATOMY", 20, 37], ["infection", "DISEASE", 82, 91], ["enteric viruses", "DISEASE", 105, 120], ["intestinal slices", "MULTI-TISSUE_STRUCTURE", 20, 37], ["GH", "GENE_OR_GENE_PRODUCT", 356, 358], ["a valuable culture system", "TEST", 52, 77], ["infection studies", "PROBLEM", 82, 99], ["enteric viruses", "PROBLEM", 105, 120], ["DP", "TEST", 216, 218], ["DP", "TEST", 239, 241], ["GH", "TEST", 243, 245], ["CW", "TEST", 247, 249], ["AKW", "TEST", 251, 254], ["intestinal", "ANATOMY", 20, 30], ["infection", "OBSERVATION", 82, 91], ["HN", "ANATOMY", 264, 266], ["DP", "ANATOMY", 353, 355], ["GH", "ANATOMY", 356, 358]]]], "0d8253f5a43e9e921ae199909474c06f8bbd3f6a": [["IntroductionAutomatic Text Generation (ATG) is a task that has been widely studied by researchers in the area of Natural Language Processing (NLP) [13, [20] [21] [22] [23] .", [["[20] [21] [22", "SIMPLE_CHEMICAL", 152, 165], ["IntroductionAutomatic Text Generation (ATG", "TREATMENT", 0, 42]]], ["Results from several investigations have presented very encouraging results that have allowed the establishment of progressively more challenging objectives in this field.", [["several investigations", "TEST", 13, 35]]], ["Currently, the scope of ATG is being expanded and there is much recent work that aims at generating text related to a specific domain [8, 10, 18] .", [["ATG", "DNA", 24, 27], ["ATG", "TREATMENT", 24, 27]]], ["In this research, algorithms have been developed, oriented to such diverse purposes as creating chat-bots for customer service in commercial applications, automatic generation of summaries for academic support, or developing generators of literary poetry, short stories, novels, plays and essays [3, 17, 25] .IntroductionThe creation of a literary text is particularly interesting and challenging, when compared to other types of ATG, as these texts are not universally and perpetually perceived.", [["academic support", "TREATMENT", 193, 209], ["ATG", "TREATMENT", 430, 433]]], ["The model is based on the assumption that these psychological traits determine a person's emotions and speech.", [["person", "SPECIES", 81, 87], ["these psychological traits", "PROBLEM", 42, 68]]], ["It is then possible to perform an analysis of the personality of a character through the author's writing, considering parts of speech such as verbs, adjectives, conjunctions, and the spinning of words or concepts, as well as other characteristics.IntroductionIn Sect.", [["an analysis", "TEST", 31, 42]]], ["2, we present a review of the main literature that has addressed topics related to ATG, with focus on those that proposed methods and algorithms integrated into this work.", [["ATG", "DNA", 83, 86], ["ATG", "TREATMENT", 83, 86]]], ["5, we show some experiments, as well as the results of human evaluations of the generated sentences.", [["human", "ORGANISM", 55, 60], ["human", "SPECIES", 55, 60], ["human", "SPECIES", 55, 60], ["human evaluations", "TEST", 55, 72]]], ["6 we present our conclusions.Related WorkThe task of ATG has been widely addressed by the research community in recent years.", [["ATG", "CHEMICAL", 53, 56], ["ATG", "DNA", 53, 56], ["ATG", "TREATMENT", 53, 56]]], ["In [21] , Szymanski and Ciota presented a model based on Markov sequences for the stochastic generation of text, where the intention is to generate grammatically correct text, although without considering a context or meaning.", [["Markov sequences", "TEST", 57, 73]]], ["Given the signature and body of a method, their generator identifies the content for the summary and generates natural language text that summarizes the method's overall actions.Related WorkWork with an artistic, literary approach has also been developed for GLT.", [["GLT", "CANCER", 259, 262], ["GLT", "PROBLEM", 259, 262]]], ["The works of Riedl and Young [17] and Clark, Ji and Smith [3] propose stochastic models, based on contextual analysis, for the generation of fictional narratives (stories).", [["contextual analysis", "TEST", 98, 117]]], ["Zhang and Lapata [25] use neural networks and Oliveira [12, 13] uses the technique of canned text for generating poems.", [["neural networks", "ANATOMY", 26, 41], ["neural networks", "MULTI-TISSUE_STRUCTURE", 26, 41], ["Zhang and Lapata", "TREATMENT", 0, 16], ["neural networks", "TREATMENT", 26, 41], ["poems", "OBSERVATION", 113, 118]]], ["Some research has achieved the difficult task of generating large texts, overcoming the barrier of phrases and paragraphs, such as the MEXICA project [15] .Related WorkPersonality analysis is a complicated task that can be studied from different perspectives (see [19, 24] and references therein).", [["large", "OBSERVATION_MODIFIER", 60, 65]]], ["In [7] , a type of personality is detected from the analysis of a text, using an artificial neural network (ANN), which classifies text into one of five personality classes considered by the authors (Extroversion, Neuroticism, Agreeableness, Conscientiousness, Openness).", [["Agreeableness", "DISEASE", 227, 240], ["neural network", "MULTI-TISSUE_STRUCTURE", 92, 106]]], ["Some characteristics that are considered by the authors are writing styles and relationships between pairs of words.CorpusWe have built two corpora in Spanish consisting of the main works of Johann Wolfgang von Goethe and Edgar Allan Poe, called cGoethe and cPoe, respectively.", [["two", "OBSERVATION_MODIFIER", 136, 139], ["corpora", "OBSERVATION", 140, 147], ["main", "OBSERVATION_MODIFIER", 177, 181]]], ["These corpora are analyzed and used to extract information about the vocabulary used by these authors.", [["corpora", "MULTI-TISSUE_STRUCTURE", 6, 13]]], ["We also use the corpora 5KL described in [11] for the final phase of the sentence generation procedure described in 4.2.CorpusTo build the cGoethe and cPoe corpora, we processed each constituent literary work (originally found in heterogeneous formats), creating a single document for each corpus, encoded in utf8.", [["corpus", "ANATOMY", 290, 296], ["corpus", "CANCER", 290, 296], ["utf8", "GENE_OR_GENE_PRODUCT", 309, 313], ["utf8", "DNA", 309, 313], ["the corpora 5KL", "TREATMENT", 12, 27], ["the sentence generation procedure", "TREATMENT", 69, 102]]], ["This processing consisted of automatically segmenting the phrases into regular expressions, using a program developed in PERL 5.0, to obtain one sentence per line in each corpus.CorpusFrom the segmented phrases in cGoethe and cPoe, we selected only those that belong to the works The Sorrows of Young Werther (set 1) and The Cask of Amontillado (set 2).", [["corpus", "ANATOMY", 171, 177], ["corpus", "CANCER", 171, 177], ["line", "OBSERVATION", 158, 162], ["corpus", "ANATOMY", 171, 177], ["segmented", "OBSERVATION_MODIFIER", 193, 202], ["phrases", "OBSERVATION", 203, 210]]], ["From sets 1 and 2, we manually extracted phrases that we considered to be very literary, to form two new corpora, cWerther and cCask, respectively.", [["corpora", "MULTI-TISSUE_STRUCTURE", 105, 112]]], ["In this step, we chose phrases with complex vocabulary, a directly expressed message and some literary styles like rhymes, anaphoras, etc. Table 1 shows basic statistical information of the cGoethe and cPoe corpora.", [["anaphoras", "PROBLEM", 123, 132]]], ["Table 2 , shows similar information for cWerther and cCask.", [["cCask", "PROTEIN", 53, 58]]], ["Table 3 shows statistical information of the 5KL corpus.", [["5KL corpus", "ANATOMY", 45, 55], ["5KL corpus", "TISSUE", 45, 55]]], ["The 5KL corpus contains approximately 4 000 literary works, some originally written in Spanish and the rest in their translations to Spanish, from various authors and different genres, and is extremely useful, as it consists of an enormous vocabulary, that forms a highly representative set to train our Word2vec based model, described in Sect.", [["approximately", "OBSERVATION_MODIFIER", 24, 37]]], ["In the first phase, the Partially Empty Grammatical Structures (PGSs), each composed by elements constituted either by parts of speech (POS) tags or function words 1 , are generated.", [["Partially", "OBSERVATION_MODIFIER", 24, 33], ["Empty", "OBSERVATION", 34, 39], ["Grammatical Structures", "OBSERVATION", 40, 62]]], ["A PGS is constructed, through a morphosyntactic analysis made with FreeLing 2 , for each phrase of the corpora cWerther and cCask, described in the Sect.", [["PGS", "CHEMICAL", 2, 5], ["PGS", "DNA", 2, 5], ["A PGS", "TEST", 0, 5], ["a morphosyntactic analysis", "TEST", 30, 56]]], ["The POS tags of these PGSs are replaced by words during the second phase.", [["PGSs", "GENE_OR_GENE_PRODUCT", 22, 26], ["POS tags", "DNA", 4, 12], ["PGSs", "DNA", 22, 26], ["POS tags", "OBSERVATION", 4, 12]]], ["FreeLing [14] is a commonly used tool for morphosyntactic analysis, which receives as input a string of text and returns a POS tag as output, for each word in the string.", [["POS tag", "DNA", 123, 130], ["morphosyntactic analysis", "TEST", 42, 66]]], ["The POS tag indicates the type of word (verb, noun, adjective, adverb, etc.), and also information about inflections, i.e., gender, conjugation and number.", [["POS tag", "DNA", 4, 11], ["POS tag", "OBSERVATION", 4, 11]]], ["For example, for the word \"Investigador\" FreeLing generates the POS tag [NCMS000].", [["POS tag", "DNA", 64, 71]]], ["The last 3 characters give information about semantics, named entities, etc. We will use only the first 4 symbols of the POS tags.", [["POS tags", "DNA", 121, 129]]], ["In the second phase, each POS tag in the PGSs are replaced by a corresponding word, using a semantic approach algorithm based on an ANN model (Word2vec 3 ).", [["PGSs", "CANCER", 41, 45], ["POS tag", "DNA", 26, 33], ["PGSs", "DNA", 41, 45], ["a semantic approach algorithm", "TREATMENT", 90, 119]]], ["3, was used for training Word2vec, as well as the following parameters: only words with more than 5 occurrences in 5KL were considered, the size of the context window is 10, the dimensions of the vector representations were tested within a range of 50 to 100, being 60 the dimension with the best results.", [["Word2vec", "PROTEIN", 25, 33], ["training Word2vec", "TREATMENT", 16, 33], ["size", "OBSERVATION_MODIFIER", 140, 144]]], ["The process for the generation of sentences is described in what follows.Phase I: PGS GenerationFor the generation of each PGS, we use methods guided by fixed morphosyntactic structures, called Template-based Generation or canned text.", [["PGS", "CHEMICAL", 82, 85], ["PGS", "CHEMICAL", 123, 126], ["the generation of each PGS", "TREATMENT", 100, 126]]], ["In [10] , it is argued that the use of these techniques saves time in syntactic analysis and allows one to concentrate directly on the vocabulary.", [["these techniques", "TREATMENT", 39, 55], ["syntactic analysis", "TEST", 70, 88]]], ["The canned text technique has also been used in several works, with specific purposes, such as in [4, 8] , where the authors developed models for the generation of simple dialogues and phrases.Phase I: PGS GenerationWe use canned text to generate text based on templates obtained from cCask and cWerther.", [["PGS", "CHEMICAL", 202, 205], ["The canned text technique", "TREATMENT", 0, 25]]], ["These corpora contain flexible grammatical structures that can be manipulated to create new phrases.", [["corpora", "MULTI-TISSUE_STRUCTURE", 6, 13], ["corpora", "ANATOMY", 6, 13], ["flexible grammatical structures", "OBSERVATION", 22, 53], ["new", "OBSERVATION_MODIFIER", 88, 91]]], ["The templates in a corpus can be selected randomly or through heuristics, according to a predefined objective.", [["corpus", "ANATOMY", 19, 25], ["corpus", "ORGAN", 19, 25], ["corpus", "ANATOMY", 19, 25]]], ["A template PGS is built from the words of f o , where content words, verbs (v), nouns (n) or adjectives (a), are replaced by their respective POS tags and function words are retained. f o is analyzed with FreeLing and words with \"values\" in {v, n, a} are replaced by their respective POS tags.", [["PGS", "CHEMICAL", 11, 14], ["template PGS", "DNA", 2, 14], ["A template PGS", "TREATMENT", 0, 14]]], ["The output of this process is a PGS with function words that give grammatical support and POS tags that will be replaced, in order to change the meaning of the sentence.", [["PGS", "CHEMICAL", 32, 35], ["grammatical support", "TREATMENT", 66, 85], ["POS tags", "TREATMENT", 90, 98], ["output", "OBSERVATION_MODIFIER", 4, 10]]], ["Phase I is illustrated in Fig. 1 , where full boxes represent function words and empty boxes represent POS tags.Phase II: Semantic Analysis and Substitution of POS TagsIn this phase, the POS tags of the PGS generated in Phase I are replaced.", [["PGS", "CHEMICAL", 203, 206], ["empty boxes", "DNA", 81, 92], ["POS tags", "DNA", 103, 111], ["Semantic Analysis", "TEST", 122, 139], ["POS tags", "OBSERVATION", 103, 111]]], ["Corpus 5KL is pre-processed to standardize text formatting, eliminating characters that are not important for semantic analysis such as punctuation and numbers.", [["5KL", "DNA", 7, 10], ["semantic analysis", "TEST", 110, 127], ["not important", "UNCERTAINTY", 92, 105]]], ["This stage prepares the Word2vec training data that uses a vector representation of 5KL.", [["5KL", "GENE_OR_GENE_PRODUCT", 84, 87], ["5KL", "PROTEIN", 84, 87], ["a vector representation", "TREATMENT", 57, 80]]], ["We use Gensim 4 , a Python implementation of Word2vec.", [["Word2vec", "GENE_OR_GENE_PRODUCT", 45, 53], ["Word2vec", "PROTEIN", 45, 53]]], ["A query Q, provided by the user, is given as input to this algorithm, and its output is a set of words (embeddings) associated with a context defined by Q. In other words, Word2vec receives a term Q and returns a lexicon L(Q) = (Q 1 , Q 2 , ..., Q m ), that represents a set of m = 10 words semantically close to Q. We chose this value of m because we found that if we increase the number of words obtained by Word2vec, they start to lose their relation to Q. Formally, we represnt a mapping by Word2vec as Q \u2192 L(Q).Phase II: Semantic Analysis and Substitution of POS TagsCorpora cGoethe or cPoe, previously analyzed using FreeLing to obtain PGSs, had a POS tag associated to each content word.", [["Word2vec", "GENE_OR_GENE_PRODUCT", 410, 418], ["Word2vec", "PROTEIN", 172, 180], ["Word2vec", "PROTEIN", 410, 418], ["Word2vec", "PROTEIN", 495, 503], ["cPoe", "DNA", 591, 595], ["PGSs", "DNA", 642, 646], ["POS tag", "DNA", 654, 661], ["Semantic Analysis", "TEST", 526, 543]]], ["Now, with FreeLing, each POS tag is used to create a set of words, with the same grammatical information (identical POS tags).", [["POS tag", "DNA", 25, 32]]], ["The AT consists of entries of the type: POS k \u2192 list of words v k,i , with same grammatical information, formallyPhase II: Semantic Analysis and Substitution of POS TagsTo generate a new phrase, each tag POS k \u2208 PGS, is replaced by a word selected from the lexicon V k , given by AT.Phase II: Semantic Analysis and Substitution of POS TagsTo choose a word in V k to replace POS k , we use the following algorithm.", [["PGS", "DNA", 212, 215], ["lexicon V k", "DNA", 257, 268], ["Semantic Analysis", "TEST", 123, 140], ["Substitution of POS Tags", "TREATMENT", 145, 169], ["Semantic Analysis", "TEST", 293, 310], ["POS Tags", "TEST", 331, 339], ["POS Tags", "OBSERVATION", 331, 339]]], ["A vector is constructed for each of the three words defined as:Phase II: Semantic Analysis and Substitution of POS Tagso: is the k th word in the phrase f o , corresponding to tag POS k ; -Q: word defining the query provided by the user; -w: candidate word that could replace POS k , w \u2208 V k .Phase II: Semantic Analysis and Substitution of POS TagsFor each word o, Q and w, 10 closest words, o i , Q i and w i , i = 1, ..., 10, are obtained with Word2vec.", [["Word2vec", "DNA", 447, 455], ["A vector", "TREATMENT", 0, 8], ["Semantic Analysis", "TEST", 73, 90], ["Semantic Analysis", "TEST", 303, 320], ["Substitution of POS Tags", "TREATMENT", 325, 349]]], ["The dimension was set to 30, as a compromise between lexical diversity and processing time.", [["compromise", "OBSERVATION", 34, 44], ["lexical diversity", "OBSERVATION", 53, 70]]], ["The vector U can be written as ..., o 10 , Q 11 , ..., Q 20 , w 21 , ..., w 30 ) = (u 1 , u 2 , ..., u 30 ) .Phase II: Semantic Analysis and Substitution of POS Tags(1)Phase II: Semantic Analysis and Substitution of POS TagsWords o, Q and w generate three numerical vectors of 30 dimensions respectively, o \u2192 X = (x 1 , ..., x 30 ), Q \u2192 Q = (q 1 , ..., q 30 ), and w \u2192 W = (w 1 , ..., w 30 ) , where the elements x j of X are obtained by taking the distance x j = dist(o, u j ) \u2208 [0, 1], between o and each u j \u2208 U , provided by Word2vec.", [["Word2vec", "GENE_OR_GENE_PRODUCT", 529, 537], ["Word2vec", "PROTEIN", 529, 537], ["Semantic Analysis", "TEST", 119, 136], ["POS Tags", "TEST", 157, 165], ["Semantic Analysis", "TEST", 178, 195], ["q", "TEST", 353, 354], ["w \u2192 W", "TEST", 365, 370], ["the distance", "TEST", 445, 457], ["\u2208", "TEST", 478, 479], ["U", "TEST", 513, 514], ["Word2vec", "TEST", 529, 537]]], ["A similar process is used to obtain the elements of Q and W from Q and w, respectively.", [["similar", "OBSERVATION_MODIFIER", 2, 9], ["process", "OBSERVATION", 10, 17]]], ["Cosine similarities are then calculated between Q and W , and X and W asPhase II: Semantic Analysis and Substitution of POS TagsThis process is repeated r times, once for each word w = v k,i in V k , and similarities \u03b8 i and \u03b2 i , i = 1, ..., r, are obtained for each v k,i , as well as the averages \u03b8 = \u03b8 i /r and \u03b2 = \u03b2 i /r.", [["Semantic Analysis", "TEST", 82, 99], ["Substitution of POS Tags", "TREATMENT", 104, 128], ["\u03b2", "TEST", 315, 316], ["r.", "ANATOMY", 324, 326]]], ["The normalized ratio \u03b8 \u03b8i indicates how large the similarity \u03b8 i is with respect to the average \u03b8 that is, how close is the candidate word w = v k,i to the query Q. The ratio \u03b2i \u03b2 indicates how reduced the similarity \u03b2 i is to the average \u03b2 , that is, how far away the candidate word w is from word o of f o .", [["\u03b8", "DNA", 96, 97], ["\u03b2i \u03b2", "PROTEIN", 175, 179], ["\u03b2", "PROTEIN", 239, 240], ["large", "OBSERVATION_MODIFIER", 40, 45]]], ["A score Sn i is obtained for each pair (\u03b8 i , \u03b2 i ) asPhase II: Semantic Analysis and Substitution of POS TagsThe higher the value of Sn i , the better the candidate, w = v k,i , complies to the goal of approaching Q and moving away from the semantics of f o .", [["Sn", "CHEMICAL", 134, 136], ["Sn", "PROTEIN", 134, 136], ["A score", "TEST", 0, 7], ["Semantic Analysis", "TEST", 64, 81], ["POS Tags", "TEST", 102, 110]]], ["We use candidates with large values of Sn i to replace the nouns.", [["Sn", "PROTEIN", 39, 41]]], ["To replace verbs and adjectives, we want the candidate w = v k,i closer to f o , so we choose among candidates with large Sva i , given byPhase II: Semantic Analysis and Substitution of POS TagsFinally, we sort the values of Sn i (nouns) or Sva i (verbs and adjectives) in decreasing order and choose, at random, from the highest three values, the candidate v k,i that will replace the POS k tag.", [["byPhase II", "PROTEIN", 136, 146], ["Sn", "PROTEIN", 225, 227], ["POS k tag", "DNA", 386, 395], ["Semantic Analysis", "TEST", 148, 165], ["Substitution of POS Tags", "TREATMENT", 170, 194]]], ["The result is a newly generated phrase f (Q, N ) that does not exist in the corpora, but maintains the psychological mood (emotional content) of f o .", [["corpora", "MULTI-TISSUE_STRUCTURE", 76, 83], ["corpora", "ANATOMY", 76, 83]]], ["The model is shown in Fig. 2 .Evaluation and ResultsA manual evaluation protocol has been designed to measure some characteristics of the phrases generated by our model.", [["Evaluation", "TEST", 30, 40], ["A manual evaluation protocol", "TEST", 52, 80], ["Fig", "OBSERVATION_MODIFIER", 22, 25]]], ["Although the baseline evaluation was done with a different scale for the evaluation parameters than in the current case, the comparison we present here helps us to understand the human evaluators' perception of the generated sentences.", [["human", "ORGANISM", 179, 184], ["human", "SPECIES", 179, 184], ["human", "SPECIES", 179, 184], ["the baseline evaluation", "TEST", 9, 32], ["the evaluation parameters", "TEST", 69, 94]]], ["Sentences have been generated using the corpora 5KL, cGoethe, cPoe, cWerther and cCask, as explained in SectSentences Generated Using cCask, cPoe and 5KLThe experiment we performed consisted of generating 20 sentences for each author's corpora and the 5KL corpus.", [["5KL corpus", "ANATOMY", 252, 262], ["corpora", "MULTI-TISSUE_STRUCTURE", 236, 243], ["5KL corpus", "TISSUE", 252, 262], ["cCask", "DNA", 81, 86]]], ["Five people were asked to read carefully and evaluate the total of 40 sentences.", [["people", "ORGANISM", 5, 11], ["people", "SPECIES", 5, 11]]], ["They were asked to score each sentence on a scale of [0 \u2212 4], where 0 = very bad, 1 = bad, 2 = acceptable, 3 = good and 4 = very good.", [["a scale", "TEST", 42, 49]]], ["The following criteria were used in the evaluations.Sentences Generated Using cCask, cPoe and 5KL-Grammar: spelling, conjugations and agreement between gender and number; -Coherence: legibility, perception of a general idea; -Context: relation between the sentence and the query.Sentences Generated Using cCask, cPoe and 5KLWe also asked the evaluators to indicate if, according to their own criteria, they considered the sentences as literary.", [["5KL", "PROTEIN", 94, 97], ["the evaluations", "TEST", 36, 51]]], ["Finally, the evaluators were to indicate which emotion they associate to each sentence (0 = Fear, 1 = Sadness, 2 = Hope, 3 = Love, and 4 = Happiness).", [["Sadness", "PROBLEM", 102, 109]]], ["We compared our results with the evaluation made in [11] as a baseline.", [["the evaluation", "TEST", 29, 43]]], ["However, the evaluation scale in [11] is in a range of [0 \u2212 2] (0 = bad, 1 = acceptable, 2 = very good).", [["the evaluation scale", "TEST", 9, 29]]], ["Another difference is that, for the current evaluation, we have calculated the mode instead of the arithmetic mean, since it is more feasible for the analysis of data evaluated in the Likert scale.Sentences Generated Using cCask, cPoe and 5KLIn Fig. 3a , it can be seen that the Grammar criterion obtained good results, with a general perception of very good.", [["the current evaluation", "TEST", 32, 54], ["the analysis", "TEST", 146, 158], ["the Likert scale", "TEST", 180, 196], ["the Grammar criterion", "TEST", 275, 296]]], ["This is similar to the average of 0.77 obtained in the evaluation of the model proposed in [11] .", [["the evaluation", "TEST", 51, 65]]], ["The Coherence was rated as bad, against the arithmetic mean of 0.60 obtained in [11] .", [["the arithmetic mean", "TEST", 40, 59]]], ["This score is similar with the average of 0.53 obtained in [11] .", [["This score", "TEST", 0, 10]]], ["In Fig. 4a , we observe that hope, happiness and sadness were the most perceived emotions in phrases generated with cCask and cPoe.", [["cCask", "PROTEIN", 116, 121], ["cPoe", "PROTEIN", 126, 130], ["happiness", "PROBLEM", 35, 44], ["sadness", "PROBLEM", 49, 56]]], ["Of these, we can highlight Sadness which is characteristic of much of Poe's works.", [["Sadness", "PROBLEM", 27, 34]]], ["Although Hapiness is not typical in Poe's works, we may have an explanation for this perception of the readers.", [["Hapiness", "DISEASE", 9, 17], ["not typical", "UNCERTAINTY", 21, 32]]], ["If we analyze The Cask of (a) Mode calculated from the evaluation made for the sentence generation model.", [["the evaluation", "TEST", 51, 65]]], ["Amontillado, we observe that its main character, Fortunato, was characterized as a happy and carefree man until his murder, perhaps because of his drunkenness.", [["drunkenness", "DISEASE", 147, 158], ["man", "SPECIES", 102, 105], ["Amontillado", "TREATMENT", 0, 11], ["his drunkenness", "PROBLEM", 143, 158]]], ["In Fig. 4b , we can observe that sentences generated with cWerther and cGoethe transmit mainly sadness, hope and love, which are psychological traits easily perceived when reading The Sorrows of Young Werther.Conclusions and Future WorkWe have proposed a model for the generation of literary sentences, that is influenced by two important elements: a context, given by a word input by the user, and a writing mood and style, defined by the training corpora used by our models.", [["corpora", "MULTI-TISSUE_STRUCTURE", 449, 456]]], ["The canned text technique applied to corpora cCask and cWerther, and the similarity measures and scores given by Eqs.", [["The canned text technique", "TREATMENT", 0, 25]]], ["(2) , (3), (4) and (5), used to generate the final phrases of our generator, reflect the psychological traits and emotions of the characters in the corresponding works.", [["the psychological traits", "PROBLEM", 85, 109]]], ["In the case of The Cask of Amontillado, the perceived emotions seem not to resemble the author's main moods.", [["Amontillado", "TREATMENT", 27, 38]]], ["This may be due to the fact that, in this short story, the dialogues of the main character are happy and carefree, the tragic murder occurring only in the end.", [["may be due to", "UNCERTAINTY", 5, 18], ["main", "OBSERVATION_MODIFIER", 76, 80]]], ["When characters in a literary text have different psychological traits, the semantic analysis of the generated phrases may show heterogeneous emotional characteristics.", [["different psychological traits", "PROBLEM", 40, 70], ["the semantic analysis", "TEST", 72, 93], ["heterogeneous emotional characteristics", "PROBLEM", 128, 167], ["heterogeneous", "OBSERVATION_MODIFIER", 128, 141]]], ["Experiments with characters showing more homogeneous psychological traits, such as the melancholic, suicidal tendencies of Werther in The Sorrows of Young Werther, more easily detect emotions (as sadness and love) associated with a dominant psychological trend portrayed by the author.Conclusions and Future WorkAlthough there was a poor evaluation for the Coherence criterion, it is possible to argue that coherence is not a dominant feature of literature in general, and most of the generated sentences were perceived as literary.", [["melancholic", "DISEASE", 87, 98], ["the melancholic, suicidal tendencies", "PROBLEM", 83, 119]]]]}